<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Pharmacological and mechanical interventions for labour induction in outpatient settings - Vogel, JP - 2017 | Cochrane Library</title> <meta content="Pharmacological and mechanical interventions for labour induction in outpatient settings - Vogel, JP - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007701.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Pharmacological and mechanical interventions for labour induction in outpatient settings - Vogel, JP - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007701.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007701.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Pharmacological and mechanical interventions for labour induction in outpatient settings" name="citation_title"/> <meta content="Joshua P Vogel" name="citation_author"/> <meta content="World Health Organization" name="citation_author_institution"/> <meta content="Alfred O Osoti" name="citation_author"/> <meta content="University of Nairobi" name="citation_author_institution"/> <meta content="Anthony J Kelly" name="citation_author"/> <meta content="Brighton and Sussex University Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Stefania Livio" name="citation_author"/> <meta content="University of Milan, Children's Hospital &quot;V. Buzzi&quot;" name="citation_author_institution"/> <meta content="Jane E Norman" name="citation_author"/> <meta content="University of Edinburgh Queen's Medical Research Centre" name="citation_author_institution"/> <meta content="Zarko Alfirevic" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="zarko@liverpool.ac.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD007701.pub3" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/09/13" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007701.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007701.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007701.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Ambulatory Care; Acupuncture Therapy [methods]; Cesarean Section [statistics &amp; numerical data]; Dinoprostone [administration &amp; dosage]; Feasibility Studies; Intensive Care, Neonatal [statistics &amp; numerical data]; Labor, Induced [*methods]; Misoprostol [administration &amp; dosage]; Oxytocics; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007701.pub3&amp;doi=10.1002/14651858.CD007701.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="6nHUP32m";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007701\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007701\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","th","ms","ja","fr","zh_HANS","fa","zh_HANT"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007701.pub3",title:"Pharmacological and mechanical interventions for labour induction in outpatient settings",firstPublishedDate:"Sep 13, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6nHUP32m&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007701.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007701.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007701.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007701.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007701.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007701.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007701.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007701.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007701.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007701.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6269 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007701.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-sec-0196"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-sec-0050"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-sec-0051"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-sec-0092"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-sec-0187"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/table_n/CD007701StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/table_n/CD007701StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Pharmacological and mechanical interventions for labour induction in outpatient settings</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/information#CD007701-cr-0002">Joshua P Vogel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/information#CD007701-cr-0003">Alfred O Osoti</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/information#CD007701-cr-0004">Anthony J Kelly</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/information#CD007701-cr-0005">Stefania Livio</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/information#CD007701-cr-0006">Jane E Norman</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007701.pub3/information#CD007701-cr-0007"><i class="icon corresponding-author fa fa-envelope"></i>Zarko Alfirevic</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/information/en#CD007701-sec-0203">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 13 September 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007701.pub3">https://doi.org/10.1002/14651858.CD007701.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007701-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007701-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007701-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007701-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007701-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD007701-abs-0002">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007701-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007701-abs-0001" lang="en"> <section id="CD007701-sec-0001"> <h3 class="title" id="CD007701-sec-0001">Background</h3> <p>Induction of labour is carried out for a variety of indications and using a range of methods. For women at low risk of pregnancy complications, some methods of induction of labour or cervical ripening may be suitable for use in outpatient settings. </p> </section> <section id="CD007701-sec-0002"> <h3 class="title" id="CD007701-sec-0002">Objectives</h3> <p>To examine pharmacological and mechanical interventions to induce labour or ripen the cervix in outpatient settings in terms of effectiveness, maternal satisfaction, healthcare costs and, where information is available, safety. </p> </section> <section id="CD007701-sec-0003"> <h3 class="title" id="CD007701-sec-0003">Search methods</h3> <p>We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (30 November 2016) and reference lists of retrieved studies. </p> </section> <section id="CD007701-sec-0004"> <h3 class="title" id="CD007701-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials examining outpatient cervical ripening or induction of labour with pharmacological agents or mechanical methods. Cluster trials were eligible for inclusion. </p> </section> <section id="CD007701-sec-0005"> <h3 class="title" id="CD007701-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. We assessed evidence using the GRADE approach. </p> </section> <section id="CD007701-sec-0006"> <h3 class="title" id="CD007701-sec-0006">Main results</h3> <p>This updated review included 34 studies of 11 different methods for labour induction with 5003 randomised women, where women received treatment at home or were sent home after initial treatment and monitoring in hospital. </p> <p>Studies examined vaginal and intracervical prostaglandin E₂ (PGE₂), vaginal and oral misoprostol, isosorbide mononitrate, mifepristone, oestrogens, amniotomy and acupuncture, compared with placebo, no treatment, or routine care. Trials generally recruited healthy women with a term pregnancy. The risk of bias was mostly low or unclear, however, in 16 trials blinding was unclear or not attempted. In general, limited data were available on the review's main and additional outcomes. Evidence was graded low to moderate quality. </p> <p><b>1. Vaginal PGE₂ versus expectant management or placebo (5 studies)</b> </p> <p>Fewer women in the vaginal PGE₂ group needed additional induction agents to induce labour, however, confidence intervals were wide (risk ratio (RR) 0.52, 95% confidence interval (CI) 0.27 to 0.99; 150 women; 2 trials). There were no clear differences between groups in uterine hyperstimulation (with or without fetal heart rate (FHR) changes) (RR 3.76, 95% CI 0.64 to 22.24; 244 women; 4 studies; <i>low‐quality evidence</i> ), caesarean section (RR 0.80, 95% CI 0.49 to 1.31; 288 women; 4 studies; <i>low‐quality evidence</i> ), or admission to a neonatal intensive care unit (NICU) (RR 0.32, 95% CI 0.10 to 1.03; 230 infants; 3 studies; <i>low‐quality evidence</i>). </p> <p>There was no information on vaginal birth within 24, 48 or 72 hours, length of hospital stay, use of emergency services or maternal or caregiver satisfaction. Serious maternal and neonatal morbidity or deaths were not reported. </p> <p><b>2. Intracervical PGE₂ versus expectant management or placebo (7 studies)</b> </p> <p>There was no clear difference between women receiving intracervical PGE₂ and no treatment or placebo in terms of need for additional induction agents (RR 0.98, 95% CI 0.74 to 1.32; 445 women; 3 studies), vaginal birth not achieved within 48 to 72 hours (RR 0.83, 95% CI 0.68 to 1.02; 43 women; 1 study; <i>low‐quality evidence</i> ), uterine hyperstimulation (with FHR changes) (RR 2.66, 95% CI 0.63 to 11.25; 488 women; 4 studies; <i>low‐quality evidence</i> ), caesarean section (RR 0.90, 95% CI 0.72 to 1.12; 674 women; 7 studies; <i>moderate‐quality evidence</i> ), or babies admitted to NICU (RR 1.61, 95% CI 0.43 to 6.05; 215 infants; 3 studies; <i>low‐quality evidence</i>). There were no uterine ruptures in either the PGE₂ group or placebo group. </p> <p>There was no information on vaginal birth not achieved within 24 hours, length of hospital stay, use of emergency services, mother or caregiver satisfaction, or serious morbidity or neonatal morbidity or perinatal death. </p> <p><b>3. Vaginal misoprostol versus placebo (4 studies)</b> </p> <p>One small study reported on the rate of perinatal death with no clear differences between groups; there were no deaths in the treatment group compared with one stillbirth (reason not reported) in the control group (RR 0.34, 95% CI 0.01 to 8.14; 77 infants; 1 study; <i>low‐quality evidence</i>). </p> <p>There was no clear difference between groups in rates of uterine hyperstimulation with FHR changes (RR 1.97, 95% CI 0.43 to 9.00; 265 women; 3 studies; <i>low‐quality evidence</i> ), caesarean section (RR 0.94, 95% CI 0.61 to 1.46; 325 women; 4 studies; <i>low‐quality evidence</i> ), and babies admitted to NICU (RR 0.89, 95% CI 0.54 to 1.47; 325 infants; 4 studies; <i>low‐quality evidence</i>). </p> <p>There was no information on vaginal birth not achieved within 24, 48 or 72 hours, additional induction agents required, length of hospital stay, use of emergency services, mother or caregiver satisfaction, serious maternal, and other neonatal, morbidity or death. </p> <p>No substantive differences were found for other comparisons. One small study found that women who received oral misoprostol were more likely to give birth within 24 hours (RR 0.65, 95% CI 0.48 to 0.86; 87 women; 1 study) and were less likely to require additional induction agents (RR 0.60, 95% CI 0.37 to 0.97; 127 women; 2 studies). Women who received mifepristone were also less likely to require additional induction agents (average RR 0.59, 95% CI 0.37 to 0.95; 311 women; 4 studies; I² = 74%); however, this result should be interpreted with caution due to high heterogeneity. One trial each of acupuncture and outpatient amniotomy were included, but few review outcomes were reported. </p> </section> <section id="CD007701-sec-0007"> <h3 class="title" id="CD007701-sec-0007">Authors' conclusions</h3> <p>Induction of labour in outpatient settings appears feasible and important adverse events seem rare, however, in general there is insufficient evidence to detect differences. There was no strong evidence that agents used to induce labour in outpatient settings had an impact (positive or negative) on maternal or neonatal health. There was some evidence that compared to placebo or no treatment, induction agents administered on an outpatient basis reduced the need for further interventions to induce labour, and shortened the interval from intervention to birth. </p> <p>We do not have sufficient evidence to know which induction methods are preferred by women, the interventions that are most effective and safe to use in outpatient settings, or their cost effectiveness. Further studies where various women‐friendly outpatient protocols are compared head‐to‐head are required. As part of such work, women should be consulted on what sort of management they would prefer. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007701-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007701-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD007701-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD007701-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007701-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007701-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD007701-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007701-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD007701-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD007701-abs-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007701-abs-0012">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD007701-abs-0017">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007701-abs-0004" lang="en"> <h3>Medications and mechanical interventions for induction of labour in outpatient settings</h3> <p><b>What is the issue?</b> </p> <p>Induction of labour (starting labour artificially) is often needed for medical reasons, such as when women have passed their due dates. Different induction methods can be used, such as medications (like prostaglandin E₂, misoprostol or isosorbide mononitrate) or breaking membranes. Inductions are usually carried out in hospital; some methods may be suitable for use with women treated as outpatients, and allowed to go home to wait for labour to progress. We examined the feasibility, effectiveness and safety of outpatient induction, as well as women’s satisfaction and healthcare costs. </p> <p><b>Why is this important?</b> </p> <p>Pregnant women who have reached their due date can be assessed in hospital as outpatients, given the induction treatment followed by monitoring for a short time, and then sent home. Alternatively, they are given the drug or treatment to take at home. Women may be more comfortable waiting for labour to start at home, and outpatient care may be less costly for health services. </p> <p><b>What evidence did we find?</b> </p> <p>This is an updated review that includes six new studies. We included 34 randomised controlled trials involving 5003 pregnant women (search date: November 2016). The women were healthy and at low risk of complications. They were given induction, a fake treatment (placebo) or no treatment. Limited information was available on the outcomes that were of interest, and risk of bias was generally low or unclear. The quality of evidence was judged to be low‐quality, with a few moderate‐quality findings. </p> <p>Women at term who were induced as outpatients may be less likely to need further induction, compared to women given placebo or no treatment. Medications like vaginal PGE₂, mifepristone and oral misoprostol appear to be effective. No clear differences were reported for excessive activity of the uterus (hyperstimulation), caesarean section or need for neonatal intensive care. </p> <p>There were too few women in these trials to determine differences in rare events, such as infant deaths or serious illnesses of mothers or babies. The trials did not report on use of emergency services to return to hospital. Some medications caused side effects (such as headaches). Overall, there was little information on costs of different methods. </p> <p><b>What does this mean?</b> </p> <p>For healthy, low‐risk pregnant women at term, outpatient induction and enabling women to return home to wait for labour to start appears to be feasible. Outpatient induction treatments may reduce both need for further drugs and time from treatment to birth. It does not appear to increase the likelihood of needing other interventions in labour. However, there is insufficient evidence to say definitively whether outpatient induction is safe. Future research should focus on which methods women prefer, and are most effective and safe. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007701-sec-0196" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007701-sec-0196"></div> <h3 class="title" id="CD007701-sec-0197">Implications for practice</h3> <section id="CD007701-sec-0197"> <p>Induction of labour in outpatient settings appears feasible. We do not have sufficient evidence to determine which methods are most safe or effective in outpatient settings. </p> </section> <h3 class="title" id="CD007701-sec-0198">Implications for research</h3> <section id="CD007701-sec-0198"> <p>There have been very few direct comparisons between different methods of labour induction in outpatient settings. Although it is likely that impact on cervix and uterine contractility will be similar in both inpatient and outpatient settings, it would be unwise to extrapolate the clinical outcomes from inpatient to outpatient settings. For this reason, it would be important to carry out further studies where various women‐friendly outpatient protocols are compared head‐to‐head. As part of such work it is important to ask women what sort of management they would prefer. There needs to be more careful consideration of outcomes purporting to measure progress in labour and more consistency in what is measured in trials. Little is known regarding women's preferences, and what combinations of treatment and setting would be most preferred. </p> <p>It would be particularly helpful to carry out formal cost‐effectiveness analysis which includes the use of emergency services. Data on the utilisation of out of hours community health services and emergency ambulance services might enable those providing health services to decide the best types of induction agents to use, to set out criteria for selecting women for outpatient induction, and would enable women to make more informed choices about their care. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007701-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007701-sec-0043"></div> <div class="table" id="CD007701-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vaginal PGE₂ compared to placebo or expectant management for the induction of labour in outpatient settings</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal PGE₂ compared to placebo or expectant management for the induction of labour in outpatient settings</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women requiring term labour induction<br/> <b>Setting:</b> outpatient clinics and hospitals in the USA<br/> <b>Intervention:</b> vaginal PGE₂<br/> <b>Comparison:</b> placebo or expectant management </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo or expectant management</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intravaginal PGE₂ gel</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal birth not achieved within 24 h</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Vaginal birth not achieved in 48 to 72 h</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>see comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Uterine hyperstimulation (fetal heart rate changes unclear)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.76<br/> (0.64 to 22.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>244<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were no events in the control group and so it was not possible to calculate the anticipated absolute effects. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.80<br/> (0.49 to 1.31) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>288<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>196 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>157 per 1000<br/> (96 to 257) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious neonatal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious maternal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Neonatal intensive care unit admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.32<br/> (0.10 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>230<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>93 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>30 per 1000<br/> (9 to 96) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Wide confidence interval crossing the line of no effect, few events and small sample size (‐2). </p> <p><sup>2</sup> Wide confidence interval crossing the line of no effect and small sample size (‐2). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007701-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intracervical PGE₂ compared to placebo for the induction of labour in outpatient settings</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intracervical PGE₂ compared to placebo for the induction of labour in outpatient settings</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women requiring induction of labour<br/> <b>Setting:</b> outpatient clinics and hospitals in the USA<br/> <b>Intervention:</b> intracervical PGE₂<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intracervical PGE₂</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal birth not achieved within 24 h</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal birth not achieved in 48 to 72 h</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.83<br/> (0.68 to 1.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>43<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>830 per 1000<br/> (680 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Uterine hyperstimulation (with fetal heart rate changes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.66<br/> (0.63 to 11.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>488<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000<br/> (3 to 45) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.90<br/> (0.72 to 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>674<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>310 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>279 per 1000<br/> (223 to 347) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious neonatal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious maternal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Neonatal intensive care unit admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.61<br/> (0.43 to 6.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>215<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>44 per 1000<br/> (12 to 167) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Wide confidence interval crossing the line of no effect, few events and small sample size (‐2). </p> <p><sup>2</sup> Wide confidence interval crossing the line of no effect (‐1). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007701-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Vaginal misoprostol compared to placebo for the induction of labour in outpatient settings</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal misoprostol compared to placebo for the induction of labour in outpatient settings</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women requiring induction of labour<br/> <b>Setting:</b> outpatient clinics and hospitals in the USA and Nigeria<br/> <b>Intervention:</b> Vaginal misoprostol<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with vaginal misoprostol</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal birth not achieved within 24 h</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal birth not achieved within 48 and 72 h</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Uterine hyperstimulation (with fetal heart rate changes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.97<br/> (0.43 to 9.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>265<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000<br/> (6 to 131) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.94<br/> (0.61 to 1.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>325<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>206 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>194 per 1000<br/> (126 to 301) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious neonatal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.34<br/> (0.01 to 8.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Study reported perinatal deaths.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>26 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/> (0 to 209) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious maternal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Neonatal intensive care unit admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.89<br/> (0.54 to 1.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>325<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>147 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>131 per 1000<br/> (79 to 216) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Wide confidence interval crossing the line of no effect, few events and small sample size (‐2). </p> <p><sup>2</sup> Wide confidence interval crossing the line of no effect and small sample size (‐2). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007701-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007701-sec-0044"></div> <section id="CD007701-sec-0045"> <h3 class="title" id="CD007701-sec-0045">Introduction</h3> <p>This Cochrane Review was first published in 2010 and updated in 2017. The review complements existing reviews on labour induction examining effectiveness and safety. </p> </section> <section id="CD007701-sec-0046"> <h3 class="title" id="CD007701-sec-0046">Description of the condition</h3> <p>The number of women whose labours are induced has risen over the past two decades. Rates in the USA and the UK now exceed 20% of all births (<a href="./references#CD007701-bbs2-0070" title="GlantzJC . Labor induction rate variation in upstate New York: what is the difference?. Birth2003;30(3):168‐74. ">Glantz 2003</a>; <a href="./references#CD007701-bbs2-0079" title="KirbyRS . Trends in labor induction in the United States: is it true that what goes up must come down?. Birth2004;31(2):148‐51. ">Kirby 2004</a>; <a href="./references#CD007701-bbs2-0082" title="Hospital Episode Statistics Analysis, Health and Social Care Information Centre. Hospital Episode Statistics ‐ NHS Maternity Statistics – England, 2014‐15. http://content.digital.nhs.uk/catalogue/PUB19127/nhs‐mate‐eng‐2014‐15‐summ‐repo‐rep.pdf. London: National Statistics, The Information Centre, 25 November 2015. ">NHS 2014‐15</a>). There is considerable variation in reported induction rates, and the reasons for this variability are often not clear. In some units in the USA, up to half of all births follow induction of labour (<a href="./references#CD007701-bbs2-0085" title="RayburnWF , ZhangJ . Rising rates of labor induction: present concerns and future strategies. Obstetrics and Gynecology2002;100(1):164‐7. ">Rayburn 2002</a>). Fewer data are available on induction rates in facilities in low‐ and middle‐income countries; however, the World Health Organization (WHO) Global Survey of Maternal and Perinatal Health of facility obstetric practices in 22 countries reported induction rates of 11.4% in eight Latin American countries, 4.4% in seven African countries, and 12.1% in nine Asian countries (<a href="./references#CD007701-bbs2-0071" title="GuerraG , CecattiJ , SouzaJ , FaundesA , MoraisSS , GulmezogluAM , et al. Factors and outcomes associated with the induction of labour in Latin America. BJOG: an international journal of obstetrics and gynaecology2009;116(113):1762‐72. ">Guerra 2009</a>; <a href="./references#CD007701-bbs2-0093" title="VogelJ , SouzaJP , GülmezogluAM . Patterns and outcomes of induction of labour in Africa and Asia: a secondary analysis of the WHO Global Survey on Maternal and Neonatal Health. PLoS One2013;8(6):e65612. ">Vogel 2013</a>). </p> <p>It has not been definitively shown that increased use of induction has been associated with improvements in maternal, fetal or neonatal outcomes; women who are induced also tend to be less satisfied with their experience of childbirth (<a href="./references#CD007701-bbs2-0089" title="ShettyA , BurtR , RiceP , TempletonA . Women's perceptions, expectations and satisfaction with induced labour ‐ a questionnaire‐based study. European Journal of Obstetrics, Gynecology, and Reproductive Biology2005;123(1):56‐61. ">Shetty 2005</a>). In this context, and with increasing pressure on healthcare resources, it is particularly important to address questions about how to provide induction of labour safely and effectively, in settings and ways that are acceptable to women, and in the most cost‐effective way possible. </p> </section> <section id="CD007701-sec-0047"> <h3 class="title" id="CD007701-sec-0047">Description of the intervention</h3> <p>A number of pharmacological and mechanical methods of cervical ripening and induction of labour are available, and these have been the focus of a series of Cochrane Reviews that share generic protocols (<a href="./references#CD007701-bbs2-0075" title="HofmeyrGJ , AlfirevicZ , KellyAJ , KavanaghJ , ThomasJ , NeilsonJP , et al. Methods for cervical ripening and labour induction in late pregnancy: generic protocol. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD002074] ">Hofmeyr 2009</a>). On the basis of these Cochrane Reviews, WHO currently recommends oral misoprostol (25 μg, 2 hourly) and vaginal low‐dose misoprostol (25 μg, 6 hourly) for induction of labour (misoprostol is not recommended for women with a previous caesarean section) (<a href="./references#CD007701-bbs2-0094" title="World Health Organization. WHO recommendations for Induction of labour. apps.who.int/iris/bitstream/10665/44531/1/9789241501156_eng.pdf. Geneva: World Health Organization, (accessed prior to 7 August 2017). ">WHO 2011</a>). If prostaglandins are not available, WHO recommends intravenous oxytocin alone for induction. Balloon catheter is recommended for induction, but amniotomy alone is not. The combination of balloon catheter plus oxytocin is recommended as an alternative method of induction of labour when prostaglandins (including misoprostol) are not available or are contra‐indicated. Importantly, the WHO recommendations stipulate the need to assess maternal and fetal well‐being during induction. </p> <p>In these reviews, the safety and effectiveness of different methods and agents have been examined, but less attention was paid to the setting in which cervical ripening and induction of labour take place. In this review, we brought together some of the studies included in previous reviews, focusing specifically on those studies where labour induction or cervical ripening was carried out in outpatient settings. For most methods of induction, the number of trials carried out in outpatient settings is likely to be small, making it difficult to definitively establish benefits and harms. The purpose of this review was to examine issues such as benefits and harms, health service utilisation, feasibility and women's views about their care. For some interventions, there may be sufficient data to address questions of effectiveness and safety. In this way, this review complements others in the suite rather than simply duplicating findings. </p> <p>A related review included trials in which the same methods of ripening or induction were compared in outpatient and hospital settings (<a href="./references#CD007701-bbs2-0078" title="KellyAJ , AlfirevicZ , GhoshA . Outpatient versus inpatient induction of labour for improving birth outcomes. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD007372.pub3] ">Kelly 2013</a>). </p> <p>Induction of labour is carried out for a variety of indications and using a range of pharmacological, mechanical and other methods. The main indication for induction of labour is prolonged pregnancy, and there is evidence from a related Cochrane Review (<a href="./references#CD007701-bbs2-0072" title="GülmezogluAM , CrowtherCA , MiddletonP , HeatleyE . Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database of Systematic Reviews2012, Issue 6. [DOI: 10.1002/14651858.CD004945.pub3] ">Gülmezoglu 2012</a>) that for pregnancies which have continued beyond 41 weeks, induction of labour may reduce perinatal mortality. Other inductions are carried out on an individual basis. Most inductions of labour are carried out in inpatient settings. Outpatient procedures may not be safe for women with some risk factors, and some methods may only be feasible and safe in hospital, or in settings with specialised staff and facilities available. For example, outpatient induction is unlikely to be suitable for women with serious medical conditions or complications in the current pregnancy (<a href="./references#CD007701-bbs2-0088" title="SawaiSK , O'BrienWF . Outpatient cervical ripening. Clinical Obstetrics and Gynecology1995;38(2):301‐9. ">Sawai 1995</a>). Some women may be unsuitable for home care simply because they live at an unacceptable travelling distance from emergency care facilities. </p> </section> <section id="CD007701-sec-0048"> <h3 class="title" id="CD007701-sec-0048">How the intervention might work</h3> <p>Ideally, the agents or methods used for cervical ripening at home would achieve changes in the cervix similar to the normal physiological changes which promote the 'spontaneous' onset of labour, but without causing uterine contractions (<a href="./references#CD007701-bbs2-0088" title="SawaiSK , O'BrienWF . Outpatient cervical ripening. Clinical Obstetrics and Gynecology1995;38(2):301‐9. ">Sawai 1995</a>). Most methods for cervical ripening or induction of labour do have some undesirable side effects, including, on occasions, excessive uterine activity. The consequences of excessive uterine activity as a result of iatrogenic uterine hyperstimulation can be life‐threatening for the mother and fetus. </p> <p>Sometimes drugs to induce labour can only be administered by intravenous infusion or by repeated injections, or using specialist procedures that cannot easily be carried out in an outpatient setting. Drugs that can be taken orally, or procedures that are simple to perform, and require only limited monitoring, may lend themselves more readily for use in an outpatient setting. At least theoretically, outpatient induction may offer a number of advantages to women, clinical staff and providers of health services. Outpatient induction may be more convenient for and preferred by women; it may reduce hospital bed occupancy, and therefore, be associated with lower healthcare costs. </p> <p>A number of papers have set out indications for outpatient cervical ripening or induction such as post‐dates pregnancy in women who are otherwise well, and where there have been no signs of fetal distress. Several outpatient induction protocols have been described in observational studies suggesting that such inductions are feasible, safe and acceptable to women (<a href="./references#CD007701-bbs2-0068" title="ElliottJP , ClewellWH , RadinTG . Intracervical prostaglandin E2 gel. Safety for outpatient cervical ripening before induction of labor. Journal of Reproductive Medicine1992;37(8):713‐6. ">Elliott 1992</a>; <a href="./references#CD007701-bbs2-0080" title="McGillJ , ShettyA . Mifepristone and misoprostol in the induction of labor at term. International Journal of Gynaecology and Obstetrics2007;96(2):80‐4. ">McGill 2007</a>; <a href="./references#CD007701-bbs2-0081" title="NealeE , PachulskiA , WhiterodS , McGuinnessE , GallagherN , WallaceR . Outpatient cervical ripening prior to induction of labour. Journal of Obstetrics and Gynaecology2002;22(6):634‐5. ">Neale 2002</a>). </p> </section> <section id="CD007701-sec-0049"> <h3 class="title" id="CD007701-sec-0049">Why it is important to do this review</h3> <p>For some methods, and for selected groups of women, induction of labour is already being carried out in outpatient settings. This Cochrane Review brings together evidence from available trials in outpatient settings to assess benefits and harms of outpatient induction, as well as preferences of women and providers, and the feasibility of their use in outpatient settings. To achieve this, we pooled data from trials examining the same methods to address questions of safety. </p> <p>In the context of this review, the issue of safety is of great importance. At the same time, it is unlikely that safety could be adequately addressed in studies of randomised cohorts. Severe maternal and neonatal mortality and morbidity are likely to be very rare events in the low‐risk population included in studies of outpatient induction. Information on adverse events and the relative safety of outpatient methods is most likely to emerge where there have been several large studies and where the same methods have been directly compared in different settings. Information on rare adverse events takes time to accumulate, but by systematically recording information on adverse events in all the studies included in the review, we may shed some light on this question. </p> <p>We did not include studies where the same method of cervical ripening or induction of labour was compared in outpatient versus inpatient settings: this has been addressed in a related Cochrane Review (<a href="./references#CD007701-bbs2-0078" title="KellyAJ , AlfirevicZ , GhoshA . Outpatient versus inpatient induction of labour for improving birth outcomes. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD007372.pub3] ">Kelly 2013</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007701-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007701-sec-0050"></div> <p>To examine pharmacological and mechanical interventions to induce labour or ripen the cervix in outpatient settings in terms of effectiveness, maternal satisfaction, healthcare costs and, where information is available, safety. </p> <p>This Cochrane Review complements existing Cochrane Reviews on labour induction examining effectiveness and safety. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007701-sec-0051" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007701-sec-0051"></div> <section id="CD007701-sec-0052"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007701-sec-0053"> <h4 class="title">Types of studies</h4> <p>All published and unpublished randomised trials which compared different methods of cervical ripening or induction of labour carried out in outpatient settings were eligible for inclusion. All trials included random allocation to intervention and control groups. We did not include quasi‐randomised trials. We included studies reported in abstracts and brief reports provided that sufficient information was available to allow us to assess eligibility and risk of bias; where such information was not provided we attempted to contact trial authors. We planned to include cluster‐randomised trials if they were otherwise eligible. We did not include cross‐over studies because we did not consider they were appropriate in this topic area. </p> </section> <section id="CD007701-sec-0054"> <h4 class="title">Types of participants</h4> <p>Pregnant women (with a viable fetus) at or near team (greater than 35 weeks) in an outpatient setting. Specifically, women in whom induction of labour is being considered, but where expectant management is acceptable. </p> </section> <section id="CD007701-sec-0055"> <h4 class="title">Types of interventions</h4> <p>We included studies examining outpatient cervical ripening or induction of labour with pharmacological agents or mechanical methods. We included studies where different methods of induction of labour in outpatient settings were compared; where a method was compared with a placebo; where a method was compared with expectant management or routine care; or where different doses of the same drug were compared. 'Outpatient' was defined by the trialists and included any cervical ripening or induction of labour intervention (with the exception of membrane sweeping) that can be carried out at home or within community healthcare settings. It also includes a package of care initially provided in hospital (fetal monitoring, drug administration) after which the woman is allowed home until later review or admission in labour. We did not include interventions where women remain in hospital throughout (even if they were in 'day‐care' settings, or in other parts of the hospital, but not formally admitted as inpatients) because a purpose of this review was to examine outcomes where women do not have immediate access to emergency care facilities. Trials comparing inpatient versus outpatient induction of labour were considered in <a href="./references#CD007701-bbs2-0078" title="KellyAJ , AlfirevicZ , GhoshA . Outpatient versus inpatient induction of labour for improving birth outcomes. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD007372.pub3] ">Kelly 2013</a>. </p> </section> <section id="CD007701-sec-0056"> <h4 class="title">Types of outcome measures</h4> <p>Clinically relevant outcomes for trials of methods of cervical ripening and labour induction have been pre‐specified by two authors of labour induction reviews (Justus Hofmeyr and Zarko Alfirevic) (<a href="./references#CD007701-bbs2-0075" title="HofmeyrGJ , AlfirevicZ , KellyAJ , KavanaghJ , ThomasJ , NeilsonJP , et al. Methods for cervical ripening and labour induction in late pregnancy: generic protocol. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD002074] ">Hofmeyr 2009</a>). We have used most of these outcomes (relevant to both inpatient and outpatient settings) in this review. </p> <p>In addition, we attempted to use relevant outcome measures to quantify any cost effectiveness benefits of outpatient ripening. </p> <section id="CD007701-sec-0057"> <h5 class="title">Main outcomes</h5> <p> <ol id="CD007701-list-0001"> <li> <p>Vaginal birth not achieved within 24 hours.</p> </li> <li> <p>Additional induction agents required.</p> </li> <li> <p>Length of hospital stay.</p> </li> <li> <p>Use of emergency services.</p> </li> <li> <p>Maternal satisfaction</p> </li> <li> <p>Caregiver satisfaction</p> </li> <li> <p>Serious neonatal morbidity or perinatal death (composite outcome will include, for example, seizures, birth asphyxia defined by trialists, neonatal encephalopathy, disability in childhood). </p> </li> <li> <p>Serious maternal morbidity or death (composite outcome will include, for example, uterine rupture, admission to intensive care unit, septicaemia). </p> </li> </ol> </p> </section> <section id="CD007701-sec-0058"> <h5 class="title">Additional outcomes of interest</h5> <p>Additional outcomes of interest related to measures of effectiveness, complications and satisfaction </p> <section id="CD007701-sec-0059"> <h6 class="title">Measures of effectiveness</h6> <p> <ol id="CD007701-list-0002"> <li> <p>Vaginal birth not achieved within 48 and 72 hours.</p> </li> <li> <p>Randomisation to birth interval.</p> </li> <li> <p>Oxytocin augmentation.</p> </li> <li> <p>Pain relief requirements (epidural, opioids).</p> </li> </ol> </p> </section> <section id="CD007701-sec-0060"> <h6 class="title">Complications</h6> <p> <ol id="CD007701-list-0003"> <li> <p>Uterine hyperstimulation (with fetal heart rate (FHR) changes).</p> </li> <li> <p>Uterine hyperstimulation (without FHR changes).</p> </li> <li> <p>Instrumental vaginal birth.</p> </li> <li> <p>Caesarean section.</p> </li> <li> <p>Apgar score &lt; 7 at 5 minutes.</p> </li> <li> <p>Neonatal intensive care unit admission.</p> </li> <li> <p>Perinatal death.</p> </li> <li> <p>Postpartum haemorrhage (as defined by the trial authors).</p> </li> <li> <p>Serious maternal complications (considered as separate outcomes, e.g. intensive care unit admission, septicaemia, uterine rupture). </p> </li> <li> <p>Serious neonatal complications (considered as separate outcomes).</p> </li> </ol> </p> <p>In the absence of formal economic evaluation, we had planned to estimate potential cost savings and the impact of interventions used within an outpatient setting. These estimates could involve using some measures of effectiveness and complications in combination with estimates of healthcare provision. </p> <p>We also included some additional outcomes that may serve as proxy measures of progress towards labour or birth. </p> <p> <ul id="CD007701-list-0004"> <li> <p>Indicators of progress in labour such as: preterm rupture of membranes, diagnosis of active/spontaneous labour, self‐referral back to hospital, Bishop scores at fixed time points post‐randomisation. </p> </li> <li> <p>Failed induction (as defined by trialists, but excluding the use of oxytocin for augmentation in women already in established labour). </p> </li> <li> <p>Time to birth including the interval from randomisation to birth; interval to admission along with length of labour. </p> </li> <li> <p>Side effects or adverse outcomes (not specified above) related or possibly related to the intervention. </p> </li> </ul> </p> </section> <section id="CD007701-sec-0061"> <h6 class="title"> Detailed definitions for outcomes</h6> <p> <ul id="CD007701-list-0005"> <li> <p>Perinatal and maternal morbidity and mortality are composite outcomes. This is not an ideal solution because some components are clearly less severe than others. It is possible for one intervention to cause more deaths but less severe morbidity. However, in the context of labour induction at term, this is unlikely. All these events are rare, and a modest change in their incidence will be easier to detect if composite outcomes are presented. The incidence of individual components are explored as additional outcomes (see above). </p> </li> <li> <p>'Uterine rupture' includes all clinically significant ruptures of unscarred or scarred uteri. Trivial scar dehiscence noted incidentally at the time of surgery is excluded. </p> </li> <li> <p>The terminology of uterine hyperstimulation is problematic (<a href="./references#CD007701-bbs2-0066" title="CurtisP , EvansS , ResnickJ . Uterine hyperstimulation. The need for standard terminology. Journal of Reproductive Medicine1987;32(2):91‐5. ">Curtis 1987</a>). In the reviews, the term 'uterine hyperstimulation' is defined as uterine tachysystole (more than 5 contractions per 10 minutes for at least 20 minutes) and uterine hypersystole/hypertonus (a contraction lasting at least 2 minutes). </p> </li> <li> <p>'Uterine hyperstimulation with FHR changes' is usually defined as uterine hyperstimulation syndrome (tachysystole or hypersystole with FHR changes such as persistent decelerations, tachycardia or decreased short‐term variability). However, due to varied reporting, there is the possibility of subjective bias in the interpretation of these outcomes. Also, it is not always clear from trials if these outcomes are reported in a mutually exclusive manner. More importantly, continuous monitoring is unlikely in an outpatient setting. Therefore, there is a high risk of biased reporting of uterine hyperstimulation (with or without FHR changes). It is possible that bias will favour the outpatient setting (i.e. by failure to recognise mild forms of hyperstimulation without continuous monitoring). On the other hand, clinicians who favour inpatient induction may, in the absence of continuous monitoring, label any maternal description of painful, frequent uterine contractions as hyperstimulation. Therefore, in the absence of blinding, hyperstimulation and other 'soft' outcomes should be interpreted with extreme caution. </p> </li> </ul> </p> <p>While we sought data on all of the outcomes listed above, we documented only those with data in the analysis tables. We included outcomes in the analysis if reasonable measures were taken to minimise observer bias, and data were available according to original treatment allocation. </p> </section> </section> </section> </section> <section id="CD007701-sec-0062"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD007701-sec-0063"> <h4 class="title">Electronic searches</h4> <p>We searched Cochrane Pregnancy and Childbirth’s Trials Register by contacting their Information Specialist (30 November 2016). </p> <p>The Register is a database containing over 23,000 reports of controlled trials in the field of pregnancy and childbirth. For full search methods used to populate Pregnancy and Childbirth’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth</a> in the Cochrane Library and select the ‘<b><i>Specialized Register</i> </b> ’ section from the options on the left side of the screen. </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ol id="CD007701-list-0006"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set which has been fully accounted for in the relevant review sections (<a href="./references#CD007701-bbs1-0001" title="">Included studies</a>; <a href="./references#CD007701-bbs1-0002" title="">Excluded studies</a>; <a href="./references#CD007701-bbs1-0003" title="">Studies awaiting classification</a>). </p> </section> <section id="CD007701-sec-0064"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of retrieved studies.</p> <p>We did not apply any language or date restrictions.</p> </section> </section> <section id="CD007701-sec-0065"> <h3 class="title" id="CD007701-sec-0065">Data collection and analysis</h3> <p>For methods used in the previous version of this review, see <a href="./references#CD007701-bbs2-0095" title="DowswellT , KellyAJ , LivioS , NormanJE , AlfirevicZ . Different methods for the induction of labour in outpatient settings. Cochrane Database of Systematic Reviews2010, Issue 8. [DOI: 10.1002/14651858.CD007701.pub2] ">Dowswell 2010</a>. </p> <p>For this update, the following methods were used to assess the 10 reports that were identified as a result of the updated search. </p> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD007701-sec-0066"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed all the potential studies identified as a result of the search strategy for inclusion. We resolved any disagreement through discussion or, if required, we consulted a third review author. </p> </section> <section id="CD007701-sec-0067"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted the third review author. Data were entered into Review Manager software (<a href="./references#CD007701-bbs2-0086" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and checked for accuracy. </p> <p>When information regarding any of the above was unclear, we planned to contact authors of the original reports to provide further details. </p> </section> <section id="CD007701-sec-0068"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007701-bbs2-0074" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Any disagreement was resolved by discussion or by involving a third assessor. </p> <section id="CD007701-sec-0069"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD007701-list-0007"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007701-sec-0070"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD007701-list-0008"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007701-sec-0071"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD007701-list-0009"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD007701-sec-0072"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD007701-list-0010"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007701-sec-0073"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re‐include missing data in the analyses which we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD007701-list-0011"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007701-sec-0074"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD007701-list-0012"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007701-sec-0075"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we had about other possible sources of bias. </p> </section> <section id="CD007701-sec-0076"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD007701-bbs2-0074" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we planned to assess the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings. In future updates, we will explore the impact of the level of bias through undertaking sensitivity analyses (see <a href="#CD007701-sec-0091">Sensitivity analysis</a>). </p> </section> <section id="CD007701-sec-0077"> <h5 class="title">Assessment of the quality of the evidence using the GRADE approach</h5> <p>For this update the quality of the evidence was assessed using the GRADE approach as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE handbook</a> to assess the quality of the body of evidence relating to the following outcomes for the main comparisons (vaginal PGE₂ versus placebo or expectant management; intracervical PGE₂ versus placebo or expectant management; vaginal misoprostol versus placebo or expectant management): </p> <p> <ol id="CD007701-list-0013"> <li> <p>Vaginal birth not achieved within 24 hours.</p> </li> <li> <p>Vaginal birth not achieved within 48 and 72 hours.</p> </li> <li> <p>Uterine hyperstimulation with FHR changes.</p> </li> <li> <p>Caesarean section.</p> </li> <li> <p>Serious neonatal morbidity or perinatal death (composite outcome will include, for example, seizures, birth asphyxia defined by trialists, neonatal encephalopathy, disability in childhood). </p> </li> <li> <p>Serious maternal morbidity or death (composite outcome will include, for example, uterine rupture, admission to intensive care unit, septicaemia). </p> </li> <li> <p>Neonatal intensive care unit admission.</p> </li> </ol> </p> <p><a href="http://www.guidelinedevelopment.org/" target="_blank">GRADEpro</a> Guideline Development Tool was used to import data from Review Manager 5.3 (<a href="./references#CD007701-bbs2-0086" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) to create 'Summary of findings' tables. A summary of the intervention effect and a measure of quality for each of the above outcomes was produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by 2 levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> </section> </section> <section id="CD007701-sec-0078"> <h4 class="title">Measures of treatment effect</h4> <section id="CD007701-sec-0079"> <h5 class="title">Dichotomous data</h5> <p>We presented results as summary risk ratio with 95% confidence intervals for dichotomous data. </p> </section> <section id="CD007701-sec-0080"> <h5 class="title">Continuous data</h5> <p>We used the mean difference if outcomes were measured in the same way between trials for continuous data. We used the standardised mean difference to combine trials that measured the same outcome, but used different methods. </p> </section> </section> <section id="CD007701-sec-0081"> <h4 class="title">Unit of analysis issues</h4> <section id="CD007701-sec-0082"> <h5 class="title">Cluster‐randomised trials</h5> <p>If future searches identify eligible cluster‐randomised trials, we will include these in the analyses along with individually randomised trials. We will adjust their sample sizes or standard errors using the methods described in the Handbook (Section 16.3.4 or 16.3.6 as appropriate) using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit. </p> </section> <section id="CD007701-sec-0083"> <h5 class="title">Cross‐over trials</h5> <p>We decided to exclude cross‐over trials as we did not think this design was appropriate in this topic area. </p> </section> <section id="CD007701-sec-0084"> <h5 class="title">Other unit of analysis issues</h5> <section id="CD007701-sec-0085"> <h6 class="title">Trials with multiple arms</h6> <p>Two trials had multiple intervention arms ‐ <a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a> and <a href="./references#CD007701-bbs2-0021" title="MagannE , ChauhanSP , NevilsBG , McNamaraMF , KinsellaMJ , MorrisonJC . Management of pregnancies beyond forty‐one weeks' gestation with an unfavorable cervix. American Journal of Obstetrics and Gynecology1998;178(6):1279‐87. ">Magann 1998</a>. <a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a> was a three‐arm trial comparing intracervical PGE₂, oestrogen and placebo and is included in more than one comparison. In <a href="./references#CD007701-bbs2-0021" title="MagannE , ChauhanSP , NevilsBG , McNamaraMF , KinsellaMJ , MorrisonJC . Management of pregnancies beyond forty‐one weeks' gestation with an unfavorable cervix. American Journal of Obstetrics and Gynecology1998;178(6):1279‐87. ">Magann 1998</a>, one intervention was not eligible for inclusion so data for this were not included. If we identify further multiple‐armed trials in future searches, we will divide the control group in the analysis to avoid double counting, and follow the methods set out in the Handbook (<a href="./references#CD007701-bbs2-0074" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> </section> </section> <section id="CD007701-sec-0086"> <h4 class="title">Dealing with missing data</h4> <p>Levels of attrition were noted for included studies. In future updates, if more eligible studies are included, the impact of including studies with high levels of missing data in the overall assessment of treatment effect will be explored by using sensitivity analysis. </p> <p>For all outcomes, analyses were carried out, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD007701-sec-0087"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if I² was greater than 30% and either Tau² was greater than zero, or there was a low P value (&lt; 0.10) in the Chi² test for heterogeneity. If we identified substantial heterogeneity (&gt; 30%), we planned to explore the source in pre‐specified subgroup analysis. </p> </section> <section id="CD007701-sec-0088"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates, if there are 10 or more studies in the meta‐analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate the source. </p> </section> <section id="CD007701-sec-0089"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the Review Manager software (<a href="./references#CD007701-bbs2-0086" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. </p> <p>If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary will be treated as the average range of possible treatment effects and we will discuss the clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful, we will not combine trials. If we used random‐effects analyses, the results were presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD007701-sec-0090"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If we identified substantial heterogeneity, we investigated the source using subgroup analyses. We considered whether an overall summary was meaningful, and if it was, we used random‐effects analysis to produce the effect. </p> <p>If sufficient data were available, we planned to carry out the following subgroup analyses. </p> <p> <ol id="CD007701-list-0014"> <li> <p>Nulliparous versus multiparous.</p> </li> <li> <p>Induction indication.</p> </li> </ol> </p> <p>We planned to use only the primary outcomes in subgroup analysis.</p> <p>We also planned to assess subgroup differences by interaction tests available in RevMan (<a href="./references#CD007701-bbs2-0086" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), and to report the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. However, insufficient data were available to permit any subgroup analyses. </p> </section> <section id="CD007701-sec-0091"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to carry out sensitivity analyses to explore the effect of trial quality assessed by concealment of allocation, high attrition rates, or both, with poor quality studies being excluded from the analyses in order to assess whether this makes any difference to the overall result. <a href="./references#CD007701-bbs2-0008" title="GaffaneyCA , SaulLL , RumneyPJ , MorrisonEH , ThomasS , NageotteMP , et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. American Journal of Perinatology2009;26(9):673‐7. ">Gaffaney 2009</a> and <a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a> were assessed as being at high risk of attrition bias. However, insufficient data were available to permit any sensitivity analyses. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007701-sec-0092" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007701-sec-0092"></div> <section id="CD007701-sec-0093"> <h3 class="title">Description of studies</h3> <section id="CD007701-sec-0094"> <h4 class="title">Results of the search</h4> <p>The previous version of this review identified 72 reports, representing 55 separate studies (some trials were reported in more than one published paper) (<a href="./references#CD007701-bbs2-0095" title="DowswellT , KellyAJ , LivioS , NormanJE , AlfirevicZ . Different methods for the induction of labour in outpatient settings. Cochrane Database of Systematic Reviews2010, Issue 8. [DOI: 10.1002/14651858.CD007701.pub2] ">Dowswell 2010</a>). A total of 28 studies were included in the review, 25 were excluded and two awaiting classification (<a href="./references#CD007701-bbs2-0060" title="Ascher‐WalshC , BurkeB , BaxiL . Outpatient management of prolonged pregnancy with misoprostol (mp): a randomized double‐blind placebo controlled study, prelim data. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S20. ">Ascher‐Walsh 2000</a>; <a href="./references#CD007701-bbs2-0062" title="ThakurV , DormanE , SanuL , HarringtonK . Mifepristone is an effective ripening agent in postdates primips with cervical length ≥ 2.5cm, but mode of delivery correlates with birthweight: a randomised, placebo controlled double blind study. Ultrasound in Obstetrics &amp; Gynecology2005;26:452. ">Thakur 2005</a>) (<a href="#CD007701-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD007701-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD007701-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>For this update, the search identified an additional 10 reports. We also reassessed two studies that were awaiting further classification in <a href="./references#CD007701-bbs2-0095" title="DowswellT , KellyAJ , LivioS , NormanJE , AlfirevicZ . Different methods for the induction of labour in outpatient settings. Cochrane Database of Systematic Reviews2010, Issue 8. [DOI: 10.1002/14651858.CD007701.pub2] ">Dowswell 2010</a>. A total of six new studies were included (<a href="./references#CD007701-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a>; <a href="./references#CD007701-bbs2-0002" title="AttanayakeK , GoonewardeneM . Outpatient cervical ripening with vaginal isosorbide mononitrate in uncomplicated singleton pregnancies at 39 weeks gestation: A double blind randomized controlled trial. Sri Lanka Journal of Obstetrics and Gynaecology2014;36(Suppl 1):28, Abstract no: FC 10.5. ">Attanayake 2014</a>; <a href="./references#CD007701-bbs2-0008" title="GaffaneyCA , SaulLL , RumneyPJ , MorrisonEH , ThomasS , NageotteMP , et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. American Journal of Perinatology2009;26(9):673‐7. ">Gaffaney 2009</a>; <a href="./references#CD007701-bbs2-0009" title="GhanaieMM , MirbloukF , GodarziR , ShakibaM . Effect of outpatient isorbide mononitrate on success of labor induction. Journal of Babol University of Medical Sciences2013;15(2):12‐7. ">Ghanaie 2013</a>; <a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a>; <a href="./references#CD007701-bbs2-0032" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>), one excluded (<a href="./references#CD007701-bbs2-0054" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>;), and one new study is awaiting classification (<a href="./references#CD007701-bbs2-0061" title="MostaghelN , NakhaiF . Outpatient vaginal misoprostol and its effect on post‐term pregnancy. International Journal of Gynaecology and Obstetrics2009;107(Suppl 2):S586. ">Mostaghel 2009</a>). One report was included as an additional report of a study already included in the review (<a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a>). Both studies previously awaiting classification (<a href="./references#CD007701-bbs2-0060" title="Ascher‐WalshC , BurkeB , BaxiL . Outpatient management of prolonged pregnancy with misoprostol (mp): a randomized double‐blind placebo controlled study, prelim data. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S20. ">Ascher‐Walsh 2000</a>; <a href="./references#CD007701-bbs2-0062" title="ThakurV , DormanE , SanuL , HarringtonK . Mifepristone is an effective ripening agent in postdates primips with cervical length ≥ 2.5cm, but mode of delivery correlates with birthweight: a randomised, placebo controlled double blind study. Ultrasound in Obstetrics &amp; Gynecology2005;26:452. ">Thakur 2005</a>) remain; and <a href="./references#CD007701-bbs2-0077" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). ">ISRCTN47736435</a> (previously excluded) was included as an additional report of <a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a>. See <a href="./references#CD007701-sec-0211" title="">Characteristics of studies awaiting classification</a> tables. </p> </section> <section id="CD007701-sec-0095"> <h4 class="title">Included studies</h4> <p>We included 34 studies that involved a total of 5003 women (<a href="./references#CD007701-sec-0209" title="">Characteristics of included studies</a>). </p> <p>The studies included a variety of different comparisons.</p> <p> <ul id="CD007701-list-0015"> <li> <p>Vaginal prostaglandin (PGE₂) versus expectant management or placebo (5 studies) (<a href="./references#CD007701-bbs2-0013" title="HageP , ShawJ , ZarouD , FleisherJ , WehbehH . Double blind randomized trial to evaluate the role of outpatient use of PGE2 in cervical ripening. American Journal of Obstetrics and Gynecology1993;168(1 Part 2):430. ">Hage 1993</a>; <a href="./references#CD007701-bbs2-0025" title="NewmanM , NewmanR . Multiple‐dose PGE2 cervical ripening on an outpatient basis: safety and efficacy. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S112. ">Newman 1997</a>; <a href="./references#CD007701-bbs2-0026" title="O'BrienJM , MercerB , ClearyN , SibaiBM . Efficacy of outpatient induction with low dose intravaginal prostaglandin E2: A randomized, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;172:424. O'BrienJM , MercerBM , ClearyNT , SibaiBM . Efficacy of outpatient induction with low‐dose intravaginal prostaglandin E2: A randomized, double blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;173(6):1855‐9. ">O'Brien 1995</a>; <a href="./references#CD007701-bbs2-0030" title="SawaiSK , WilliamsMC , O'BrienWF , AngelJL , MastrogiannisDS , JohnsonL . Sequential outpatient application of intravaginal prostaglandin E2 gel in the management of postdates pregnancies. Obstetrics and Gynecology1991;78(1):19‐23. WilliamsMG , O'BrienWF , SawaiSK , KnuppelRA . Outpatient cervical ripening in the postdates pregnancy. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 Jan 23‐27; Houston, Texas, USA. 1990:533. ">Sawai 1991</a>; <a href="./references#CD007701-bbs2-0031" title="SawaiSK , O'BrienWF , MastrogiannisDS , KrammerJ , MastryMG , PorterGW . Patient‐administered outpatient intravaginal prostaglandin E2 suppositories in post‐date pregnancies: a double‐blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1994;84(5):807‐10. SawaiSK , O'BrienWF , MastrogiannisMS , MastryMG , PorterGW , JohnsonL . Outpatient prostaglandin E2 suppositories in postdates pregnancies. American Journal of Obstetrics and Gynecology1992;166(1 Pt 2):400. ">Sawai 1994</a>). </p> </li> <li> <p>Intracervical prostaglandin (PgE₂) versus expectant management or placebo (7 studies) (<a href="./references#CD007701-bbs2-0005" title="ButtinoLTJr , GariteTJ . Intracervical prostaglandin in postdate pregnancy. A randomized trial. Journal of Reproductive Medicine1990;35(2):155‐8. ">Buttino 1990</a>; <a href="./references#CD007701-bbs2-0011" title="GittensL , SchenkelC , StrassbergS , ApuzzioJ . Vaginal birth after cesarean section: comparison of outpatient use of prostaglandin gel to expectant management. American Journal of Obstetrics and Gynecology1996;174(1 Pt 2):354. ">Gittens 1996</a>; <a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a>; <a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a>; <a href="./references#CD007701-bbs2-0021" title="MagannE , ChauhanSP , NevilsBG , McNamaraMF , KinsellaMJ , MorrisonJC . Management of pregnancies beyond forty‐one weeks' gestation with an unfavorable cervix. American Journal of Obstetrics and Gynecology1998;178(6):1279‐87. ">Magann 1998</a>; <a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a>; <a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a>). </p> </li> <li> <p>Vaginal misoprostol versus placebo (4 studies) (<a href="./references#CD007701-bbs2-0015" title="IncerpiM , FassettM , KjosS , TranS , WingD . Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S120. IncerpiMH , FassettMJ , KjosSL , TranSH , WingDA . Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology2001;185(4):916‐9. ">Incerpi 2001</a>; <a href="./references#CD007701-bbs2-0023" title="McKennaDS , EsterJB , ProffittM , WaddellKR . Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial. Obstetrics and Gynecology2004;104(3):579‐84. ">McKenna 2004</a>; <a href="./references#CD007701-bbs2-0027" title="OboroVO , TaboweiTO . Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post‐term pregnancy. Acta Obstetricia et Gynecologica Scandinavica2005;84(7):628‐31. ">Oboro 2005</a>; <a href="./references#CD007701-bbs2-0034" title="StitelyML , BrowningJ , FowlerM , GendronRT , GhermanRB . Outpatient cervical ripening with intravaginal misoprostol. Obstetrics and Gynecology2000;96(5 Pt 1):684‐8. ">Stitely 2000</a>). </p> </li> <li> <p>Vaginal misoprostol 25 µg versus 50 µg (1 study) (<a href="./references#CD007701-bbs2-0016" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynaecology and Obstetrics2005;88(2):108‐11. ">Kipikasa 2005</a>). </p> </li> <li> <p>Intracervical prostaglandin (PGE₂) versus vaginal misoprostol (1 study) (<a href="./references#CD007701-bbs2-0024" title="MeyerM , PflumJ . Outpatient administration of misoprostol decreases induction time. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S167. MeyerM , PflumJ , HowardD . Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial. Obstetrics and Gynecology2005;105(3):466‐72. ">Meyer 2005</a>). </p> </li> <li> <p>Oral misoprostol versus placebo (2 studies) (<a href="./references#CD007701-bbs2-0008" title="GaffaneyCA , SaulLL , RumneyPJ , MorrisonEH , ThomasS , NageotteMP , et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. American Journal of Perinatology2009;26(9):673‐7. ">Gaffaney 2009</a>; <a href="./references#CD007701-bbs2-0020" title="LyonsC , RumneyP , HuangW , MorrisonE , ThomasS , NageotteM , et al. Outpatient cervical ripening with oral misoprostol post‐term: induction rates decreased. American Journal of Obstetrics and Gynecology2001;184(1):S116. ">Lyons 2001</a>). </p> </li> <li> <p>Mifepristone versus placebo (5 studies) (<a href="./references#CD007701-bbs2-0006" title="ElliotCL , BrennandJE , CalderAA . The effect of mifepristone (RU486) on cervical ripening and induction of labour in human pregnancy. 27th British Congress of Obstetrics and Gynaecology; 1995 July 4‐7; Dublin, Ireland. 1995:207. ElliottCL , BrennandJE , CalderAA . The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstetrics and Gynecology1998;92(5):804‐9. ">Elliott 1998</a>; <a href="./references#CD007701-bbs2-0007" title="FrydmanR , BatonC , LelaidierC , VialM , BourgetP , FernandezH . Mifepristone for induction of labour. Lancet1991;337(8739):488‐9. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1992;80(6):972‐5. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double‐blind, randomized, placebo‐controlled study. International Journal of Gynecology and Obstetrics1993;42(2):220. FrydmanR , TaylorS , PaoliC , PouradeA . RU 486 (mifepristone): A new tool for labour induction in term women with fetus alive [Le RU 486 (mifepristone) un novel outil pour le declenchment du travail a terme]. Contraception, Fertilite, Sexualite1992;20(12):1133‐6. LelaidierC , BeniflaJL , FernandezH , BatonC , BourgetP , BourrierMC , et al. RU 486 (mifepristone) in medical indications for labour induction in pregnancies at term: results of a randomized, double‐blind study of RU 486 vs placebo. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1993;22:92‐100. ">Frydman 1992</a>; <a href="./references#CD007701-bbs2-0010" title="GiacalonePL , TargoszV , LaffargueF , BoogG , FaureJM . Cervical ripening with mifepristone before labor induction: a randomized study. Obstetrics and Gynecology1998;92(4 Pt 1):487‐92. ">Giacalone 1998</a>; <a href="./references#CD007701-bbs2-0018" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101(6):501‐3. ">Lelaidier 1994</a>; <a href="./references#CD007701-bbs2-0033" title="StenlundPM , BygdemanM , EkmanG . Induction of labor with mifepristone (RU 486). A randomized double‐blind study in post‐term pregnant women with unripe cervices. Acta Obstetricia et Gynecologica Scandinavica Supplement1994;73(161):Abstract FP50. StenlundPM , EkmanG , AedoAR , BygdemanM . Induction of labour with mifepristone ‐ a randomized double‐blind study versus placebo. Acta Obstetricia et Gynecologica Scandinavica1999;78:793‐8. ">Stenlund 1999</a>). </p> </li> <li> <p>Oestrogen versus placebo (1 study) (<a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a>). </p> </li> <li> <p>Vaginal isosorbide mononitrate (IMN) versus placebo (7 studies) (<a href="./references#CD007701-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a>; <a href="./references#CD007701-bbs2-0002" title="AttanayakeK , GoonewardeneM . Outpatient cervical ripening with vaginal isosorbide mononitrate in uncomplicated singleton pregnancies at 39 weeks gestation: A double blind randomized controlled trial. Sri Lanka Journal of Obstetrics and Gynaecology2014;36(Suppl 1):28, Abstract no: FC 10.5. ">Attanayake 2014</a>; <a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a>; <a href="./references#CD007701-bbs2-0004" title="BullarboM , OrrskogME , AnderschB , GranströmL , NorströmA , EkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196(1):50.e1‐5. ">Bullarbo 2007</a>; <a href="./references#CD007701-bbs2-0009" title="GhanaieMM , MirbloukF , GodarziR , ShakibaM . Effect of outpatient isorbide mononitrate on success of labor induction. Journal of Babol University of Medical Sciences2013;15(2):12‐7. ">Ghanaie 2013</a>; <a href="./references#CD007701-bbs2-0012" title="HabibSM , EmamSS , SaberAS . Outpatient cervical ripening with nitric oxide donor isosorbide mononitrate prior to induction of labor. International Journal of Gynaecology and Obstetrics2008;101(1):57‐61. ">Habib 2008</a>; <a href="./references#CD007701-bbs2-0032" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>). </p> </li> <li> <p>Acupuncture versus routine care (1 study) (<a href="./references#CD007701-bbs2-0014" title="HarperTC , CoeytauxRR , ChenW , CampbellK , KaufmanJS , MoiseKJ , et al. A randomized controlled trial of acupuncture for initiation of labor in nulliparous women. Journal of Maternal‐Fetal and Neonatal Medicine2006;19(8):465‐70. ">Harper 2006</a>). </p> </li> <li> <p>Outpatient amniotomy for induction versus routine care (1 study) (<a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a>). </p> </li> </ul> </p> <p>In all trials it was intended that women would spend part of the study period at home. In most studies women received the initial treatment in a hospital setting (and frequently underwent a period of surveillance) before discharge home. Women were advised to seek help or return to hospital if any problems arose, if labour commenced, or after a predefined period. In some studies, women self‐administered the study intervention at home, and again were advised to return either if they had concerns, if labour started, or for review after a specified period (e.g. in <a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a> women scheduled for labour induction were given vaginal IMN with instructions on self‐administration 48, 32 and 16 hours before the scheduled induction time). </p> <p>The studies almost invariably recruited healthy women at term. A small number of studies focused on women with particular histories. In the trials by <a href="./references#CD007701-bbs2-0011" title="GittensL , SchenkelC , StrassbergS , ApuzzioJ . Vaginal birth after cesarean section: comparison of outpatient use of prostaglandin gel to expectant management. American Journal of Obstetrics and Gynecology1996;174(1 Pt 2):354. ">Gittens 1996</a>, <a href="./references#CD007701-bbs2-0018" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101(6):501‐3. ">Lelaidier 1994</a> and <a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a> women who had a previous caesarean birth were recruited; <a href="./references#CD007701-bbs2-0015" title="IncerpiM , FassettM , KjosS , TranS , WingD . Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S120. IncerpiMH , FassettMJ , KjosSL , TranSH , WingDA . Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology2001;185(4):916‐9. ">Incerpi 2001</a> focused on women with insulin‐dependent diabetes and <a href="./references#CD007701-bbs2-0025" title="NewmanM , NewmanR . Multiple‐dose PGE2 cervical ripening on an outpatient basis: safety and efficacy. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S112. ">Newman 1997</a> included women with diabetes along with those requiring induction of labour for post maturity. Two studies (<a href="./references#CD007701-bbs2-0018" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101(6):501‐3. ">Lelaidier 1994</a>; <a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a>) recruited women who had a previous caesarean section and who were aiming to achieve a vaginal birth. In the remaining studies the main indication for induction of labour was prolonged pregnancy, although recruitment was not always restricted to this group. Six studies included only primiparous women (<a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a>; <a href="./references#CD007701-bbs2-0006" title="ElliotCL , BrennandJE , CalderAA . The effect of mifepristone (RU486) on cervical ripening and induction of labour in human pregnancy. 27th British Congress of Obstetrics and Gynaecology; 1995 July 4‐7; Dublin, Ireland. 1995:207. ElliottCL , BrennandJE , CalderAA . The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstetrics and Gynecology1998;92(5):804‐9. ">Elliott 1998</a>; <a href="./references#CD007701-bbs2-0009" title="GhanaieMM , MirbloukF , GodarziR , ShakibaM . Effect of outpatient isorbide mononitrate on success of labor induction. Journal of Babol University of Medical Sciences2013;15(2):12‐7. ">Ghanaie 2013</a>; <a href="./references#CD007701-bbs2-0013" title="HageP , ShawJ , ZarouD , FleisherJ , WehbehH . Double blind randomized trial to evaluate the role of outpatient use of PGE2 in cervical ripening. American Journal of Obstetrics and Gynecology1993;168(1 Part 2):430. ">Hage 1993</a>; <a href="./references#CD007701-bbs2-0014" title="HarperTC , CoeytauxRR , ChenW , CampbellK , KaufmanJS , MoiseKJ , et al. A randomized controlled trial of acupuncture for initiation of labor in nulliparous women. Journal of Maternal‐Fetal and Neonatal Medicine2006;19(8):465‐70. ">Harper 2006</a>; <a href="./references#CD007701-bbs2-0032" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>) and two multiparous women only (<a href="./references#CD007701-bbs2-0018" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101(6):501‐3. ">Lelaidier 1994</a>; <a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a>). </p> <p>The main recruitment criterion in all of these studies was that labour had not already started (i.e. women were not having regular painful contractions). Most studies also specified a Bishop score indicating an unfavourable cervix as an inclusion criterion although the definition of an unfavourable cervix (low Bishop score) varied. No studies specifically recruited women where the cervix was favourable. Where it was mentioned, studies invariably recruited women with intact membranes; no studies specifically focused on women with ruptured membranes. Most of these studies specifically mentioned that multiple pregnancies were excluded, and at recruitment it was usually specified as an inclusion criterion that the fetus was in good condition with no signs of distress (e.g. normal fetal heart rate monitoring and normal amniotic fluid volume). </p> <p>Further information on interventions, participants and inclusion and exclusion criteria are set out in the <a href="./references#CD007701-sec-0209" title="">Characteristics of included studies</a> tables. </p> </section> <section id="CD007701-sec-0096"> <h4 class="title">Excluded studies</h4> <p>We excluded 25 trials (<a href="./references#CD007701-sec-0210" title="">Characteristics of excluded studies</a>). The main reason for excluding studies was study design. </p> <p>Four studies used a cross‐over design; we had decided to exclude cross‐over trials as we did not think this design was appropriate in this topic area; in all of these studies the focus was on breast stimulation. Women in the control groups initially received no intervention, while those in intervention groups were asked to stimulate their nipples for a specified time period; after this time period, women then crossed over into the control or intervention arm (<a href="./references#CD007701-bbs2-0035" title="AdewoleIF , FranklinO , MatilukoAA . Cervical ripening and induction of labour by breast stimulation. African Journal of Medicine and Medical Sciences1993;22(4):81‐6. ">Adewole 1993</a>; <a href="./references#CD007701-bbs2-0038" title="DiLietoA , MirandaL , ArditoP , FavaleP , AlbanoG . Changes in the bishop score induced by manual nipple stimulation. A cross‐over randomized study. Clinical and Experimental Obstetrics and Gynecology1989;16(1):26‐9. ">Di Lieto 1989</a>; <a href="./references#CD007701-bbs2-0041" title="ElliottJP , FlahertyJF . The use of breast stimulation to prevent postdate pregnancy. American Journal of Obstetrics and Gynecology1984;149(6):628‐32. ElliottJP , FlahertyJF . The use of breast stimulation to ripen the cervix in term pregnancies. American Journal of Obstetrics and Gynecology1983;145(5):553‐6. ">Elliott 1984</a>; <a href="./references#CD007701-bbs2-0056" title="SalmonYM , KeeWH , TanSL , JenSW . Cervical ripening by breast stimulation. Obstetrics and Gynecology1986;67(1):21‐4. ">Salmon 1986</a>). </p> <p>In three studies (<a href="./references#CD007701-bbs2-0036" title="DamaniaKR , NanavatiMS , DasturNA , DaftarySN . Breast stimulation for cervical ripening. Journal of Obstetrics and Gynaecology of India1988;58:663‐5. ">Damania 1988</a>; <a href="./references#CD007701-bbs2-0044" title="GriffinC . Outpatient cervical ripening using sequential oestrogen ‐ a randomised controlled pilot study. Australian and New Zealand Journal of Obstetrics and Gynaecology2003;43:183. ">Griffin 2003</a>; <a href="./references#CD007701-bbs2-0050" title="ManidakisG , SifakisS , OrfanoudakiE , MikelakisG , ProkopakisP , MagouM , et al. Prostaglandin versus stripping of membranes in management of pregnancy beyond 40‐41 weeks [abstract]. European Journal of Obstetrics, Gynecology, and Reproductive Biology1999;86:S79‐S80. ">Manidakis 1999</a>) there was too little information on study methods to allow us to ascertain whether group allocation was truly random, or to allow us to carry out an assessment of risk of bias (the studies by <a href="./references#CD007701-bbs2-0044" title="GriffinC . Outpatient cervical ripening using sequential oestrogen ‐ a randomised controlled pilot study. Australian and New Zealand Journal of Obstetrics and Gynaecology2003;43:183. ">Griffin 2003</a> and <a href="./references#CD007701-bbs2-0050" title="ManidakisG , SifakisS , OrfanoudakiE , MikelakisG , ProkopakisP , MagouM , et al. Prostaglandin versus stripping of membranes in management of pregnancy beyond 40‐41 weeks [abstract]. European Journal of Obstetrics, Gynecology, and Reproductive Biology1999;86:S79‐S80. ">Manidakis 1999</a> were reported in brief abstracts; we attempted to contact the authors for more information without success). Two studies used quasi‐randomisation and were at high risk of bias (<a href="./references#CD007701-bbs2-0043" title="GarryD , FigueroaR , GuillaumeJ , CuccoV . Use of castor oil in pregnancies at term. Alternative Therapies in Health and Medicine2000;6(1):77‐9. ">Garry 2000</a>; <a href="./references#CD007701-bbs2-0046" title="KadarN , TappA , WongA . The influence of nipple stimulation at term on the duration of pregnancy. Journal of Perinatology1990;10(2):164‐6. ">Kadar 1990</a>). <a href="./references#CD007701-bbs2-0042" title="EvansMI , DouganMB , MoawadAH , EvansWJ , Bryant‐GreenwoodGD , GreenwoodFC . Ripening of the human cervix with porcine ovarian relaxin. American Journal of Obstetrics and Gynecology1983;147(4):410‐4. ">Evans 1983</a> described findings from two separate studies, one of which seemed to be carried out in a hospital setting and included a control group receiving no treatment; a second "outpatient" study did not include a control group; different doses of porcine ovarian relaxin were compared. In the study by <a href="./references#CD007701-bbs2-0052" title="OhelG , RahavD , RothbartH , RuachM . Randomised trial of outpatient induction of labor with vaginal PGE2 at 40‐41 weeks of gestation versus expectant management. Archives of Gynecology and Obstetrics1996;258(3):109‐12. ">Ohel 1996</a>, whilst there seemed to be random allocation to treatment groups, results were not reported by randomisation group, and we were not able to include data in the review. In one study reported in a brief abstract, no original data were reported in the results section (<a href="./references#CD007701-bbs2-0048" title="KrammerJ , O'BrienW , WilliamsM . Outpatient cervical ripening does not affect gestational age at delivery. American Journal of Obstetrics and Gynecology1995;172:425. ">Krammer 1995</a>). </p> <p>A number of studies focused on interventions that we had either specifically excluded (e.g. <a href="./references#CD007701-bbs2-0039" title="DoanyW . Outpatient management of postdate pregnancy with intravaginal prostaglandin E2 and membrane stripping. American Journal of Obstetrics and Gynecology1996;174(1Pt 2):351. DoanyW , McCartyJ . Outpatient management of the uncomplicated postdate pregnancy with intravaginal prostaglandin E2 gel and membrane stripping. Journal of Maternal‐Fetal Medicine1997;6(2):71‐8. ">Doany 1997</a>; <a href="./references#CD007701-bbs2-0047" title="KaulV , AggarwalN , RayP . Membrane stripping versus single dose intracervical prostaglandin gel administration for cervical ripening. International Journal of Gynaecology and Obstetrics2004;86(3):388‐9. ">Kaul 2004</a>; <a href="./references#CD007701-bbs2-0049" title="MagannEF , ChauhanSP , McNamaraMF , BassJD , EstesCM , MorrisonJC . Membrane stripping vs dinoprostone vaginal insert in the management of pregnancies beyond 41 weeks with unfavorable cervix. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. MagannEF , ChauhanSP , McNamaraMF , BassJD , EstesCM , MorrisonJC . Membrane sweeping versus dinoprostone vaginal insert in the management of pregnancies beyond 41 weeks with an unfavorable cervix. Journal of Perinatology1999;19(2):88‐91. ">Magann 1999</a>; <a href="./references#CD007701-bbs2-0055" title="SalamalekisE , VitoratosN , KassanosD , LoghisC , BataliasL , PanayotopoulosN , et al. Sweeping of the membranes versus uterine stimulation by oxytocin in nulliparous women: a randomized controlled trial. Gynecologic and Obstetric Investigation2000;49(4):240‐3. ">Salamalekis 2000</a> looked at membrane sweeping), or interventions that are not currently used in clinical practice (extra amniotic saline infusion was examined by <a href="./references#CD007701-bbs2-0051" title="MoghtadaeiP . A randomized trial comparing outpatient vaginal isosorbide‐mononitrate versus extra‐amnion saline infusion with concurrent oxytocin for cervical ripening and labor induction in nulliparous women. American Journal of Obstetrics and Gynecology2007;197(6 Suppl 1):S103. ">Moghtadaei 2007</a>; it was not clear that women in both arms of this trial were discharged home; <a href="./references#CD007701-bbs2-0057" title="SpallicciMD , ChieaMA , SingerJM , AlbuquerquePB , BittarRE , ZugaibM . Use of hyaluronidase for cervical ripening: a randomized trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology2007;130(1):46‐50. SpallicciMDB , BittarRE . Randomized double blind study of ripening the cervix with hyaluronidase in term gestations [Estudo clinico aleatorizado com grupo controle e mascaramento duplo da maturacao do colo uterino pela hialuronidase em gestacoes a termo]. Revista Brasileira de Ginecologia e Obstetricia2003;25(1):67. ">Spallicci 2007</a> examined the use of hyaluronidase injection). </p> <p>In five studies it was not clear that the study was carried out in an outpatient setting or that the women were expected to spend some of the study period at home (<a href="./references#CD007701-bbs2-0037" title="DamaniaKK , NatuU , MhatrePN , MataliyaM , MehtaAC , DaftarySN . Evaluation of two methods employed for cervical ripening. Journal of Postgraduate Medicine1992;38(2):58‐9. ">Damania 1992</a>; <a href="./references#CD007701-bbs2-0045" title="HerabutyaY , PrasertsawatPO , TongyaiT , IsaranguraN , AyudthyaN . Prolonged pregnancy: the management dilemma. International Journal of Gynaecology and Obstetrics1992;37(4):253‐8. ">Herabutya 1992</a>; <a href="./references#CD007701-bbs2-0053" title="RayburnW , GosenR , RamadeiC , WoodsR , ScottJJr . Outpatient cervical ripening with prostaglandin E2 gel in uncomplicated postdate pregnancies. American Journal of Obstetrics and Gynecology1988;158(6 Pt 1):1417‐23. ">Rayburn 1988</a>; <a href="./references#CD007701-bbs2-0058" title="VossDH , CumminskyKC , CookVD , NethersMS , SpinnatoJA , GallSA . Effect of three concentrations of intracervical prostaglandin E2 gel for cervical ripening. Journal of Maternal‐Fetal Medicine1996;5(4):186‐93. ">Voss 1996</a>; <a href="./references#CD007701-bbs2-0059" title="ZiaeiS , RosebehaniN , KazeminejadA , ZafarghandiS . The effects of intramuscular administration of corticosteroids on the induction of parturition. Journal of Perinatal Medicine2003;31(2):134‐9. ">Ziaei 2003</a>). One study (<a href="./references#CD007701-bbs2-0054" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>) was not conducted in an outpatient setting. </p> <p><a href="./references#CD007701-bbs2-0040" title="DorfmanP , LasserreMN , TetauM . Preparation for childbirth by homeopathy [Preparation a l'accouchement par homeopathie: experimentation en double insu versus placebo]. Cahiers de Biothérapie1987;94:77‐81. ">Dorfman 1987</a> looked at homeopathic preparations (caulophyllum‐arnica‐actea and racemosa‐pulsatilla‐gelsemium) used with the intention of generally preparing women for childbirth rather than for labour induction. </p> </section> </section> <section id="CD007701-sec-0097"> <h3 class="title">Risk of bias in included studies</h3> <p>Summary of risk bias assessments are presented graphically (<a href="#CD007701-fig-0002">Figure 2</a>; <a href="#CD007701-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD007701-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007701-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD007701-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007701-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD007701-sec-0098"> <h4 class="title">Allocation</h4> <p>We assessed most of the included studies as using adequate methods to generate the randomisation sequence and to conceal group allocation. </p> <p>Sequence generation was either computer generated or derived from random number tables in 26 of the 34 included studies. In eight trials the methods used to generate the randomisation order were not clear (<a href="./references#CD007701-bbs2-0006" title="ElliotCL , BrennandJE , CalderAA . The effect of mifepristone (RU486) on cervical ripening and induction of labour in human pregnancy. 27th British Congress of Obstetrics and Gynaecology; 1995 July 4‐7; Dublin, Ireland. 1995:207. ElliottCL , BrennandJE , CalderAA . The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstetrics and Gynecology1998;92(5):804‐9. ">Elliott 1998</a>; <a href="./references#CD007701-bbs2-0007" title="FrydmanR , BatonC , LelaidierC , VialM , BourgetP , FernandezH . Mifepristone for induction of labour. Lancet1991;337(8739):488‐9. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1992;80(6):972‐5. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double‐blind, randomized, placebo‐controlled study. International Journal of Gynecology and Obstetrics1993;42(2):220. FrydmanR , TaylorS , PaoliC , PouradeA . RU 486 (mifepristone): A new tool for labour induction in term women with fetus alive [Le RU 486 (mifepristone) un novel outil pour le declenchment du travail a terme]. Contraception, Fertilite, Sexualite1992;20(12):1133‐6. LelaidierC , BeniflaJL , FernandezH , BatonC , BourgetP , BourrierMC , et al. RU 486 (mifepristone) in medical indications for labour induction in pregnancies at term: results of a randomized, double‐blind study of RU 486 vs placebo. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1993;22:92‐100. ">Frydman 1992</a>; <a href="./references#CD007701-bbs2-0011" title="GittensL , SchenkelC , StrassbergS , ApuzzioJ . Vaginal birth after cesarean section: comparison of outpatient use of prostaglandin gel to expectant management. American Journal of Obstetrics and Gynecology1996;174(1 Pt 2):354. ">Gittens 1996</a>; <a href="./references#CD007701-bbs2-0013" title="HageP , ShawJ , ZarouD , FleisherJ , WehbehH . Double blind randomized trial to evaluate the role of outpatient use of PGE2 in cervical ripening. American Journal of Obstetrics and Gynecology1993;168(1 Part 2):430. ">Hage 1993</a>; <a href="./references#CD007701-bbs2-0018" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101(6):501‐3. ">Lelaidier 1994</a>; <a href="./references#CD007701-bbs2-0020" title="LyonsC , RumneyP , HuangW , MorrisonE , ThomasS , NageotteM , et al. Outpatient cervical ripening with oral misoprostol post‐term: induction rates decreased. American Journal of Obstetrics and Gynecology2001;184(1):S116. ">Lyons 2001</a>; <a href="./references#CD007701-bbs2-0025" title="NewmanM , NewmanR . Multiple‐dose PGE2 cervical ripening on an outpatient basis: safety and efficacy. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S112. ">Newman 1997</a>; <a href="./references#CD007701-bbs2-0030" title="SawaiSK , WilliamsMC , O'BrienWF , AngelJL , MastrogiannisDS , JohnsonL . Sequential outpatient application of intravaginal prostaglandin E2 gel in the management of postdates pregnancies. Obstetrics and Gynecology1991;78(1):19‐23. WilliamsMG , O'BrienWF , SawaiSK , KnuppelRA . Outpatient cervical ripening in the postdates pregnancy. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 Jan 23‐27; Houston, Texas, USA. 1990:533. ">Sawai 1991</a>). </p> <p>Eighteen studies used either external or pharmacy randomisation services, or identical coded drug packs from pharmacy to conceal group allocation (<a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a>; <a href="./references#CD007701-bbs2-0005" title="ButtinoLTJr , GariteTJ . Intracervical prostaglandin in postdate pregnancy. A randomized trial. Journal of Reproductive Medicine1990;35(2):155‐8. ">Buttino 1990</a>; <a href="./references#CD007701-bbs2-0007" title="FrydmanR , BatonC , LelaidierC , VialM , BourgetP , FernandezH . Mifepristone for induction of labour. Lancet1991;337(8739):488‐9. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1992;80(6):972‐5. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double‐blind, randomized, placebo‐controlled study. International Journal of Gynecology and Obstetrics1993;42(2):220. FrydmanR , TaylorS , PaoliC , PouradeA . RU 486 (mifepristone): A new tool for labour induction in term women with fetus alive [Le RU 486 (mifepristone) un novel outil pour le declenchment du travail a terme]. Contraception, Fertilite, Sexualite1992;20(12):1133‐6. LelaidierC , BeniflaJL , FernandezH , BatonC , BourgetP , BourrierMC , et al. RU 486 (mifepristone) in medical indications for labour induction in pregnancies at term: results of a randomized, double‐blind study of RU 486 vs placebo. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1993;22:92‐100. ">Frydman 1992</a>; <a href="./references#CD007701-bbs2-0008" title="GaffaneyCA , SaulLL , RumneyPJ , MorrisonEH , ThomasS , NageotteMP , et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. American Journal of Perinatology2009;26(9):673‐7. ">Gaffaney 2009</a>; <a href="./references#CD007701-bbs2-0010" title="GiacalonePL , TargoszV , LaffargueF , BoogG , FaureJM . Cervical ripening with mifepristone before labor induction: a randomized study. Obstetrics and Gynecology1998;92(4 Pt 1):487‐92. ">Giacalone 1998</a>; <a href="./references#CD007701-bbs2-0012" title="HabibSM , EmamSS , SaberAS . Outpatient cervical ripening with nitric oxide donor isosorbide mononitrate prior to induction of labor. International Journal of Gynaecology and Obstetrics2008;101(1):57‐61. ">Habib 2008</a>; <a href="./references#CD007701-bbs2-0015" title="IncerpiM , FassettM , KjosS , TranS , WingD . Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S120. IncerpiMH , FassettMJ , KjosSL , TranSH , WingDA . Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology2001;185(4):916‐9. ">Incerpi 2001</a>; <a href="./references#CD007701-bbs2-0016" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynaecology and Obstetrics2005;88(2):108‐11. ">Kipikasa 2005</a>; <a href="./references#CD007701-bbs2-0018" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101(6):501‐3. ">Lelaidier 1994</a>; <a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a>; <a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a>; <a href="./references#CD007701-bbs2-0023" title="McKennaDS , EsterJB , ProffittM , WaddellKR . Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial. Obstetrics and Gynecology2004;104(3):579‐84. ">McKenna 2004</a>; <a href="./references#CD007701-bbs2-0026" title="O'BrienJM , MercerB , ClearyN , SibaiBM . Efficacy of outpatient induction with low dose intravaginal prostaglandin E2: A randomized, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;172:424. O'BrienJM , MercerBM , ClearyNT , SibaiBM . Efficacy of outpatient induction with low‐dose intravaginal prostaglandin E2: A randomized, double blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;173(6):1855‐9. ">O'Brien 1995</a>; <a href="./references#CD007701-bbs2-0033" title="StenlundPM , BygdemanM , EkmanG . Induction of labor with mifepristone (RU 486). A randomized double‐blind study in post‐term pregnant women with unripe cervices. Acta Obstetricia et Gynecologica Scandinavica Supplement1994;73(161):Abstract FP50. StenlundPM , EkmanG , AedoAR , BygdemanM . Induction of labour with mifepristone ‐ a randomized double‐blind study versus placebo. Acta Obstetricia et Gynecologica Scandinavica1999;78:793‐8. ">Stenlund 1999</a>; <a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a>; <a href="./references#CD007701-bbs2-0031" title="SawaiSK , O'BrienWF , MastrogiannisDS , KrammerJ , MastryMG , PorterGW . Patient‐administered outpatient intravaginal prostaglandin E2 suppositories in post‐date pregnancies: a double‐blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1994;84(5):807‐10. SawaiSK , O'BrienWF , MastrogiannisMS , MastryMG , PorterGW , JohnsonL . Outpatient prostaglandin E2 suppositories in postdates pregnancies. American Journal of Obstetrics and Gynecology1992;166(1 Pt 2):400. ">Sawai 1994</a>; <a href="./references#CD007701-bbs2-0032" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>; <a href="./references#CD007701-bbs2-0034" title="StitelyML , BrowningJ , FowlerM , GendronRT , GhermanRB . Outpatient cervical ripening with intravaginal misoprostol. Obstetrics and Gynecology2000;96(5 Pt 1):684‐8. ">Stitely 2000</a>). Four trials used sealed, opaque, sequentially numbered envelopes to conceal allocation (<a href="./references#CD007701-bbs2-0004" title="BullarboM , OrrskogME , AnderschB , GranströmL , NorströmA , EkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196(1):50.e1‐5. ">Bullarbo 2007</a>; <a href="./references#CD007701-bbs2-0014" title="HarperTC , CoeytauxRR , ChenW , CampbellK , KaufmanJS , MoiseKJ , et al. A randomized controlled trial of acupuncture for initiation of labor in nulliparous women. Journal of Maternal‐Fetal and Neonatal Medicine2006;19(8):465‐70. ">Harper 2006</a>; <a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a>; <a href="./references#CD007701-bbs2-0021" title="MagannE , ChauhanSP , NevilsBG , McNamaraMF , KinsellaMJ , MorrisonJC . Management of pregnancies beyond forty‐one weeks' gestation with an unfavorable cervix. American Journal of Obstetrics and Gynecology1998;178(6):1279‐87. ">Magann 1998</a>). Opaque envelopes were used in <a href="./references#CD007701-bbs2-0002" title="AttanayakeK , GoonewardeneM . Outpatient cervical ripening with vaginal isosorbide mononitrate in uncomplicated singleton pregnancies at 39 weeks gestation: A double blind randomized controlled trial. Sri Lanka Journal of Obstetrics and Gynaecology2014;36(Suppl 1):28, Abstract no: FC 10.5. ">Attanayake 2014</a> and <a href="./references#CD007701-bbs2-0024" title="MeyerM , PflumJ . Outpatient administration of misoprostol decreases induction time. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S167. MeyerM , PflumJ , HowardD . Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial. Obstetrics and Gynecology2005;105(3):466‐72. ">Meyer 2005</a> , although it was not stated that they were sealed. <a href="./references#CD007701-bbs2-0027" title="OboroVO , TaboweiTO . Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post‐term pregnancy. Acta Obstetricia et Gynecologica Scandinavica2005;84(7):628‐31. ">Oboro 2005</a> used sealed envelopes, but did not state they were opaque. In nine trials, methods to conceal group allocation were not clear (<a href="./references#CD007701-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a>; <a href="./references#CD007701-bbs2-0006" title="ElliotCL , BrennandJE , CalderAA . The effect of mifepristone (RU486) on cervical ripening and induction of labour in human pregnancy. 27th British Congress of Obstetrics and Gynaecology; 1995 July 4‐7; Dublin, Ireland. 1995:207. ElliottCL , BrennandJE , CalderAA . The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstetrics and Gynecology1998;92(5):804‐9. ">Elliott 1998</a>; <a href="./references#CD007701-bbs2-0009" title="GhanaieMM , MirbloukF , GodarziR , ShakibaM . Effect of outpatient isorbide mononitrate on success of labor induction. Journal of Babol University of Medical Sciences2013;15(2):12‐7. ">Ghanaie 2013</a>; <a href="./references#CD007701-bbs2-0011" title="GittensL , SchenkelC , StrassbergS , ApuzzioJ . Vaginal birth after cesarean section: comparison of outpatient use of prostaglandin gel to expectant management. American Journal of Obstetrics and Gynecology1996;174(1 Pt 2):354. ">Gittens 1996</a>; <a href="./references#CD007701-bbs2-0013" title="HageP , ShawJ , ZarouD , FleisherJ , WehbehH . Double blind randomized trial to evaluate the role of outpatient use of PGE2 in cervical ripening. American Journal of Obstetrics and Gynecology1993;168(1 Part 2):430. ">Hage 1993</a>; <a href="./references#CD007701-bbs2-0020" title="LyonsC , RumneyP , HuangW , MorrisonE , ThomasS , NageotteM , et al. Outpatient cervical ripening with oral misoprostol post‐term: induction rates decreased. American Journal of Obstetrics and Gynecology2001;184(1):S116. ">Lyons 2001</a>; <a href="./references#CD007701-bbs2-0025" title="NewmanM , NewmanR . Multiple‐dose PGE2 cervical ripening on an outpatient basis: safety and efficacy. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S112. ">Newman 1997</a>; <a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a>; <a href="./references#CD007701-bbs2-0030" title="SawaiSK , WilliamsMC , O'BrienWF , AngelJL , MastrogiannisDS , JohnsonL . Sequential outpatient application of intravaginal prostaglandin E2 gel in the management of postdates pregnancies. Obstetrics and Gynecology1991;78(1):19‐23. WilliamsMG , O'BrienWF , SawaiSK , KnuppelRA . Outpatient cervical ripening in the postdates pregnancy. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 Jan 23‐27; Houston, Texas, USA. 1990:533. ">Sawai 1991</a>). </p> </section> <section id="CD007701-sec-0099"> <h4 class="title">Blinding</h4> <p>Most (26) of the included studies were placebo controlled, and women and clinical staff were described as blind to group allocation. However, it was not always clear when the randomisation code was broken, so it was difficult to assess whether outcome assessment was carried out by blinded investigators. Eighteen studies were judged to be at low risk of bias by adequately blinding the women and staff (<a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a>; <a href="./references#CD007701-bbs2-0004" title="BullarboM , OrrskogME , AnderschB , GranströmL , NorströmA , EkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196(1):50.e1‐5. ">Bullarbo 2007</a>; <a href="./references#CD007701-bbs2-0005" title="ButtinoLTJr , GariteTJ . Intracervical prostaglandin in postdate pregnancy. A randomized trial. Journal of Reproductive Medicine1990;35(2):155‐8. ">Buttino 1990</a>; <a href="./references#CD007701-bbs2-0006" title="ElliotCL , BrennandJE , CalderAA . The effect of mifepristone (RU486) on cervical ripening and induction of labour in human pregnancy. 27th British Congress of Obstetrics and Gynaecology; 1995 July 4‐7; Dublin, Ireland. 1995:207. ElliottCL , BrennandJE , CalderAA . The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstetrics and Gynecology1998;92(5):804‐9. ">Elliott 1998</a>; <a href="./references#CD007701-bbs2-0007" title="FrydmanR , BatonC , LelaidierC , VialM , BourgetP , FernandezH . Mifepristone for induction of labour. Lancet1991;337(8739):488‐9. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1992;80(6):972‐5. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double‐blind, randomized, placebo‐controlled study. International Journal of Gynecology and Obstetrics1993;42(2):220. FrydmanR , TaylorS , PaoliC , PouradeA . RU 486 (mifepristone): A new tool for labour induction in term women with fetus alive [Le RU 486 (mifepristone) un novel outil pour le declenchment du travail a terme]. Contraception, Fertilite, Sexualite1992;20(12):1133‐6. LelaidierC , BeniflaJL , FernandezH , BatonC , BourgetP , BourrierMC , et al. RU 486 (mifepristone) in medical indications for labour induction in pregnancies at term: results of a randomized, double‐blind study of RU 486 vs placebo. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1993;22:92‐100. ">Frydman 1992</a>; <a href="./references#CD007701-bbs2-0008" title="GaffaneyCA , SaulLL , RumneyPJ , MorrisonEH , ThomasS , NageotteMP , et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. American Journal of Perinatology2009;26(9):673‐7. ">Gaffaney 2009</a>; <a href="./references#CD007701-bbs2-0010" title="GiacalonePL , TargoszV , LaffargueF , BoogG , FaureJM . Cervical ripening with mifepristone before labor induction: a randomized study. Obstetrics and Gynecology1998;92(4 Pt 1):487‐92. ">Giacalone 1998</a>; <a href="./references#CD007701-bbs2-0012" title="HabibSM , EmamSS , SaberAS . Outpatient cervical ripening with nitric oxide donor isosorbide mononitrate prior to induction of labor. International Journal of Gynaecology and Obstetrics2008;101(1):57‐61. ">Habib 2008</a>; <a href="./references#CD007701-bbs2-0015" title="IncerpiM , FassettM , KjosS , TranS , WingD . Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S120. IncerpiMH , FassettMJ , KjosSL , TranSH , WingDA . Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology2001;185(4):916‐9. ">Incerpi 2001</a>; <a href="./references#CD007701-bbs2-0018" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101(6):501‐3. ">Lelaidier 1994</a>; <a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a>; <a href="./references#CD007701-bbs2-0020" title="LyonsC , RumneyP , HuangW , MorrisonE , ThomasS , NageotteM , et al. Outpatient cervical ripening with oral misoprostol post‐term: induction rates decreased. American Journal of Obstetrics and Gynecology2001;184(1):S116. ">Lyons 2001</a>; <a href="./references#CD007701-bbs2-0026" title="O'BrienJM , MercerB , ClearyN , SibaiBM . Efficacy of outpatient induction with low dose intravaginal prostaglandin E2: A randomized, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;172:424. O'BrienJM , MercerBM , ClearyNT , SibaiBM . Efficacy of outpatient induction with low‐dose intravaginal prostaglandin E2: A randomized, double blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;173(6):1855‐9. ">O'Brien 1995</a>; <a href="./references#CD007701-bbs2-0030" title="SawaiSK , WilliamsMC , O'BrienWF , AngelJL , MastrogiannisDS , JohnsonL . Sequential outpatient application of intravaginal prostaglandin E2 gel in the management of postdates pregnancies. Obstetrics and Gynecology1991;78(1):19‐23. WilliamsMG , O'BrienWF , SawaiSK , KnuppelRA . Outpatient cervical ripening in the postdates pregnancy. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 Jan 23‐27; Houston, Texas, USA. 1990:533. ">Sawai 1991</a>; <a href="./references#CD007701-bbs2-0031" title="SawaiSK , O'BrienWF , MastrogiannisDS , KrammerJ , MastryMG , PorterGW . Patient‐administered outpatient intravaginal prostaglandin E2 suppositories in post‐date pregnancies: a double‐blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1994;84(5):807‐10. SawaiSK , O'BrienWF , MastrogiannisMS , MastryMG , PorterGW , JohnsonL . Outpatient prostaglandin E2 suppositories in postdates pregnancies. American Journal of Obstetrics and Gynecology1992;166(1 Pt 2):400. ">Sawai 1994</a>; <a href="./references#CD007701-bbs2-0032" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>; <a href="./references#CD007701-bbs2-0033" title="StenlundPM , BygdemanM , EkmanG . Induction of labor with mifepristone (RU 486). A randomized double‐blind study in post‐term pregnant women with unripe cervices. Acta Obstetricia et Gynecologica Scandinavica Supplement1994;73(161):Abstract FP50. StenlundPM , EkmanG , AedoAR , BygdemanM . Induction of labour with mifepristone ‐ a randomized double‐blind study versus placebo. Acta Obstetricia et Gynecologica Scandinavica1999;78:793‐8. ">Stenlund 1999</a>; <a href="./references#CD007701-bbs2-0034" title="StitelyML , BrowningJ , FowlerM , GendronRT , GhermanRB . Outpatient cervical ripening with intravaginal misoprostol. Obstetrics and Gynecology2000;96(5 Pt 1):684‐8. ">Stitely 2000</a>). In two of the placebo controlled trials, blinding may not have been convincing; in the <a href="./references#CD007701-bbs2-0016" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynaecology and Obstetrics2005;88(2):108‐11. ">Kipikasa 2005</a> trial women in both groups were given tablet fragments (either an eighth or a quarter of whole tablets) so the tablets may have not appeared identical (at least to staff). In the <a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a> study women may have been blind to intravaginal preparations, but staff are unlikely to have been. </p> <p>In eight trials women in both arms of the studies were given different interventions; therefore blinding of women and staff was not feasible, or not attempted (<a href="./references#CD007701-bbs2-0011" title="GittensL , SchenkelC , StrassbergS , ApuzzioJ . Vaginal birth after cesarean section: comparison of outpatient use of prostaglandin gel to expectant management. American Journal of Obstetrics and Gynecology1996;174(1 Pt 2):354. ">Gittens 1996</a>; <a href="./references#CD007701-bbs2-0014" title="HarperTC , CoeytauxRR , ChenW , CampbellK , KaufmanJS , MoiseKJ , et al. A randomized controlled trial of acupuncture for initiation of labor in nulliparous women. Journal of Maternal‐Fetal and Neonatal Medicine2006;19(8):465‐70. ">Harper 2006</a>; <a href="./references#CD007701-bbs2-0021" title="MagannE , ChauhanSP , NevilsBG , McNamaraMF , KinsellaMJ , MorrisonJC . Management of pregnancies beyond forty‐one weeks' gestation with an unfavorable cervix. American Journal of Obstetrics and Gynecology1998;178(6):1279‐87. ">Magann 1998</a>; <a href="./references#CD007701-bbs2-0024" title="MeyerM , PflumJ . Outpatient administration of misoprostol decreases induction time. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S167. MeyerM , PflumJ , HowardD . Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial. Obstetrics and Gynecology2005;105(3):466‐72. ">Meyer 2005</a>; <a href="./references#CD007701-bbs2-0025" title="NewmanM , NewmanR . Multiple‐dose PGE2 cervical ripening on an outpatient basis: safety and efficacy. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S112. ">Newman 1997</a>; <a href="./references#CD007701-bbs2-0027" title="OboroVO , TaboweiTO . Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post‐term pregnancy. Acta Obstetricia et Gynecologica Scandinavica2005;84(7):628‐31. ">Oboro 2005</a>; <a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a>; <a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a>). The lack of blinding in these studies may have affected some of the outcomes examined in the review. </p> <p>Outcome assessors were not blinded in three studies (<a href="./references#CD007701-bbs2-0024" title="MeyerM , PflumJ . Outpatient administration of misoprostol decreases induction time. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S167. MeyerM , PflumJ , HowardD . Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial. Obstetrics and Gynecology2005;105(3):466‐72. ">Meyer 2005</a>; <a href="./references#CD007701-bbs2-0027" title="OboroVO , TaboweiTO . Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post‐term pregnancy. Acta Obstetricia et Gynecologica Scandinavica2005;84(7):628‐31. ">Oboro 2005</a>; <a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a>). Six studies reportedly blinded outcome assessors until analysis was completed (<a href="./references#CD007701-bbs2-0010" title="GiacalonePL , TargoszV , LaffargueF , BoogG , FaureJM . Cervical ripening with mifepristone before labor induction: a randomized study. Obstetrics and Gynecology1998;92(4 Pt 1):487‐92. ">Giacalone 1998</a>; <a href="./references#CD007701-bbs2-0016" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynaecology and Obstetrics2005;88(2):108‐11. ">Kipikasa 2005</a>; <a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a>; <a href="./references#CD007701-bbs2-0032" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>; <a href="./references#CD007701-bbs2-0033" title="StenlundPM , BygdemanM , EkmanG . Induction of labor with mifepristone (RU 486). A randomized double‐blind study in post‐term pregnant women with unripe cervices. Acta Obstetricia et Gynecologica Scandinavica Supplement1994;73(161):Abstract FP50. StenlundPM , EkmanG , AedoAR , BygdemanM . Induction of labour with mifepristone ‐ a randomized double‐blind study versus placebo. Acta Obstetricia et Gynecologica Scandinavica1999;78:793‐8. ">Stenlund 1999</a>; <a href="./references#CD007701-bbs2-0034" title="StitelyML , BrowningJ , FowlerM , GendronRT , GhermanRB . Outpatient cervical ripening with intravaginal misoprostol. Obstetrics and Gynecology2000;96(5 Pt 1):684‐8. ">Stitely 2000</a>). The blinding of outcome assessors was unclear in the remaining studies. </p> </section> <section id="CD007701-sec-0100"> <h4 class="title">Incomplete outcome data</h4> <p>Loss of women to follow up and missing data were not serious problems in most of the included studies. In 10 studies the levels of attrition were not clear (<a href="./references#CD007701-bbs2-0006" title="ElliotCL , BrennandJE , CalderAA . The effect of mifepristone (RU486) on cervical ripening and induction of labour in human pregnancy. 27th British Congress of Obstetrics and Gynaecology; 1995 July 4‐7; Dublin, Ireland. 1995:207. ElliottCL , BrennandJE , CalderAA . The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstetrics and Gynecology1998;92(5):804‐9. ">Elliott 1998</a>; <a href="./references#CD007701-bbs2-0007" title="FrydmanR , BatonC , LelaidierC , VialM , BourgetP , FernandezH . Mifepristone for induction of labour. Lancet1991;337(8739):488‐9. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1992;80(6):972‐5. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double‐blind, randomized, placebo‐controlled study. International Journal of Gynecology and Obstetrics1993;42(2):220. FrydmanR , TaylorS , PaoliC , PouradeA . RU 486 (mifepristone): A new tool for labour induction in term women with fetus alive [Le RU 486 (mifepristone) un novel outil pour le declenchment du travail a terme]. Contraception, Fertilite, Sexualite1992;20(12):1133‐6. LelaidierC , BeniflaJL , FernandezH , BatonC , BourgetP , BourrierMC , et al. RU 486 (mifepristone) in medical indications for labour induction in pregnancies at term: results of a randomized, double‐blind study of RU 486 vs placebo. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1993;22:92‐100. ">Frydman 1992</a>; <a href="./references#CD007701-bbs2-0009" title="GhanaieMM , MirbloukF , GodarziR , ShakibaM . Effect of outpatient isorbide mononitrate on success of labor induction. Journal of Babol University of Medical Sciences2013;15(2):12‐7. ">Ghanaie 2013</a>; <a href="./references#CD007701-bbs2-0011" title="GittensL , SchenkelC , StrassbergS , ApuzzioJ . Vaginal birth after cesarean section: comparison of outpatient use of prostaglandin gel to expectant management. American Journal of Obstetrics and Gynecology1996;174(1 Pt 2):354. ">Gittens 1996</a>; <a href="./references#CD007701-bbs2-0013" title="HageP , ShawJ , ZarouD , FleisherJ , WehbehH . Double blind randomized trial to evaluate the role of outpatient use of PGE2 in cervical ripening. American Journal of Obstetrics and Gynecology1993;168(1 Part 2):430. ">Hage 1993</a>; <a href="./references#CD007701-bbs2-0014" title="HarperTC , CoeytauxRR , ChenW , CampbellK , KaufmanJS , MoiseKJ , et al. A randomized controlled trial of acupuncture for initiation of labor in nulliparous women. Journal of Maternal‐Fetal and Neonatal Medicine2006;19(8):465‐70. ">Harper 2006</a>; <a href="./references#CD007701-bbs2-0015" title="IncerpiM , FassettM , KjosS , TranS , WingD . Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S120. IncerpiMH , FassettMJ , KjosSL , TranSH , WingDA . Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology2001;185(4):916‐9. ">Incerpi 2001</a>; <a href="./references#CD007701-bbs2-0016" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynaecology and Obstetrics2005;88(2):108‐11. ">Kipikasa 2005</a>; <a href="./references#CD007701-bbs2-0020" title="LyonsC , RumneyP , HuangW , MorrisonE , ThomasS , NageotteM , et al. Outpatient cervical ripening with oral misoprostol post‐term: induction rates decreased. American Journal of Obstetrics and Gynecology2001;184(1):S116. ">Lyons 2001</a>; <a href="./references#CD007701-bbs2-0025" title="NewmanM , NewmanR . Multiple‐dose PGE2 cervical ripening on an outpatient basis: safety and efficacy. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S112. ">Newman 1997</a>). </p> <p>Five trials were assessed as high risk of attrition bias. In the study by <a href="./references#CD007701-bbs2-0031" title="SawaiSK , O'BrienWF , MastrogiannisDS , KrammerJ , MastryMG , PorterGW . Patient‐administered outpatient intravaginal prostaglandin E2 suppositories in post‐date pregnancies: a double‐blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1994;84(5):807‐10. SawaiSK , O'BrienWF , MastrogiannisMS , MastryMG , PorterGW , JohnsonL . Outpatient prostaglandin E2 suppositories in postdates pregnancies. American Journal of Obstetrics and Gynecology1992;166(1 Pt 2):400. ">Sawai 1994</a>, attrition was approximately 12% and some of the exclusions were for non‐compliance. Attrition was also high in the study by <a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a>; in this trial randomisation occurred up to nine days before the initiation of treatment, hence 80 of the 350 women did not start treatment as they had already gone into labour. To reduce risk of bias, the authors reported an intention‐to‐treat analysis (including all women randomised) for the trial's primary outcomes but not for secondary outcomes. In <a href="./references#CD007701-bbs2-0008" title="GaffaneyCA , SaulLL , RumneyPJ , MorrisonEH , ThomasS , NageotteMP , et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. American Journal of Perinatology2009;26(9):673‐7. ">Gaffaney 2009</a>, nine women were excluded post‐randomisation and not included for analysis. In <a href="./references#CD007701-bbs2-0032" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>, 10 women (5 in each group) were excluded post‐randomisation, and the maternal satisfaction outcome had 23% attrition. <a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a> and used a satisfaction survey, however, responses were not balanced (221 at home and 183 in hospital). In <a href="./references#CD007701-bbs2-0016" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynaecology and Obstetrics2005;88(2):108‐11. ">Kipikasa 2005</a>, there were inconsistencies in figures between the text and the tables, hence rated unclear risk of attrition bias. </p> </section> <section id="CD007701-sec-0101"> <h4 class="title">Selective reporting</h4> <p>Reporting bias was difficult to assess, as many studies did not pre‐specify all the outcomes that were reported (<a href="./references#CD007701-bbs2-0007" title="FrydmanR , BatonC , LelaidierC , VialM , BourgetP , FernandezH . Mifepristone for induction of labour. Lancet1991;337(8739):488‐9. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1992;80(6):972‐5. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double‐blind, randomized, placebo‐controlled study. International Journal of Gynecology and Obstetrics1993;42(2):220. FrydmanR , TaylorS , PaoliC , PouradeA . RU 486 (mifepristone): A new tool for labour induction in term women with fetus alive [Le RU 486 (mifepristone) un novel outil pour le declenchment du travail a terme]. Contraception, Fertilite, Sexualite1992;20(12):1133‐6. LelaidierC , BeniflaJL , FernandezH , BatonC , BourgetP , BourrierMC , et al. RU 486 (mifepristone) in medical indications for labour induction in pregnancies at term: results of a randomized, double‐blind study of RU 486 vs placebo. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1993;22:92‐100. ">Frydman 1992</a>; <a href="./references#CD007701-bbs2-0009" title="GhanaieMM , MirbloukF , GodarziR , ShakibaM . Effect of outpatient isorbide mononitrate on success of labor induction. Journal of Babol University of Medical Sciences2013;15(2):12‐7. ">Ghanaie 2013</a>; <a href="./references#CD007701-bbs2-0011" title="GittensL , SchenkelC , StrassbergS , ApuzzioJ . Vaginal birth after cesarean section: comparison of outpatient use of prostaglandin gel to expectant management. American Journal of Obstetrics and Gynecology1996;174(1 Pt 2):354. ">Gittens 1996</a>; <a href="./references#CD007701-bbs2-0013" title="HageP , ShawJ , ZarouD , FleisherJ , WehbehH . Double blind randomized trial to evaluate the role of outpatient use of PGE2 in cervical ripening. American Journal of Obstetrics and Gynecology1993;168(1 Part 2):430. ">Hage 1993</a>; <a href="./references#CD007701-bbs2-0015" title="IncerpiM , FassettM , KjosS , TranS , WingD . Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S120. IncerpiMH , FassettMJ , KjosSL , TranSH , WingDA . Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology2001;185(4):916‐9. ">Incerpi 2001</a>; <a href="./references#CD007701-bbs2-0016" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynaecology and Obstetrics2005;88(2):108‐11. ">Kipikasa 2005</a>; <a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a>; <a href="./references#CD007701-bbs2-0018" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101(6):501‐3. ">Lelaidier 1994</a>; <a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a>; <a href="./references#CD007701-bbs2-0020" title="LyonsC , RumneyP , HuangW , MorrisonE , ThomasS , NageotteM , et al. Outpatient cervical ripening with oral misoprostol post‐term: induction rates decreased. American Journal of Obstetrics and Gynecology2001;184(1):S116. ">Lyons 2001</a>; <a href="./references#CD007701-bbs2-0021" title="MagannE , ChauhanSP , NevilsBG , McNamaraMF , KinsellaMJ , MorrisonJC . Management of pregnancies beyond forty‐one weeks' gestation with an unfavorable cervix. American Journal of Obstetrics and Gynecology1998;178(6):1279‐87. ">Magann 1998</a>; <a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a>; <a href="./references#CD007701-bbs2-0023" title="McKennaDS , EsterJB , ProffittM , WaddellKR . Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial. Obstetrics and Gynecology2004;104(3):579‐84. ">McKenna 2004</a>; <a href="./references#CD007701-bbs2-0025" title="NewmanM , NewmanR . Multiple‐dose PGE2 cervical ripening on an outpatient basis: safety and efficacy. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S112. ">Newman 1997</a>; <a href="./references#CD007701-bbs2-0026" title="O'BrienJM , MercerB , ClearyN , SibaiBM . Efficacy of outpatient induction with low dose intravaginal prostaglandin E2: A randomized, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;172:424. O'BrienJM , MercerBM , ClearyNT , SibaiBM . Efficacy of outpatient induction with low‐dose intravaginal prostaglandin E2: A randomized, double blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;173(6):1855‐9. ">O'Brien 1995</a>; <a href="./references#CD007701-bbs2-0027" title="OboroVO , TaboweiTO . Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post‐term pregnancy. Acta Obstetricia et Gynecologica Scandinavica2005;84(7):628‐31. ">Oboro 2005</a>; <a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a>; <a href="./references#CD007701-bbs2-0033" title="StenlundPM , BygdemanM , EkmanG . Induction of labor with mifepristone (RU 486). A randomized double‐blind study in post‐term pregnant women with unripe cervices. Acta Obstetricia et Gynecologica Scandinavica Supplement1994;73(161):Abstract FP50. StenlundPM , EkmanG , AedoAR , BygdemanM . Induction of labour with mifepristone ‐ a randomized double‐blind study versus placebo. Acta Obstetricia et Gynecologica Scandinavica1999;78:793‐8. ">Stenlund 1999</a>; <a href="./references#CD007701-bbs2-0034" title="StitelyML , BrowningJ , FowlerM , GendronRT , GhermanRB . Outpatient cervical ripening with intravaginal misoprostol. Obstetrics and Gynecology2000;96(5 Pt 1):684‐8. ">Stitely 2000</a>). <a href="./references#CD007701-bbs2-0032" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a> pre‐specified maternal and newborn intensive care unit admission outcomes, but these were not reported. </p> </section> <section id="CD007701-sec-0102"> <h4 class="title">Other potential sources of bias</h4> <p>In many included studies women were likely to receive other interventions at some stage in their treatment as well as the study allocated intervention (e.g. amniotomy, membrane sweeping, additional medication) and these in turn may have affected other outcomes (e.g. length of labour and rate of caesarean section). Without adequate blinding, it is possible that women in intervention and control groups may have had different co‐interventions, or co‐interventions at different stages. For example, in the study by <a href="./references#CD007701-bbs2-0014" title="HarperTC , CoeytauxRR , ChenW , CampbellK , KaufmanJS , MoiseKJ , et al. A randomized controlled trial of acupuncture for initiation of labor in nulliparous women. Journal of Maternal‐Fetal and Neonatal Medicine2006;19(8):465‐70. ">Harper 2006</a>, women in the intervention group attended for treatment on three occasions, and at these visits (not available to women in the control group) may have been exposed to a range of co‐interventions, or additional tests or observations, that may have had an impact on outcomes. </p> <p>Other sources of bias included baseline imbalance in parity between groups (<a href="./references#CD007701-bbs2-0027" title="OboroVO , TaboweiTO . Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post‐term pregnancy. Acta Obstetricia et Gynecologica Scandinavica2005;84(7):628‐31. ">Oboro 2005</a>) and imbalance in numbers of randomised women between the treatment and control groups (<a href="./references#CD007701-bbs2-0006" title="ElliotCL , BrennandJE , CalderAA . The effect of mifepristone (RU486) on cervical ripening and induction of labour in human pregnancy. 27th British Congress of Obstetrics and Gynaecology; 1995 July 4‐7; Dublin, Ireland. 1995:207. ElliottCL , BrennandJE , CalderAA . The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstetrics and Gynecology1998;92(5):804‐9. ">Elliott 1998</a>). </p> </section> </section> <section id="CD007701-sec-0103"> <h3 class="title" id="CD007701-sec-0103">Effects of interventions</h3> <p>See: <a href="./full#CD007701-tbl-0001"><b>Summary of findings for the main comparison</b> Vaginal PGE₂ compared to placebo or expectant management for the induction of labour in outpatient settings</a>; <a href="./full#CD007701-tbl-0002"><b>Summary of findings 2</b> Intracervical PGE₂ compared to placebo for the induction of labour in outpatient settings</a>; <a href="./full#CD007701-tbl-0003"><b>Summary of findings 3</b> Vaginal misoprostol compared to placebo for the induction of labour in outpatient settings</a> </p> <section id="CD007701-sec-0104"> <h4 class="title">1. Vaginal prostaglandin (PGE₂) versus placebo or expectant management: five studies, 335 women </h4> </section> <section id="CD007701-sec-0105"> <h4 class="title">Main outcomes</h4> <p>We included five studies in this comparison (<a href="./references#CD007701-bbs2-0013" title="HageP , ShawJ , ZarouD , FleisherJ , WehbehH . Double blind randomized trial to evaluate the role of outpatient use of PGE2 in cervical ripening. American Journal of Obstetrics and Gynecology1993;168(1 Part 2):430. ">Hage 1993</a>; <a href="./references#CD007701-bbs2-0025" title="NewmanM , NewmanR . Multiple‐dose PGE2 cervical ripening on an outpatient basis: safety and efficacy. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S112. ">Newman 1997</a>; <a href="./references#CD007701-bbs2-0026" title="O'BrienJM , MercerB , ClearyN , SibaiBM . Efficacy of outpatient induction with low dose intravaginal prostaglandin E2: A randomized, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;172:424. O'BrienJM , MercerBM , ClearyNT , SibaiBM . Efficacy of outpatient induction with low‐dose intravaginal prostaglandin E2: A randomized, double blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;173(6):1855‐9. ">O'Brien 1995</a>; <a href="./references#CD007701-bbs2-0030" title="SawaiSK , WilliamsMC , O'BrienWF , AngelJL , MastrogiannisDS , JohnsonL . Sequential outpatient application of intravaginal prostaglandin E2 gel in the management of postdates pregnancies. Obstetrics and Gynecology1991;78(1):19‐23. WilliamsMG , O'BrienWF , SawaiSK , KnuppelRA . Outpatient cervical ripening in the postdates pregnancy. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 Jan 23‐27; Houston, Texas, USA. 1990:533. ">Sawai 1991</a>; <a href="./references#CD007701-bbs2-0031" title="SawaiSK , O'BrienWF , MastrogiannisDS , KrammerJ , MastryMG , PorterGW . Patient‐administered outpatient intravaginal prostaglandin E2 suppositories in post‐date pregnancies: a double‐blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1994;84(5):807‐10. SawaiSK , O'BrienWF , MastrogiannisMS , MastryMG , PorterGW , JohnsonL . Outpatient prostaglandin E2 suppositories in postdates pregnancies. American Journal of Obstetrics and Gynecology1992;166(1 Pt 2):400. ">Sawai 1994</a>). None of the studies collected information on most of the review's main outcomes. We do not have information on the numbers of women achieving vaginal birth within 24 hours, on length of hospital stay, on the use of emergency services or on maternal or caregiver satisfaction. Maternal and perinatal deaths were not reported. </p> <section id="CD007701-sec-0106"> <h5 class="title">Additional induction agents required</h5> <p><a href="./references#CD007701-bbs2-0026" title="O'BrienJM , MercerB , ClearyN , SibaiBM . Efficacy of outpatient induction with low dose intravaginal prostaglandin E2: A randomized, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;172:424. O'BrienJM , MercerBM , ClearyNT , SibaiBM . Efficacy of outpatient induction with low‐dose intravaginal prostaglandin E2: A randomized, double blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;173(6):1855‐9. ">O'Brien 1995</a> and <a href="./references#CD007701-bbs2-0030" title="SawaiSK , WilliamsMC , O'BrienWF , AngelJL , MastrogiannisDS , JohnsonL . Sequential outpatient application of intravaginal prostaglandin E2 gel in the management of postdates pregnancies. Obstetrics and Gynecology1991;78(1):19‐23. WilliamsMG , O'BrienWF , SawaiSK , KnuppelRA . Outpatient cervical ripening in the postdates pregnancy. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 Jan 23‐27; Houston, Texas, USA. 1990:533. ">Sawai 1991</a> reported the numbers of women requiring further (non‐study) induction agents with fewer women in the PGE₂ group needing further medication to induce labour. While 14.8% of the PGE₂ group needed further induction agents this applied to 28.9% of the control group. However, as only two relatively small studies contributed data for this outcome, confidence intervals were wide and very close to the line of no effect (risk ratio (RR) 0.52, 95% confidence interval (CI) 0.27 to 0.99; 150 women; 2 trials; <a href="./references#CD007701-fig-0004" title="">Analysis 1.1</a>). </p> </section> </section> <section id="CD007701-sec-0107"> <h4 class="title">Additional outcomes of interest</h4> <section id="CD007701-sec-0108"> <h5 class="title">Measures of effectiveness</h5> <p>None of the trials reported vaginal birth not achieved within 48 and 72 hours, randomisation to birth interval, or oxytocin augmentation. </p> <section id="CD007701-sec-0109"> <h6 class="title">Pain relief requirements (epidural, opioids)</h6> <p><a href="./references#CD007701-bbs2-0026" title="O'BrienJM , MercerB , ClearyN , SibaiBM . Efficacy of outpatient induction with low dose intravaginal prostaglandin E2: A randomized, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;172:424. O'BrienJM , MercerBM , ClearyNT , SibaiBM . Efficacy of outpatient induction with low‐dose intravaginal prostaglandin E2: A randomized, double blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;173(6):1855‐9. ">O'Brien 1995</a> examined the use of epidural; again, there was no strong evidence of any difference between groups (RR 0.83, 95% CI 0.62 to 1.12; 100 women; 1 study; <a href="./references#CD007701-fig-0005" title="">Analysis 1.2</a>). </p> </section> </section> <section id="CD007701-sec-0110"> <h5 class="title">Complications</h5> <p>There was no clear evidence of differences between women who received vaginal PGE₂ and placebo or expectant management for the following outcomes: </p> <p> <ul id="CD007701-list-0016"> <li> <p>Uterine hyperstimulation (with or without FHR changes ‐ unclear) (RR 3.76, 95% CI 0.64 to 22.24; 244 women; 4 studies; <a href="./references#CD007701-fig-0006" title="">Analysis 1.3</a>; <i>low‐quality evidence</i>). </p> </li> <li> <p>Caesarean section (RR 0.80, 95% CI 0.49 to 1.31; 288 women; 4 studies; <a href="./references#CD007701-fig-0007" title="">Analysis 1.4</a>; <i>low‐quality evidence</i>). </p> </li> <li> <p>Apgar score less than seven at five minutes (RR 0.45, 95% CI 0.07 to 2.93; 180 infants; 2 studies; <a href="./references#CD007701-fig-0008" title="">Analysis 1.5</a>). </p> </li> <li> <p>Neonatal intensive care unit (NICU) admission (RR 0.32, 95% CI 0.10 to 1.03; 230 infants; 3 studies; <a href="./references#CD007701-fig-0009" title="">Analysis 1.6</a>; <i>low‐quality evidence</i>). </p> </li> </ul> </p> <section id="CD007701-sec-0111"> <h6 class="title">Serious maternal complications (considered as separate outcomes, e.g. intensive care unit admission, septicaemia, uterine rupture) </h6> <p>There was only limited information on the impact of interventions on the health of mothers and babies. <a href="./references#CD007701-bbs2-0026" title="O'BrienJM , MercerB , ClearyN , SibaiBM . Efficacy of outpatient induction with low dose intravaginal prostaglandin E2: A randomized, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;172:424. O'BrienJM , MercerBM , ClearyNT , SibaiBM . Efficacy of outpatient induction with low‐dose intravaginal prostaglandin E2: A randomized, double blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;173(6):1855‐9. ">O'Brien 1995</a> and <a href="./references#CD007701-bbs2-0031" title="SawaiSK , O'BrienWF , MastrogiannisDS , KrammerJ , MastryMG , PorterGW . Patient‐administered outpatient intravaginal prostaglandin E2 suppositories in post‐date pregnancies: a double‐blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1994;84(5):807‐10. SawaiSK , O'BrienWF , MastrogiannisMS , MastryMG , PorterGW , JohnsonL . Outpatient prostaglandin E2 suppositories in postdates pregnancies. American Journal of Obstetrics and Gynecology1992;166(1 Pt 2):400. ">Sawai 1994</a> reported rates of chorioamnionitis and results favoured women in the PGE₂ group (RR 0.37, 95% CI 0.15 to 0.90; 180 women; 2 studies; <a href="./references#CD007701-fig-0010" title="">Analysis 1.7</a>). There was no information on the use of antibiotics or on rates of endometritis. </p> <p>Instrumental vaginal birth, perinatal death, postpartum haemorrhage (as defined by the trial authors), and serious neonatal complications (considered as separate outcomes) were not reported by any study. </p> </section> </section> <section id="CD007701-sec-0112"> <h5 class="title">Non‐prespecified outcomes</h5> <p>While none of these five studies reported the numbers of women achieving vaginal birth within a certain specified period, other 'proxy' measures of progress towards labour or birth were included. Each study reported different outcomes. </p> <p><a href="./references#CD007701-bbs2-0013" title="HageP , ShawJ , ZarouD , FleisherJ , WehbehH . Double blind randomized trial to evaluate the role of outpatient use of PGE2 in cervical ripening. American Journal of Obstetrics and Gynecology1993;168(1 Part 2):430. ">Hage 1993</a> reported on the rate of change in Bishop scores and, compared with women receiving PGE₂, those in the control group were more likely to have score changes of less than three at follow‐up (RR 0.13, 95% CI 0.03 to 0.47; 36 women; 1 study; <a href="./references#CD007701-fig-0011" title="">Analysis 1.8</a>) although it was not clear when follow‐up occurred. </p> <p><a href="./references#CD007701-bbs2-0025" title="NewmanM , NewmanR . Multiple‐dose PGE2 cervical ripening on an outpatient basis: safety and efficacy. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S112. ">Newman 1997</a> reported figures for the number of women going into "spontaneous labour" within 48 hours of treatment commencing; it was more likely for labour to start in the PGE₂ group compared with women receiving routine care (RR 6.43, 95% CI 2.12 to 19.48; 58 women; 1 study; <a href="./references#CD007701-fig-0012" title="">Analysis 1.9</a>). </p> <p><a href="./references#CD007701-bbs2-0026" title="O'BrienJM , MercerB , ClearyN , SibaiBM . Efficacy of outpatient induction with low dose intravaginal prostaglandin E2: A randomized, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;172:424. O'BrienJM , MercerBM , ClearyNT , SibaiBM . Efficacy of outpatient induction with low‐dose intravaginal prostaglandin E2: A randomized, double blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;173(6):1855‐9. ">O'Brien 1995</a> reported that the median interval from study enrolment to birth was four days in the PGE₂ group (range 0 to 28 days) versus 10 days (range 0 to 26 days) in the control group (P = 0.002). The shorter interval between randomisation and birth was reflected in a lower gestational age (weeks) at birth in the intervention group (mean difference (MD) ‐0.60 weeks, 95% CI ‐0.99 to ‐0.21; 100 women; 1 study; <a href="./references#CD007701-fig-0014" title="">Analysis 1.11</a>). It was also reported that, during the five‐day treatment period, compared with controls, more women in the intervention group were admitted to hospital "for labour" (RR 2.70, 95% CI 1.47 to 4.97; 100 women; 1 study; <a href="./references#CD007701-fig-0013" title="">Analysis 1.10</a>), although it was not clear whether this included women in active labour only, or women admitted after premature rupture of membranes (PROM) or for other reasons. The numbers of women diagnosed with post‐term pregnancy was small in both groups (2 women in the intervention group and 3 in the control group). </p> <p><a href="./references#CD007701-bbs2-0030" title="SawaiSK , WilliamsMC , O'BrienWF , AngelJL , MastrogiannisDS , JohnsonL . Sequential outpatient application of intravaginal prostaglandin E2 gel in the management of postdates pregnancies. Obstetrics and Gynecology1991;78(1):19‐23. WilliamsMG , O'BrienWF , SawaiSK , KnuppelRA . Outpatient cervical ripening in the postdates pregnancy. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 Jan 23‐27; Houston, Texas, USA. 1990:533. ">Sawai 1991</a> described Bishop scores in control and intervention groups at hospital admission, but there were differences between groups at baseline and the authors report no significant differences between groups at follow‐up (data not shown). <a href="./references#CD007701-bbs2-0031" title="SawaiSK , O'BrienWF , MastrogiannisDS , KrammerJ , MastryMG , PorterGW . Patient‐administered outpatient intravaginal prostaglandin E2 suppositories in post‐date pregnancies: a double‐blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1994;84(5):807‐10. SawaiSK , O'BrienWF , MastrogiannisMS , MastryMG , PorterGW , JohnsonL . Outpatient prostaglandin E2 suppositories in postdates pregnancies. American Journal of Obstetrics and Gynecology1992;166(1 Pt 2):400. ">Sawai 1994</a> reported the mean gestational age (in days) at hospital admission (although the indications for admission included pregnancy complications as well as signs of the onset of labour). There was not a clear difference between groups (MD ‐2.00 days, 95% CI ‐4.17 to 0.17; 80 women; 1 study; <a href="./references#CD007701-fig-0015" title="">Analysis 1.12</a>). </p> </section> </section> <section id="CD007701-sec-0113"> <h4 class="title">2. Intracervical prostaglandin (PGE₂) versus expectant management or placebo: seven studies, 678 women </h4> </section> <section id="CD007701-sec-0114"> <h4 class="title">Main outcomes</h4> <p>We included seven studies in this comparison (<a href="./references#CD007701-bbs2-0005" title="ButtinoLTJr , GariteTJ . Intracervical prostaglandin in postdate pregnancy. A randomized trial. Journal of Reproductive Medicine1990;35(2):155‐8. ">Buttino 1990</a>; <a href="./references#CD007701-bbs2-0011" title="GittensL , SchenkelC , StrassbergS , ApuzzioJ . Vaginal birth after cesarean section: comparison of outpatient use of prostaglandin gel to expectant management. American Journal of Obstetrics and Gynecology1996;174(1 Pt 2):354. ">Gittens 1996</a>; <a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a>; <a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a>; <a href="./references#CD007701-bbs2-0021" title="MagannE , ChauhanSP , NevilsBG , McNamaraMF , KinsellaMJ , MorrisonJC . Management of pregnancies beyond forty‐one weeks' gestation with an unfavorable cervix. American Journal of Obstetrics and Gynecology1998;178(6):1279‐87. ">Magann 1998</a>; <a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a>; <a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a>). </p> <section id="CD007701-sec-0115"> <h5 class="title">Additional induction agents required</h5> <p>Three studies (<a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a>; <a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a>; <a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a>) looked at whether, compared with no treatment or placebo, women receiving intracervical PGE₂ were less likely to need further (non‐study) interventions to induce labour. There was no strong evidence of a difference between groups (RR 0.98, 95% CI 0.74 to 1.32; 445 women; 3 studies; <a href="./references#CD007701-fig-0016" title="">Analysis 2.1</a>). <a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a> also examined whether women given intracervical PGE₂ were less likely to receive further doses of prostaglandin to induce labour. Again, there was no evidence to suggest a difference between groups (RR 0.61, 95% CI 0.22 to 1.67; 90 women; 1 study; <a href="./references#CD007701-fig-0017" title="">Analysis 2.2</a>). </p> <section id="CD007701-sec-0116"> <h6 class="title">Serious maternal morbidity or death (composite outcome will include, for example, uterine rupture, admission to intensive care unit, septicaemia) </h6> <p><a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a> reported rates of uterine rupture, and there were no events in either the PGE₂ group or control group participants (<a href="./references#CD007701-fig-0018" title="">Analysis 2.3</a>). </p> <p>There was no information on vaginal birth not achieved within 24 hours, length of hospital stay, use of emergency services, maternal or caregiver satisfaction, or serious neonatal morbidity or perinatal death. </p> </section> </section> </section> <section id="CD007701-sec-0117"> <h4 class="title">Additional outcomes of interest</h4> <section id="CD007701-sec-0118"> <h5 class="title">Measures of effectiveness</h5> <section id="CD007701-sec-0119"> <h6 class="title">Vaginal birth not achieved within 48 and 72 hours</h6> <p><a href="./references#CD007701-bbs2-0005" title="ButtinoLTJr , GariteTJ . Intracervical prostaglandin in postdate pregnancy. A randomized trial. Journal of Reproductive Medicine1990;35(2):155‐8. ">Buttino 1990</a> reported on the number of women not giving birth within 48 to 72 hours, and although results favoured the PGE₂ group, did not show a clear difference as the confidence intervals just crossed the line of no effect (RR 0.83, 95% CI 0.68 to 1.02; 43 women; 1 study; <a href="./references#CD007701-fig-0019" title="">Analysis 2.4</a>; <i>low‐quality evidence</i>). </p> </section> <section id="CD007701-sec-0120"> <h6 class="title">Oxytocin augmentation</h6> <p>There was no strong evidence of differences between groups for the number of women who received oxytocin augmentation (RR 0.67, 95% CI 0.40 to 1.12; 84 women; 1 study; <a href="./references#CD007701-fig-0020" title="">Analysis 2.5</a>). </p> <p>Randomisation to birth interval, and pain relief requirements were not reported under this comparison. </p> <p><b>Complications</b> </p> <p>The impact of interventions on maternal health were explored in five studies (<a href="./references#CD007701-bbs2-0005" title="ButtinoLTJr , GariteTJ . Intracervical prostaglandin in postdate pregnancy. A randomized trial. Journal of Reproductive Medicine1990;35(2):155‐8. ">Buttino 1990</a>; <a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a>; <a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a>; <a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a>; <a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a>). </p> <p>There was no clear evidence of differences between women who received intracervical PGE₂ and placebo or expectant management for the following outcomes: </p> <p> <ul id="CD007701-list-0017"> <li> <p>Uterine hyperstimulation (with FHR changes) (RR 2.66, 95% CI 0.63 to 11.25; 488 women; 4 studies; <a href="./references#CD007701-fig-0021" title="">Analysis 2.6</a>; <i>low‐quality evidence</i>). </p> </li> <li> <p>Assisted (instrumental) vaginal birth (RR 1.29, 95% CI 0.85 to 1.96; 538 women; 4 studies; <a href="./references#CD007701-fig-0022" title="">Analysis 2.7</a>). </p> </li> <li> <p>Caesarean section (RR 0.90, 95% CI 0.72 to 1.12; 674 women; 7 studies; <a href="./references#CD007701-fig-0023" title="">Analysis 2.8</a>; <i>moderate‐quality evidence</i>). </p> </li> <li> <p>Apgar score less than seven at five minutes (RR 0.82, 95% CI 0.42 to 1.60; 515 infants; 4 studies; <a href="./references#CD007701-fig-0024" title="">Analysis 2.9</a>). </p> </li> <li> <p>NICU admission (RR 1.61, 95% CI 0.43 to 6.05; 215 infants; 3 studies; <a href="./references#CD007701-fig-0025" title="">Analysis 2.10</a>; <i>low‐quality evidence</i>). </p> </li> <li> <p>Postpartum haemorrhage (RR 3.10, 95% CI 0.13 to 73.16; 61 women; 1 study; <a href="./references#CD007701-fig-0026" title="">Analysis 2.11</a>). </p> </li> <li> <p>Serious maternal complications (considered as separate outcomes, e.g. intensive care unit admission, septicaemia, uterine rupture) </p> <ul id="CD007701-list-0018"> <li> <p>Chorioamnionitis (RR 2.03, 95% CI 0.66 to 6.18; 468 women; 3 studies; <a href="./references#CD007701-fig-0027" title="">Analysis 2.12</a>). </p> </li> <li> <p>Endometritis (RR 1.60, 95% CI 0.27 to 9.37; 174 women; 2 studies; <a href="./references#CD007701-fig-0028" title="">Analysis 2.13</a>). </p> </li> <li> <p>Maternal side effects (RR 0.59, 95% CI 0.13 to 2.77; 384 women; 2 studies; <a href="./references#CD007701-fig-0029" title="">Analysis 2.14</a>). </p> </li> </ul> </li> </ul> </p> <p>The included studies did not provide information on other review outcomes including uterine hyperstimulation (without FHR changes), perinatal death, other serious maternal complications such as admission to intensive care, and other serious neonatal complications such as the use of antibiotics, and neonatal infection. </p> </section> </section> <section id="CD007701-sec-0121"> <h5 class="title">Non‐prespecified outcomes</h5> <p>All seven studies collected information on progress towards labour and birth; again reported outcomes were different in each study (<a href="./references#CD007701-bbs2-0005" title="ButtinoLTJr , GariteTJ . Intracervical prostaglandin in postdate pregnancy. A randomized trial. Journal of Reproductive Medicine1990;35(2):155‐8. ">Buttino 1990</a>; <a href="./references#CD007701-bbs2-0011" title="GittensL , SchenkelC , StrassbergS , ApuzzioJ . Vaginal birth after cesarean section: comparison of outpatient use of prostaglandin gel to expectant management. American Journal of Obstetrics and Gynecology1996;174(1 Pt 2):354. ">Gittens 1996</a>; <a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a>; <a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a>; <a href="./references#CD007701-bbs2-0021" title="MagannE , ChauhanSP , NevilsBG , McNamaraMF , KinsellaMJ , MorrisonJC . Management of pregnancies beyond forty‐one weeks' gestation with an unfavorable cervix. American Journal of Obstetrics and Gynecology1998;178(6):1279‐87. ">Magann 1998</a>; <a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a>; <a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a>). </p> <p><a href="./references#CD007701-bbs2-0005" title="ButtinoLTJr , GariteTJ . Intracervical prostaglandin in postdate pregnancy. A randomized trial. Journal of Reproductive Medicine1990;35(2):155‐8. ">Buttino 1990</a> and <a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a> reported no differences between women in the PGE₂ and control groups in the time interval (days) between the first dose of drug or placebo and birth (SMD ‐0.20 days, 95% CI ‐0.55 to 0.14; 133 women; 2 studies; <a href="./references#CD007701-fig-0030" title="">Analysis 2.15</a>). </p> <p><a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a> found no differences between groups for the median number of days from recruitment to hospital admission (16.8 days for the PGE₂ group versus 15.4 days for the control group (data not shown)). For other outcomes reported in this study (Bishop score on admission, and estimated gestational age on admission) there were no clear differences between groups. However, some women were admitted for induction rather than in labour and it was not clear if these mean figures included all women. </p> <p><a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a> and <a href="./references#CD007701-bbs2-0021" title="MagannE , ChauhanSP , NevilsBG , McNamaraMF , KinsellaMJ , MorrisonJC . Management of pregnancies beyond forty‐one weeks' gestation with an unfavorable cervix. American Journal of Obstetrics and Gynecology1998;178(6):1279‐87. ">Magann 1998</a> reported the estimated gestational age at birth (in weeks) and found no difference between groups for this outcome (MD ‐0.06 weeks, 95% CI ‐0.35 to 0.23; 156 women; 2 studies; I² = 85%; Tau² = 0.04; Chi² = 6.79; <a href="./references#CD007701-fig-0031" title="">Analysis 2.16</a>) (there was high heterogeneity for this outcome and results should be interpreted with caution). <a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a> and <a href="./references#CD007701-bbs2-0021" title="MagannE , ChauhanSP , NevilsBG , McNamaraMF , KinsellaMJ , MorrisonJC . Management of pregnancies beyond forty‐one weeks' gestation with an unfavorable cervix. American Journal of Obstetrics and Gynecology1998;178(6):1279‐87. ">Magann 1998</a> provided information on the number of women requiring induction for 'postdates' pregnancy (women reaching 42 weeks' gestation). In view of high heterogeneity and different clinical management in the two studies, we did not pool results for this outcome but have set out the data in <a href="./references#CD007701-fig-0032" title="">Analysis 2.17</a>. While in the <a href="./references#CD007701-bbs2-0021" title="MagannE , ChauhanSP , NevilsBG , McNamaraMF , KinsellaMJ , MorrisonJC . Management of pregnancies beyond forty‐one weeks' gestation with an unfavorable cervix. American Journal of Obstetrics and Gynecology1998;178(6):1279‐87. ">Magann 1998</a> study more women in the control group required induction (22 of 35 women) compared to the PGE₂ group (7 of 35 women) the results were difficult to interpret as some women had been admitted to hospital for induction at an earlier stage because of changes in Bishop score or for other reasons. </p> <p><a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a> reported the median time from recruitment to admission to hospital; the interval was shorter in the PGE₂ group compared with control group participants (2.5 days versus 7 days, P = 0.02). However, reasons for admission included change in Bishop score, as well as for onset of labour. <a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a> also reported the number of women delivering within two days of commencing treatment; more women gave birth within two days if they had the active treatment (RR 3.10, 95% CI 1.29 to 7.47; 61 women; 1 study; <a href="./references#CD007701-fig-0033" title="">Analysis 2.18</a>). </p> <p><a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a> reported the numbers of women delivering at various gestational ages (all deliveries). There were no clear differences between groups at any of the time points measured (data not shown). </p> </section> </section> <section id="CD007701-sec-0122"> <h4 class="title">3. Vaginal misoprostol versus placebo: four studies, 274 women</h4> <p>Four studies compared vaginal misoprostol with placebo (<a href="./references#CD007701-bbs2-0015" title="IncerpiM , FassettM , KjosS , TranS , WingD . Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S120. IncerpiMH , FassettMJ , KjosSL , TranSH , WingDA . Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology2001;185(4):916‐9. ">Incerpi 2001</a>; <a href="./references#CD007701-bbs2-0023" title="McKennaDS , EsterJB , ProffittM , WaddellKR . Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial. Obstetrics and Gynecology2004;104(3):579‐84. ">McKenna 2004</a>; <a href="./references#CD007701-bbs2-0027" title="OboroVO , TaboweiTO . Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post‐term pregnancy. Acta Obstetricia et Gynecologica Scandinavica2005;84(7):628‐31. ">Oboro 2005</a>; <a href="./references#CD007701-bbs2-0034" title="StitelyML , BrowningJ , FowlerM , GendronRT , GhermanRB . Outpatient cervical ripening with intravaginal misoprostol. Obstetrics and Gynecology2000;96(5 Pt 1):684‐8. ">Stitely 2000</a>). In all four studies the initial dose of misoprostol was 25 µg; in the study by <a href="./references#CD007701-bbs2-0015" title="IncerpiM , FassettM , KjosS , TranS , WingD . Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S120. IncerpiMH , FassettMJ , KjosSL , TranSH , WingDA . Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology2001;185(4):916‐9. ">Incerpi 2001</a> women received a second dose after three to four days if labour had not commenced, and in the study by <a href="./references#CD007701-bbs2-0034" title="StitelyML , BrowningJ , FowlerM , GendronRT , GhermanRB . Outpatient cervical ripening with intravaginal misoprostol. Obstetrics and Gynecology2000;96(5 Pt 1):684‐8. ">Stitely 2000</a> a second dose was administered after one day. </p> </section> <section id="CD007701-sec-0123"> <h4 class="title">Main outcomes</h4> <section id="CD007701-sec-0124"> <h5 class="title">Serious neonatal morbidity or perinatal death (composite outcome will include, for example, seizures, birth asphyxia defined by trialists, neonatal encephalopathy, disability in childhood) </h5> <p>For this comparison, only <a href="./references#CD007701-bbs2-0027" title="OboroVO , TaboweiTO . Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post‐term pregnancy. Acta Obstetricia et Gynecologica Scandinavica2005;84(7):628‐31. ">Oboro 2005</a> reported on the rate of perinatal death with no clear differences between groups; there were no deaths in the active treatment group (N = 38) compared with one stillbirth (reason not reported) in the control group (N = 39) (RR 0.34, 95% CI 0.01 to 8.14; 77 infants; 1 study; <a href="./references#CD007701-fig-0034" title="">Analysis 3.1</a>; <i>low‐quality evidence</i>). </p> <p>There was no information on other review outcomes such as failure to achieve vaginal birth within 24 hours, additional induction agents required, length of hospital stay, use of emergency services, maternal or caregiver satisfaction, and serious maternal morbidity or death. </p> </section> </section> <section id="CD007701-sec-0125"> <h4 class="title">Additional outcomes of interest</h4> <section id="CD007701-sec-0126"> <h5 class="title">Measures of effectiveness</h5> <section id="CD007701-sec-0127"> <h6 class="title">Oxytocin augmentation</h6> <p>No study reported rates of oxytocin augmentation between groups; however, mean dose of oxytocin used was reported in <a href="./references#CD007701-bbs2-0015" title="IncerpiM , FassettM , KjosS , TranS , WingD . Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S120. IncerpiMH , FassettMJ , KjosSL , TranSH , WingDA . Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology2001;185(4):916‐9. ">Incerpi 2001</a>, and is described in <i>Non‐prespecified outcomes</i>. </p> </section> <section id="CD007701-sec-0128"> <h6 class="title">Pain relief requirements (epidural, opioids)</h6> <p><a href="./references#CD007701-bbs2-0023" title="McKennaDS , EsterJB , ProffittM , WaddellKR . Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial. Obstetrics and Gynecology2004;104(3):579‐84. ">McKenna 2004</a> reported similar numbers of women in each group had epidural anaesthesia (RR 0.98, 95% CI 0.77 to 1.26; 50 women; 1 study; <a href="./references#CD007701-fig-0035" title="">Analysis 3.2</a>). Opioid use was not reported. </p> <p>Vaginal birth not achieved within 48 and 72 hours, and randomisation to birth interval were not reported in any study. </p> </section> </section> <section id="CD007701-sec-0129"> <h5 class="title">Complications</h5> <p>There was little information from these studies on the impact of interventions on mothers' and babies' health. </p> <p>There was no clear evidence of differences between women who received vaginal misoprostol and placebo for the following outcomes: </p> <p> <ul id="CD007701-list-0019"> <li> <p>Uterine hyperstimulation (with fetal heart rate (FHR) changes) (RR 1.97, 95% CI 0.43 to 9.00; 265 women; 3 studies; <a href="./references#CD007701-fig-0036" title="">Analysis 3.3</a>; <i>low‐quality evidence</i>). </p> </li> <li> <p>Uterine hyperstimulation (without FHR changes) (RR 3.64, 95% CI 0.15 to 85.97; 137 women; 2 studies; <a href="./references#CD007701-fig-0037" title="">Analysis 3.4</a>). </p> </li> <li> <p>Instrumental vaginal birth (RR 0.91, 95% CI 0.50 to 1.67; 145 women; 2 studies; <a href="./references#CD007701-fig-0038" title="">Analysis 3.5</a>). </p> </li> <li> <p>Caesarean section (RR 0.94, 95% CI 0.61 to 1.46; 325 women; 4 studies; <a href="./references#CD007701-fig-0039" title="">Analysis 3.6</a>; <i>low‐quality evidence</i>). </p> </li> <li> <p>Apgar score less than seven at five minutes (RR 0.21, 95% CI 0.01 to 4.25; 248 infants; 3 studies; <a href="./references#CD007701-fig-0040" title="">Analysis 3.7</a>). </p> </li> <li> <p>NICU admission (RR 0.89, 95% CI 0.54 to 1.47; 325 infants; 4 studies; <a href="./references#CD007701-fig-0041" title="">Analysis 3.8</a>; <i>low‐quality evidence</i>). </p> </li> <li> <p>Serious neonatal complications (considered as separate outcomes).</p> <ul id="CD007701-list-0020"> <li> <p>Neonatal infection (RR 0.30, 95% CI 0.07 to 1.36; 68 infants; 1 study; <a href="./references#CD007701-fig-0043" title="">Analysis 3.10</a>). </p> </li> </ul> </li> </ul> </p> <p>No information was provided in these studies on other review outcomes including postpartum haemorrhage, use of neonatal antibiotics or other maternal or neonatal complications. </p> </section> <section id="CD007701-sec-0130"> <h5 class="title">Non‐prespecified outcomes</h5> <p><a href="./references#CD007701-bbs2-0015" title="IncerpiM , FassettM , KjosS , TranS , WingD . Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S120. IncerpiMH , FassettMJ , KjosSL , TranSH , WingDA . Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology2001;185(4):916‐9. ">Incerpi 2001</a> reported the mean dose of oxytocin used for each group; there was no evidence of any difference between the groups (MD 1508.70 mU, 95% CI ‐2357.55 to 5374.95; 72 women; 1 study; <a href="./references#CD007701-fig-0044" title="">Analysis 3.11</a>). </p> <p><a href="./references#CD007701-bbs2-0034" title="StitelyML , BrowningJ , FowlerM , GendronRT , GhermanRB . Outpatient cervical ripening with intravaginal misoprostol. Obstetrics and Gynecology2000;96(5 Pt 1):684‐8. ">Stitely 2000</a> gave information about the number doses of medication given to the women (MD ‐0.44, 95% CI ‐0.49 to ‐0.39; 60 women; 1 study; <a href="./references#CD007701-fig-0045" title="">Analysis 3.12</a>) and the number of women requiring subsequent doses on study days two and three; fewer women received further doses in the intravaginal misoprostol group (P &lt; 0.01 for both time points: day two RR 0.61, 95% CI 0.43 to 0.87; 60 women; 1 study; <a href="./references#CD007701-fig-0046" title="">Analysis 3.13</a>, day three RR 0.13, 95% CI 0.04 to 0.38; 60 women; 1 study; <a href="./references#CD007701-fig-0047" title="">Analysis 3.14</a>). </p> <p><a href="./references#CD007701-bbs2-0027" title="OboroVO , TaboweiTO . Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post‐term pregnancy. Acta Obstetricia et Gynecologica Scandinavica2005;84(7):628‐31. ">Oboro 2005</a> reported that the interval from the commencement of treatment to hospital admission (in days) was shorter for the misoprostol group both for nulliparous and parous women (MD ‐2.90 days, 95% CI ‐4.99 to ‐0.81; 77 women; 1 study; <a href="./references#CD007701-fig-0048" title="">Analysis 3.15</a>). Data are shown separately for nulliparous and parous women in <a href="./references#CD007701-fig-0049" title="">Analysis 3.16</a>. There was also evidence from this trial that the gestational age at labour (in weeks) was reduced in the misoprostol group compared with women in the control group, with labour approximately a week earlier in the misoprostol group (MD ‐0.80 weeks, 95% CI ‐1.05 to ‐0.55; 77 women; 1 study; <a href="./references#CD007701-fig-0050" title="">Analysis 3.17</a>). There was also evidence that the time to preterm rupture of membranes (in days) was shorter in the misoprostol group (MD ‐2.50 days, 95% CI ‐4.14 to ‐0.86; 77 women; 1 study; <a href="./references#CD007701-fig-0052" title="">Analysis 3.19</a>), although it was not clear whether this was the interval from commencement of treatment or from hospital admission. </p> <p><a href="./references#CD007701-bbs2-0023" title="McKennaDS , EsterJB , ProffittM , WaddellKR . Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial. Obstetrics and Gynecology2004;104(3):579‐84. ">McKenna 2004</a> provided data on the interval from treatment to vaginal birth (in days); the difference between groups was not clear (MD ‐1.40 days, 95% CI ‐3.51 to 0.71; 50 women; 1 study; <a href="./references#CD007701-fig-0053" title="">Analysis 3.20</a>). <a href="./references#CD007701-bbs2-0023" title="McKennaDS , EsterJB , ProffittM , WaddellKR . Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial. Obstetrics and Gynecology2004;104(3):579‐84. ">McKenna 2004</a> also reported the mean interval from recruitment to birth (in days), which was less for the misoprostol group compared with women receiving placebo (<a href="./references#CD007701-fig-0054" title="">Analysis 3.21</a>); information was provided separately for nulliparous and multiparous women (<a href="./references#CD007701-fig-0055" title="">Analysis 3.22</a>). It was not clear whether the figures included those women who had caesarean sections or other interventions in labour. </p> </section> </section> <section id="CD007701-sec-0131"> <h4 class="title">4. Vaginal misoprostol 25 µg versus 50 µg: one study with 52 women</h4> <p><a href="./references#CD007701-bbs2-0016" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynaecology and Obstetrics2005;88(2):108‐11. ">Kipikasa 2005</a> looked at two different doses of vaginal misoprostol. </p> </section> <section id="CD007701-sec-0132"> <h4 class="title">Main outcomes</h4> <section id="CD007701-sec-0133"> <h5 class="title">Additional induction agents required</h5> <p>There were no differences between groups in the number of women requiring further induction agents (oxytocin) (RR 2.26, 95% CI 0.22 to 23.33; 49 women; 1 study; <a href="./references#CD007701-fig-0056" title="">Analysis 4.1</a>). </p> <p>There was no information on any other of the review's main outcomes: vaginal birth not achieved within 24 hours, length of hospital stay, use of emergency services, maternal or caregiver satisfaction, serious neonatal morbidity or perinatal death (composite outcome will include, for example, seizures, birth asphyxia defined by trialists, neonatal encephalopathy, disability in childhood), and serious maternal morbidity or death (composite outcome will include, for example, uterine rupture, admission to intensive care unit, septicaemia). </p> </section> </section> <section id="CD007701-sec-0134"> <h4 class="title">Additional outcomes</h4> <section id="CD007701-sec-0135"> <h5 class="title">Measures of effectiveness</h5> <p>No outcomes of measures of effectiveness were reported: vaginal birth not achieved within 48 and 72 hours, randomisation to birth interval, oxytocin augmentation, pain relief requirements (epidural, opioids). </p> </section> <section id="CD007701-sec-0136"> <h5 class="title">Complications</h5> <p>There was little difference between groups for the following outcomes:</p> <p> <ul id="CD007701-list-0021"> <li> <p>uterine hyperstimulation ‐ there were no cases of hyperstimulation in either group (<a href="./references#CD007701-fig-0057" title="">Analysis 4.2</a>); </p> </li> <li> <p>rates of caesarean section (RR 0.94, 95% CI 0.33 to 2.68; 49 women; 1 study; <a href="./references#CD007701-fig-0058" title="">Analysis 4.3</a>); and </p> </li> <li> <p>NICU admission (RR 0.57, 95% CI 0.05 to 5.83; 49 infants; 1 study; <a href="./references#CD007701-fig-0059" title="">Analysis 4.4</a>). </p> </li> </ul> </p> <section id="CD007701-sec-0137"> <h6 class="title">Apgar score</h6> <p>One baby in the higher dose group had a low Apgar score (&lt; 6) at five minutes (data not shown). </p> <p>There was no information on instrumental vaginal birth, perinatal death, postpartum haemorrhage (as defined by the trial authors), serious maternal complications (considered as separate outcomes, e.g. intensive care unit admission, septicaemia, uterine rupture), or serious neonatal complications (considered as separate outcomes). </p> </section> </section> <section id="CD007701-sec-0138"> <h5 class="title">Non‐prespecified outcomes</h5> <p>The interval to birth (in days) was reported to be shorter in the group receiving the higher dose of misoprostol; with women receiving 50 µg delivering, on average, one and a half days earlier than those receiving 25 µg (MD 1.50 days, 95% CI 1.19 to 1.81; 49 women; 1 study; <a href="./references#CD007701-fig-0060" title="">Analysis 4.5</a>). </p> </section> </section> <section id="CD007701-sec-0139"> <h4 class="title">5. Intracervical PGE₂ versus vaginal misoprostol: one study, 84 women</h4> </section> <section id="CD007701-sec-0140"> <h4 class="title">Main outcomes</h4> <p>One study is included in this comparison between intracervical PGE₂ and vaginal misoprostol (<a href="./references#CD007701-bbs2-0024" title="MeyerM , PflumJ . Outpatient administration of misoprostol decreases induction time. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S167. MeyerM , PflumJ , HowardD . Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial. Obstetrics and Gynecology2005;105(3):466‐72. ">Meyer 2005</a>). None of the review's primary outcomes were considered in this study. </p> </section> <section id="CD007701-sec-0141"> <h4 class="title">Additional outcomes</h4> <section id="CD007701-sec-0142"> <h5 class="title">Measures of effectiveness</h5> <p>No outcomes of measures of effectiveness were reported.</p> </section> <section id="CD007701-sec-0143"> <h5 class="title">Complications</h5> <p>There was no strong evidence of differences between intervention and control groups for the following outcomes: </p> <p> <ul id="CD007701-list-0022"> <li> <p>uterine hyperstimulation (with or without FHR changes) (RR 0.26, 95% CI 0.03 to 2.73; 64 women; 1 study; <a href="./references#CD007701-fig-0061" title="">Analysis 5.1</a>); </p> </li> <li> <p>caesarean section (RR 0.89, 95% CI 0.38 to 2.08; 84 women; 1 study; <a href="./references#CD007701-fig-0062" title="">Analysis 5.2</a>) </p> </li> <li> <p>Apgar scores less than seven at five minutes (RR 0.33, 95% CI 0.01 to 7.96; 84 infants; 1 study; <a href="./references#CD007701-fig-0063" title="">Analysis 5.3</a>); and </p> </li> <li> <p>NICU admission (RR 1.25, 95% CI 0.36 to 4.33; 84 women; 1 study; <a href="./references#CD007701-fig-0064" title="">Analysis 5.4</a>). </p> </li> </ul> </p> <p>There was no information on instrumental vaginal birth, perinatal death, postpartum haemorrhage (as defined by the trial authors), serious maternal complications (considered as separate outcomes, e.g. intensive care unit admission, septicaemia, uterine rupture), or serious neonatal complications (considered as separate outcomes). </p> </section> <section id="CD007701-sec-0144"> <h5 class="title">Non‐prespecified outcomes</h5> <p>It was reported that the proportion of women not requiring oxytocin was 22% in the misoprostol group versus 2% in for those in the PGE₂ group (P = 0.006). The dose of oxytocin used was also reported to be decreased in those women receiving misoprostol (P = 0.008 for cumulative dose of oxytocin) (data not shown) (<a href="./references#CD007701-bbs2-0024" title="MeyerM , PflumJ . Outpatient administration of misoprostol decreases induction time. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S167. MeyerM , PflumJ , HowardD . Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial. Obstetrics and Gynecology2005;105(3):466‐72. ">Meyer 2005</a>). </p> <p>The interval from the administration of the cervical ripening agent to admission (hours) was shorter for women who received misoprostol (MD 2.50 hours, 95% CI 2.22 to 2.78; 75 women; 1 study; <a href="./references#CD007701-fig-0065" title="">Analysis 5.5</a>), and misoprostol was also reported to increase by 32% the number of women starting labour or with SROM during the ripening period (RR 0.31, 95% CI 0.14 to 0.69; 83 women; 1 study; <a href="./references#CD007701-fig-0066" title="">Analysis 5.6</a>). </p> <p>Misoprostol was reported to increase the number of deliveries within 24 and 48 hours (RR 0.90, 95% CI 0.75 to 1.07; <a href="./references#CD007701-fig-0067" title="">Analysis 5.7</a>; and RR 0.93, 95% CI 0.81 to 1.06; <a href="./references#CD007701-fig-0068" title="">Analysis 5.8</a> (respectively); 83 women; 1 study), but the differences between groups were not clear. </p> </section> </section> <section id="CD007701-sec-0145"> <h4 class="title">6. Oral misoprostol versus placebo: two studies, 127 women</h4> </section> <section id="CD007701-sec-0146"> <h4 class="title">Main outcomes</h4> <p>Two studies were included in this comparison (<a href="./references#CD007701-bbs2-0008" title="GaffaneyCA , SaulLL , RumneyPJ , MorrisonEH , ThomasS , NageotteMP , et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. American Journal of Perinatology2009;26(9):673‐7. ">Gaffaney 2009</a>; <a href="./references#CD007701-bbs2-0020" title="LyonsC , RumneyP , HuangW , MorrisonE , ThomasS , NageotteM , et al. Outpatient cervical ripening with oral misoprostol post‐term: induction rates decreased. American Journal of Obstetrics and Gynecology2001;184(1):S116. ">Lyons 2001</a>). <a href="./references#CD007701-bbs2-0008" title="GaffaneyCA , SaulLL , RumneyPJ , MorrisonEH , ThomasS , NageotteMP , et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. American Journal of Perinatology2009;26(9):673‐7. ">Gaffaney 2009</a> was assessed as being at high risk of attrition bias so should have been removed according to the pre‐specified sensitivity analysis. However, there were insufficient studies in this comparison for meaningful sensitivity analysis. </p> <section id="CD007701-sec-0147"> <h5 class="title">Vaginal birth not achieved within 24 hours</h5> <p>Women in the oral misoprostol group had a higher rate of vaginal birth achieved within 24 hours (RR 0.65, 95% CI 0.48 to 0.86; 87 women; 1 study; <a href="./references#CD007701-fig-0069" title="">Analysis 6.1</a>). </p> </section> <section id="CD007701-sec-0148"> <h5 class="title">Additional induction agents required</h5> <p>Women in the oral misoprostol group had lower rates of additional induction agents compared to the placebo group (RR 0.60, 95% CI 0.37 to 0.97; 127 women; 2 studies; <a href="./references#CD007701-fig-0070" title="">Analysis 6.2</a>). </p> <p>There was no information for length of hospital stay, use of emergency services, maternal or caregiver satisfaction, serious neonatal morbidity or perinatal death, or serious maternal morbidity or death. </p> </section> </section> <section id="CD007701-sec-0149"> <h4 class="title">Additional outcomes</h4> <section id="CD007701-sec-0150"> <h5 class="title">Measures of effectiveness</h5> <section id="CD007701-sec-0151"> <h6 class="title">Oxytocin augmentation</h6> <p>There was no evidence of a difference between groups for women who received oxytocin augmentation (RR 0.81, 95% CI 0.61 to 1.08; 87 women; 1 study; <a href="./references#CD007701-fig-0071" title="">Analysis 6.3</a>). </p> <p>Vaginal birth not achieved within 48 and 72 hours, randomisation to birth interval, and pain relief requirements (epidural, opioids) were not reported. </p> </section> </section> <section id="CD007701-sec-0152"> <h5 class="title">Complications</h5> <p>There was no evidence of differences between the misoprostol and placebo groups for the following outcomes: </p> <p> <ul id="CD007701-list-0023"> <li> <p>uterine hyperstimulation with FHR changes (RR 1.53, 95% CI 0.47 to 5.06; 87 women; 1 studies; <a href="./references#CD007701-fig-0072" title="">Analysis 6.4</a>), or where it was unclear if there were FHR changes (RR 0.61, 95% CI 0.06 to 6.21; 40 women; 1 study; <a href="./references#CD007701-fig-0073" title="">Analysis 6.5</a>); </p> </li> <li> <p>rate of instrumental vaginal birth (RR 0.51, 95% CI 0.17 to 1.57; 87 women; 1 study; <a href="./references#CD007701-fig-0074" title="">Analysis 6.6</a>); </p> </li> <li> <p>rate of caesarean section (RR 0.62, 95% CI 0.28 to 1.33; 86 women; 1 study; <a href="./references#CD007701-fig-0075" title="">Analysis 6.7</a>); </p> </li> <li> <p>Apgar scores of less than seven at five minutes (there were none in either group) (<a href="./references#CD007701-fig-0076" title="">Analysis 6.8</a>); </p> </li> <li> <p>NICU admission (RR 1.02, 95% CI 0.07 to 15.84; 87 infants; 1 study; <a href="./references#CD007701-fig-0077" title="">Analysis 6.9</a>); </p> </li> <li> <p>postpartum haemorrhage (RR 5.11, 95% CI 0.25 to 103.51; 87 women; 1 study; <a href="./references#CD007701-fig-0078" title="">Analysis 6.10</a>); </p> </li> <li> <p>serious maternal complications:</p> <ul id="CD007701-list-0024"> <li> <p>chorioamnionitis (RR 1.06, 95% CI 0.52 to 2.17; 124 women; 2 studies; <a href="./references#CD007701-fig-0079" title="">Analysis 6.11</a>); and </p> </li> <li> <p>endometritis (RR 0.51, 95% CI 0.05 to 5.44; 87 women; 1 study; <a href="./references#CD007701-fig-0080" title="">Analysis 6.12</a>). </p> </li> </ul> </li> </ul> </p> <p>Perinatal death, other serious maternal complication, and serious neonatal complications are not reported. </p> </section> <section id="CD007701-sec-0153"> <h5 class="title">Non‐pre‐specified outcomes</h5> <p>Oral misoprostol may be associated with a reduction in the times (hours) from first dose to active labour and first dose to birth (MD ‐37.08, 95% CI ‐52.44 to ‐21.72; 127 women; 2 studies; <a href="./references#CD007701-fig-0081" title="">Analysis 6.13</a>, and MD ‐37.94, 95% CI ‐57.97 to ‐17.91; 87 women; 1 study; <a href="./references#CD007701-fig-0082" title="">Analysis 6.14</a>), which is reflected in the larger total doses of medication in the placebo group (MD ‐0.51, 95% CI ‐0.92 to ‐0.10; 40 women; 1 study; <a href="./references#CD007701-fig-0083" title="">Analysis 6.15</a>). </p> </section> </section> <section id="CD007701-sec-0154"> <h4 class="title">7. Mifepristone versus placebo: five studies, 393 women</h4> <p>We included five studies in this comparison (<a href="./references#CD007701-bbs2-0006" title="ElliotCL , BrennandJE , CalderAA . The effect of mifepristone (RU486) on cervical ripening and induction of labour in human pregnancy. 27th British Congress of Obstetrics and Gynaecology; 1995 July 4‐7; Dublin, Ireland. 1995:207. ElliottCL , BrennandJE , CalderAA . The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstetrics and Gynecology1998;92(5):804‐9. ">Elliott 1998</a>; <a href="./references#CD007701-bbs2-0007" title="FrydmanR , BatonC , LelaidierC , VialM , BourgetP , FernandezH . Mifepristone for induction of labour. Lancet1991;337(8739):488‐9. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1992;80(6):972‐5. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double‐blind, randomized, placebo‐controlled study. International Journal of Gynecology and Obstetrics1993;42(2):220. FrydmanR , TaylorS , PaoliC , PouradeA . RU 486 (mifepristone): A new tool for labour induction in term women with fetus alive [Le RU 486 (mifepristone) un novel outil pour le declenchment du travail a terme]. Contraception, Fertilite, Sexualite1992;20(12):1133‐6. LelaidierC , BeniflaJL , FernandezH , BatonC , BourgetP , BourrierMC , et al. RU 486 (mifepristone) in medical indications for labour induction in pregnancies at term: results of a randomized, double‐blind study of RU 486 vs placebo. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1993;22:92‐100. ">Frydman 1992</a>; <a href="./references#CD007701-bbs2-0010" title="GiacalonePL , TargoszV , LaffargueF , BoogG , FaureJM . Cervical ripening with mifepristone before labor induction: a randomized study. Obstetrics and Gynecology1998;92(4 Pt 1):487‐92. ">Giacalone 1998</a>; <a href="./references#CD007701-bbs2-0018" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101(6):501‐3. ">Lelaidier 1994</a>; <a href="./references#CD007701-bbs2-0033" title="StenlundPM , BygdemanM , EkmanG . Induction of labor with mifepristone (RU 486). A randomized double‐blind study in post‐term pregnant women with unripe cervices. Acta Obstetricia et Gynecologica Scandinavica Supplement1994;73(161):Abstract FP50. StenlundPM , EkmanG , AedoAR , BygdemanM . Induction of labour with mifepristone ‐ a randomized double‐blind study versus placebo. Acta Obstetricia et Gynecologica Scandinavica1999;78:793‐8. ">Stenlund 1999</a>). </p> </section> <section id="CD007701-sec-0155"> <h4 class="title">Main outcomes</h4> <section id="CD007701-sec-0156"> <h5 class="title">Additional induction agents required</h5> <p>Women in the mifepristone group were less likely to require further medication to induce labour compared with those in the control group (average RR 0.59, 95% CI 0.37 to 0.95; 311 women; 4 studies; I² = 74%; <a href="./references#CD007701-fig-0084" title="">Analysis 7.1</a>). However, there was considerable heterogeneity for this outcome (I² = 74%, Tau² = 0.16, Chi² test for heterogeneity P = 0.009). The wide 95% prediction interval (0.08 to 4.39) indicated that this result should be interpreted cautiously as some further study might yield a negative result. </p> <section id="CD007701-sec-0157"> <h6 class="title">Serious neonatal morbidity or perinatal death (composite outcome will include, for example, seizures, birth asphyxia defined by trialists, neonatal encephalopathy, disability in childhood) </h6> <p><a href="./references#CD007701-bbs2-0033" title="StenlundPM , BygdemanM , EkmanG . Induction of labor with mifepristone (RU 486). A randomized double‐blind study in post‐term pregnant women with unripe cervices. Acta Obstetricia et Gynecologica Scandinavica Supplement1994;73(161):Abstract FP50. StenlundPM , EkmanG , AedoAR , BygdemanM . Induction of labour with mifepristone ‐ a randomized double‐blind study versus placebo. Acta Obstetricia et Gynecologica Scandinavica1999;78:793‐8. ">Stenlund 1999</a> examined serious neonatal morbidity (the number of babies requiring antIconvulsive therapy); there was little difference between groups (RR 1.56, 95% CI 0.07 to 35.67; 36 infants; 1 study; <a href="./references#CD007701-fig-0085" title="">Analysis 7.2</a>). <a href="./references#CD007701-bbs2-0018" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101(6):501‐3. ">Lelaidier 1994</a> reported on perinatal mortality and there were no deaths in either group (<a href="./references#CD007701-fig-0092" title="">Analysis 7.9</a>). </p> <p>There was no information on vaginal birth not achieved within 24 hours, length of hospital stay, use of emergency services, maternal or caregiver satisfaction, or serious maternal morbidity or death. </p> </section> </section> </section> <section id="CD007701-sec-0158"> <h4 class="title">Additional outcomes of interest</h4> <section id="CD007701-sec-0159"> <h5 class="title">Measures of effectiveness</h5> <section id="CD007701-sec-0160"> <h6 class="title">Oxytocin augmentation</h6> <p>There was no evidence that mifepristone had an impact on the number of women who required oxytocin augmentation (RR 0.89, 95% CI 0.63 to 1.26; 116 women; 2 studies; <a href="./references#CD007701-fig-0086" title="">Analysis 7.3</a>). </p> </section> <section id="CD007701-sec-0161"> <h6 class="title">Pain relief requirements (epidural, opioids)</h6> <p>A similar number of women in each group used epidural anaesthesia (RR 0.87, 95% CI 0.73 to 1.03; 112 women; 1 study; <a href="./references#CD007701-fig-0087" title="">Analysis 7.4</a>). </p> <p>Vaginal birth not achieved within 48 and 72 hours, and randomisation to birth interval were not reported. </p> </section> </section> <section id="CD007701-sec-0162"> <h5 class="title">Complications</h5> <p>There was only limited evidence on the impact of mifepristone on maternal and neonatal health. </p> <p>There were no clear differences between the groups for the following outcomes:</p> <p> <ul id="CD007701-list-0025"> <li> <p>instrumental vaginal birth (RR 1.35, 95% CI 0.93 to 1.97; 343 women; 5 studies; <a href="./references#CD007701-fig-0088" title="">Analysis 7.5</a>); </p> </li> <li> <p>caesarean section (RR 0.88, 95% CI 0.62 to 1.25; 343 women; 5 studies; <a href="./references#CD007701-fig-0089" title="">Analysis 7.6</a>); </p> </li> <li> <p>Apgar score &lt; 7 at five minutes (RR 1.56, 95% CI 0.07 to 35.67; 119 infants; 2 studies; <a href="./references#CD007701-fig-0090" title="">Analysis 7.7</a>); </p> </li> <li> <p>NICU admission (RR 0.93, 95% CI 0.31 to 2.79; 163 infants; 2 studies; <a href="./references#CD007701-fig-0091" title="">Analysis 7.8</a>) </p> </li> <li> <p>Serious maternal complications:</p> <ul id="CD007701-list-0026"> <li> <p>uterine scar separation (one women in each group) (RR 1.00, 95% CI 0.07 to 14.64; 32 women; 1 study; <a href="./references#CD007701-fig-0093" title="">Analysis 7.10</a>); and </p> </li> <li> <p>chorioamnionitis (RR 2.00, 95% CI 0.20 to 19.91; 32 women; 1 study; <a href="./references#CD007701-fig-0094" title="">Analysis 7.11</a>). </p> </li> </ul> </li> </ul> </p> <p>Uterine hyperstimulation (with and without fetal heart rate (FHR) changes), postpartum haemorrhage (as defined by the trial authors), other serious maternal complications, and serious neonatal complications were not reported. </p> </section> <section id="CD007701-sec-0163"> <h5 class="title">Non‐prespecified outcomes</h5> <p><a href="./references#CD007701-bbs2-0033" title="StenlundPM , BygdemanM , EkmanG . Induction of labor with mifepristone (RU 486). A randomized double‐blind study in post‐term pregnant women with unripe cervices. Acta Obstetricia et Gynecologica Scandinavica Supplement1994;73(161):Abstract FP50. StenlundPM , EkmanG , AedoAR , BygdemanM . Induction of labour with mifepristone ‐ a randomized double‐blind study versus placebo. Acta Obstetricia et Gynecologica Scandinavica1999;78:793‐8. ">Stenlund 1999</a> reported that during the first 48 hours after treatment started, 83.3% of women with mifepristone and 41.7% with placebo went into labour or had a ripe cervix (RR 2.00, 95% CI 1.00 to 4.00; 36 women; 1 study; <a href="./references#CD007701-fig-0095" title="">Analysis 7.12</a>). The median time to onset of labour from commencing treatment was 24 hours 10 minutes for women who had mifepristone and 52 hours for women with placebo. <a href="./references#CD007701-bbs2-0010" title="GiacalonePL , TargoszV , LaffargueF , BoogG , FaureJM . Cervical ripening with mifepristone before labor induction: a randomized study. Obstetrics and Gynecology1998;92(4 Pt 1):487‐92. ">Giacalone 1998</a> and <a href="./references#CD007701-bbs2-0033" title="StenlundPM , BygdemanM , EkmanG . Induction of labor with mifepristone (RU 486). A randomized double‐blind study in post‐term pregnant women with unripe cervices. Acta Obstetricia et Gynecologica Scandinavica Supplement1994;73(161):Abstract FP50. StenlundPM , EkmanG , AedoAR , BygdemanM . Induction of labour with mifepristone ‐ a randomized double‐blind study versus placebo. Acta Obstetricia et Gynecologica Scandinavica1999;78:793‐8. ">Stenlund 1999</a> looked at failure to achieve changes in the cervix after 24 to 48 hours and here results favoured the mifepristone group (RR 0.36, 95% CI 0.20 to 0.63; 119 women; 2 studies; <a href="./references#CD007701-fig-0096" title="">Analysis 7.13</a>). </p> <p>None of the studies reported on the number of women achieving vaginal birth within 24 hours, but <a href="./references#CD007701-bbs2-0006" title="ElliotCL , BrennandJE , CalderAA . The effect of mifepristone (RU486) on cervical ripening and induction of labour in human pregnancy. 27th British Congress of Obstetrics and Gynaecology; 1995 July 4‐7; Dublin, Ireland. 1995:207. ElliottCL , BrennandJE , CalderAA . The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstetrics and Gynecology1998;92(5):804‐9. ">Elliott 1998</a> described the number of women in spontaneous labour within 72 hours. There was no evidence of a difference between groups receiving mifepristone versus placebo (RR 1.46, 95% CI 0.68 to 3.10; 80 women; 1 study; <a href="./references#CD007701-fig-0097" title="">Analysis 7.14</a>). The time to onset of labour was similar in all three study groups, with a median of 81 hours 15 minutes for placebo, 80 hours 20 minutes for 50 mg mifepristone, and 75 hours 50 minutes for 200 mg mifepristone. </p> <p><a href="./references#CD007701-bbs2-0010" title="GiacalonePL , TargoszV , LaffargueF , BoogG , FaureJM . Cervical ripening with mifepristone before labor induction: a randomized study. Obstetrics and Gynecology1998;92(4 Pt 1):487‐92. ">Giacalone 1998</a> reported on "spontaneous labour" within 48 hours and results favoured the mifepristone group (RR 2.05, 95% CI 1.27 to 3.30; 83 women; 1 study; <a href="./references#CD007701-fig-0098" title="">Analysis 7.15</a>). There was a shorter interval between the beginning of treatment and onset of labour, and between treatment and vaginal birth for the mifepristone group (the median interval to labour onset was 31.7 hours for mifepristone group versus 53.9 hours for placebo, and 31.3 hours versus 58.5 hours between treatment and birth; with a reported P = 0.02 for both outcomes). <a href="./references#CD007701-bbs2-0018" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101(6):501‐3. ">Lelaidier 1994</a> reported a reduction in oxytocin dose (international units, IU) (MD ‐2.56 IU, 95% CI ‐4.01 to ‐1.11; 32 women; 1 study; <a href="./references#CD007701-fig-0099" title="">Analysis 7.16</a>) and also reported that the interval between the start of treatment and the onset of labour (hours) was shorter in the mifepristone group (MD ‐22.15, 95% CI ‐35.96 to ‐8.34; 32 women; 1 study; <a href="./references#CD007701-fig-0100" title="">Analysis 7.17</a>). In the <a href="./references#CD007701-bbs2-0007" title="FrydmanR , BatonC , LelaidierC , VialM , BourgetP , FernandezH . Mifepristone for induction of labour. Lancet1991;337(8739):488‐9. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1992;80(6):972‐5. FrydmanR , LelaidierC , Baton‐Saint‐MleuxC , FernandezH , VialM , BourgetP . Labor induction in women at term with mifepristone (RU 486): a double‐blind, randomized, placebo‐controlled study. International Journal of Gynecology and Obstetrics1993;42(2):220. FrydmanR , TaylorS , PaoliC , PouradeA . RU 486 (mifepristone): A new tool for labour induction in term women with fetus alive [Le RU 486 (mifepristone) un novel outil pour le declenchment du travail a terme]. Contraception, Fertilite, Sexualite1992;20(12):1133‐6. LelaidierC , BeniflaJL , FernandezH , BatonC , BourgetP , BourrierMC , et al. RU 486 (mifepristone) in medical indications for labour induction in pregnancies at term: results of a randomized, double‐blind study of RU 486 vs placebo. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1993;22:92‐100. ">Frydman 1992</a> study, mifepristone reduced the total dose (described in French as "international measurement" units, IM) of oxytocin for women having both vaginal (MD ‐2.07 IM, 95% CI ‐3.21 to ‐0.93; 76 women) and caesarean deliveries (MD ‐1.97 IM, 95% CI ‐3.37 to ‐0.57; 36 women); however, this should be interpreted with caution (data not shown). </p> </section> </section> <section id="CD007701-sec-0164"> <h4 class="title">8. Oestrogen versus placebo: one study, analysis for 87 women</h4> </section> <section id="CD007701-sec-0165"> <h4 class="title">Main outcomes</h4> <p>We included one study (<a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a>) in this comparison and there was no information reported on any of the review's main outcomes. </p> </section> <section id="CD007701-sec-0166"> <h4 class="title">Additional outcomes of interest</h4> <section id="CD007701-sec-0167"> <h5 class="title">Measures of effectiveness</h5> <section id="CD007701-sec-0168"> <h6 class="title">Oxytocin augmentation</h6> <p>Similar numbers of women in each group received oxytocin augmentation (RR 0.93, 95% CI 0.61 to 1.43; 87 women; 1 study; <a href="./references#CD007701-fig-0101" title="">Analysis 8.1</a>) </p> <p>There was no information on vaginal birth not achieved within 48 and 72 hours, randomisation to birth interval, and pain relief requirements (epidural, opioids). </p> </section> </section> <section id="CD007701-sec-0169"> <h5 class="title">Complications</h5> <p>There was no clear differences between the oestrogen and placebo groups for:</p> <p> <ul id="CD007701-list-0027"> <li> <p>instrumental vaginal birth (RR 0.84, 95% CI 0.44 to 1.60; 87 women; 1 study; <a href="./references#CD007701-fig-0102" title="">Analysis 8.2</a>); </p> </li> <li> <p>caesarean section (RR 1.27, 95% CI 0.63 to 2.58; 87 women; 1 study; <a href="./references#CD007701-fig-0103" title="">Analysis 8.3</a>); </p> </li> <li> <p>NICU admission (RR 0.98, 95% CI 0.06 to 15.13; 87 infants; 1 study; <a href="./references#CD007701-fig-0104" title="">Analysis 8.4</a>) </p> </li> <li> <p>serious maternal complications:</p> <ul id="CD007701-list-0028"> <li> <p>chorioamnionitis (RR 1.95, 95% CI 0.38 to 10.12; 87 women; 1 study; <a href="./references#CD007701-fig-0105" title="">Analysis 8.5</a>); and </p> </li> <li> <p>endometritis (RR 2.93, 95% CI 0.32 to 27.10; 87 women; 1 study; <a href="./references#CD007701-fig-0106" title="">Analysis 8.6</a>). </p> </li> </ul> </li> </ul> </p> <p>There was no information for uterine hyperstimulation (with or without FHR changes), Apgar score less than seven at five minutes, perinatal death, postpartum haemorrhage, other serious maternal complications, or serious neonatal complications. </p> </section> </section> <section id="CD007701-sec-0170"> <h4 class="title">9. Vaginal isosorbide mononitrate (IMN) versus placebo: seven studies, 2287 women</h4> <p>We included four trials in this comparison group (<a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a>; <a href="./references#CD007701-bbs2-0004" title="BullarboM , OrrskogME , AnderschB , GranströmL , NorströmA , EkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196(1):50.e1‐5. ">Bullarbo 2007</a>; <a href="./references#CD007701-bbs2-0012" title="HabibSM , EmamSS , SaberAS . Outpatient cervical ripening with nitric oxide donor isosorbide mononitrate prior to induction of labor. International Journal of Gynaecology and Obstetrics2008;101(1):57‐61. ">Habib 2008</a>; <a href="./references#CD007701-bbs2-0032" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>). <a href="./references#CD007701-bbs2-0032" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a> was a large multicenter trial of 1362 women in France which provided additional data for a range of outcomes for this update. </p> </section> <section id="CD007701-sec-0171"> <h4 class="title">Main outcomes</h4> <p>There was no clear differences between the vaginal isosorbide mononitrate and placebo groups for: </p> <p> <ul id="CD007701-list-0029"> <li> <p>vaginal birth not achieved within 24 hours (RR 0.97, 95% CI 0.83 to 1.15; 238 women; 1 study; <a href="./references#CD007701-fig-0107" title="">Analysis 9.1</a>); </p> </li> <li> <p>additional induction agents required (average RR 0.87, 95% CI 0.75 to 1.00; 4 studies; I² = 66%; Tau² = 0.01; Chi² = 8.92; <a href="./references#CD007701-fig-0108" title="">Analysis 9.2</a>); </p> </li> <li> <p>serious neonatal morbidity or perinatal death:</p> <ul id="CD007701-list-0030"> <li> <p>perinatal death (average RR 1.61, 95% CI 0.08 to 33.26; 1712 infants; 2 studies; I² = 48%; Tau² = 2.31; Chi² = 1.94; <a href="./references#CD007701-fig-0111" title="">Analysis 9.5</a>); </p> </li> <li> <p>neonatal trauma (long bone fracture, collarbone fracture, basal skull fracture, brachial plexus palsy, facial nerve palsy, phrenic nerve palsy, or subdural haemorrhage) (RR 0.67, 95% CI 0.19 to 2.37; 1362 infants; 1 study; <a href="./references#CD007701-fig-0112" title="">Analysis 9.6</a>); </p> </li> <li> <p>neonatal convulsions in first 24 hours (there were no incidences of this outcome in either group; <a href="./references#CD007701-fig-0113" title="">Analysis 9.7</a>); </p> </li> <li> <p>tracheal ventilation longer than 24 hours (RR 1.01, 95% CI 0.14 to 7.14; 1362 infants; 1 study; <a href="./references#CD007701-fig-0114" title="">Analysis 9.8</a>); </p> </li> <li> <p>NICU admission for five or more days (RR 0.67, 95% CI 0.19 to 2.37; 1362 infants; 1 study; <a href="./references#CD007701-fig-0115" title="">Analysis 9.9</a>); </p> </li> <li> <p>neonatal transfer (RR 1.07, 95% CI 0.67 to 1.70; 1362 infants; 1 study; <a href="./references#CD007701-fig-0116" title="">Analysis 9.10</a>); </p> </li> </ul> </li> <li> <p>serious maternal morbidity or death:</p> <ul id="CD007701-list-0031"> <li> <p>maternal death (there were no incidences of maternal death in either group; <a href="./references#CD007701-fig-0117" title="">Analysis 9.11</a>); </p> </li> <li> <p>severe postpartum haemorrhage (RR 1.55, 95% CI 0.78 to 3.09; 1362 women; 1 study; <a href="./references#CD007701-fig-0118" title="">Analysis 9.12</a>); </p> </li> <li> <p>deep vein thrombosis (RR 3.03, 95% CI 0.12 to 74.16; 1362 women; 1 study; <a href="./references#CD007701-fig-0119" title="">Analysis 9.13</a>); </p> </li> <li> <p>perinatal death (average RR 1.61, 95% CI 0.08 to 33.26; 1712 infants; 2 studies; I² = 48%; Tau² = 2.31; Chi² = 1.94; <a href="./references#CD007701-fig-0111" title="">Analysis 9.5</a>); </p> </li> <li> <p>neonatal trauma (long bone fracture, collarbone fracture, basal skull fracture, brachial plexus palsy, facial nerve palsy, phrenic nerve palsy, or subdural haemorrhage) (RR 0.67, 95% CI 0.19 to 2.37; 1362 infants; 1 study; <a href="./references#CD007701-fig-0112" title="">Analysis 9.6</a>); </p> </li> <li> <p>neonatal convulsions in first 24 hours (there were no incidences of this outcome in either group; <a href="./references#CD007701-fig-0113" title="">Analysis 9.7</a>); </p> </li> <li> <p>tracheal ventilation longer than 24 hours (RR 1.01, 95% CI 0.14 to 7.14; 1362 infants; 1 study; <a href="./references#CD007701-fig-0114" title="">Analysis 9.8</a>); </p> </li> <li> <p>NICU admission for five or more days (RR 0.67, 95% CI 0.19 to 2.37; 1362 infants; 1 study; <a href="./references#CD007701-fig-0115" title="">Analysis 9.9</a>); </p> </li> <li> <p>neonatal transfer (RR 1.07, 95% CI 0.67 to 1.70; 1362 infants; 1 study; <a href="./references#CD007701-fig-0116" title="">Analysis 9.10</a>); </p> </li> </ul> </li> </ul> </p> <section id="CD007701-sec-0172"> <h5 class="title">Maternal satisfaction</h5> <p>In four trials, women were asked to rate their satisfaction, however results could not be meta‐analysed due to differences in how questions were structured. <a href="./references#CD007701-bbs2-0004" title="BullarboM , OrrskogME , AnderschB , GranströmL , NorströmA , EkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196(1):50.e1‐5. ">Bullarbo 2007</a> found no difference in levels of satisfaction between women in the two arms of the trial (<a href="./references#CD007701-fig-0110" title="">Analysis 9.4</a>). <a href="./references#CD007701-bbs2-0032" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a> asked women to rate their satisfaction, and whether they would recommend the same treatment, finding that more women in the IMN group felt very or extremely satisfied, and would recommend the same treatment (<a href="./references#CD007701-fig-0110" title="">Analysis 9.4</a>). In the study by <a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a>, women were asked to rate their satisfaction with the induction process at home. On five of the six measures of satisfaction, women in the placebo group were slightly more satisfied with their care compared with those in the IMN group, although the differences between groups were not large, and the mean scores in both groups suggested general satisfaction (<a href="./references#CD007701-fig-0109" title="">Analysis 9.3</a>). Satisfaction data from <a href="./references#CD007701-bbs2-0002" title="AttanayakeK , GoonewardeneM . Outpatient cervical ripening with vaginal isosorbide mononitrate in uncomplicated singleton pregnancies at 39 weeks gestation: A double blind randomized controlled trial. Sri Lanka Journal of Obstetrics and Gynaecology2014;36(Suppl 1):28, Abstract no: FC 10.5. ">Attanayake 2014</a> could not be meta‐analysed, as only narrative results were provided ‐ they reported that greater than 75% of women in both groups considered the therapy as a good intervention (rather than inpatient therapy), and greater than 85% were happy to use outpatient therapy in a subsequent pregnancy, and would recommend to a friend. </p> <p>Length of hospital stay, use of emergency services, and caregiver satisfaction were not reported. </p> </section> </section> <section id="CD007701-sec-0173"> <h4 class="title">Additional outcomes of interest</h4> <section id="CD007701-sec-0174"> <h5 class="title">Measures of effectiveness</h5> <p>There were no clear differences between the groups for the outcomes:</p> <p> <ul id="CD007701-list-0032"> <li> <p>oxytocin augmentation (average RR 0.95, 95% CI 0.78 to 1.14; 1816 women; 3 studies; I² = 72%; Tau² = 0.02; Chi² = 7.11; <a href="./references#CD007701-fig-0120" title="">Analysis 9.14</a>); and </p> </li> <li> <p>pain relief requirements (epidural) (RR 0.94, 95% CI 0.82 to 1.09; 350 women; 1 study; <a href="./references#CD007701-fig-0121" title="">Analysis 9.15</a>). </p> </li> </ul> </p> <p>No information was available for vaginal birth not achieved within 48 and 72 hours, or randomisation to birth interval. </p> </section> <section id="CD007701-sec-0175"> <h5 class="title">Complications</h5> <p>There was no evidence of clear difference between groups for:</p> <p> <ul id="CD007701-list-0033"> <li> <p>uterine hyperstimulation (with FHR changes) (RR 0.20, 95% CI 0.01 to 4.07; 102 women; 1 study; <a href="./references#CD007701-fig-0122" title="">Analysis 9.16</a>); </p> </li> <li> <p>uterine hyperstimulation (unclear if with or without FHR changes) (RR 0.09, 95% CI 0.01 to 1.62; 200 women; 1 study; <a href="./references#CD007701-fig-0123" title="">Analysis 9.17</a>); </p> </li> <li> <p>Instrumental vaginal birth (RR 0.81, 95% CI 0.61 to 1.07; 1712 women; 2 studies; <a href="./references#CD007701-fig-0124" title="">Analysis 9.18</a>); </p> </li> <li> <p>caesarean section (RR 0.99, 95% CI 0.87 to 1.14; 2286 women; 6 studies; <a href="./references#CD007701-fig-0125" title="">Analysis 9.19</a>); </p> </li> <li> <p>Apgar score less than seven at five minutes (RR 0.88, 95% CI 0.44 to 1.76; 2214 infants; 5 studies; <a href="./references#CD007701-fig-0126" title="">Analysis 9.20</a>); </p> </li> <li> <p>NICU admission (RR 0.89, 95% CI 0.59 to 1.36; 1068 infants; 6 studies; <a href="./references#CD007701-fig-0127" title="">Analysis 9.21</a>); </p> </li> <li> <p>perinatal death (reported in <i>Serious neonatal morbidity or perinatal death</i>); </p> </li> <li> <p>postpartum haemorrhage (&gt; 500 mL) (RR 1.13, 95% CI 0.95 to 1.36; 2214 women; 5 studies; <a href="./references#CD007701-fig-0128" title="">Analysis 9.22</a>); and </p> </li> <li> <p>serious neonatal complications:</p> <ul id="CD007701-list-0034"> <li> <p>neonatal infection (RR 1.00, 95% CI 0.26 to 3.89; 200 infants; 1 study; <a href="./references#CD007701-fig-0129" title="">Analysis 9.23</a>). </p> </li> </ul> </li> </ul> </p> <p>No other serious maternal complications were reported.</p> </section> <section id="CD007701-sec-0176"> <h5 class="title">Non‐prespecified outcomes</h5> <p>IMN use was associated with increased side effects, including nausea (RR 2.39, 95% CI 1.54 to 3.70; 1926 women; 4 studies; I² = 37%; Tau² = 0.07; Chi² = 4.78; <a href="./references#CD007701-fig-0130" title="">Analysis 9.24</a>), and particularly headaches (RR 5.45, 95% CI 3.38 to 8.81; 2300 women; 7 studies; I² = 76%; Tau² = 0.21; Chi² = 21.09; <a href="./references#CD007701-fig-0131" title="">Analysis 9.25</a>). In one study 22/112 women in the IMN group reported severe headaches compared with only 1/108 in the placebo group (RR 21.21, 95% CI 2.91 to 154.65; 220 women; 1 study; <a href="./references#CD007701-fig-0132" title="">Analysis 9.26</a>). </p> <p>Several measures of progress in labour were reported, with one to three trials available per outcome. In general, results indicate that IMN increased the likelihood of being admitted in established labour within 24 hours (RR 2.75, 95% CI 1.29 to 5.88; 200 women; 1 study; <a href="./references#CD007701-fig-0133" title="">Analysis 9.27</a>) and caused changes in the Bishop score (Bishop score &lt; 6 or active labour at 36 hours: RR 3.80, 95% CI 1.54 to 9.40; 102 women; 1 study; <a href="./references#CD007701-fig-0134" title="">Analysis 9.28</a>, Bishop score on admission after treatment: MD 2.73, 95% CI 2.17 to 3.29; 200 women; 1 study; <a href="./references#CD007701-fig-0136" title="">Analysis 9.30</a>. Change in Bishop score: MD 2.76, 95% CI 2.48 to 3.03; 272 women; 2 studies; <a href="./references#CD007701-fig-0137" title="">Analysis 9.31</a>). Time in hours from admission to birth (days) was also reduced (MD ‐4.7 hours, 95% CI ‐6.08 to ‐3.31; I² =42%; Tau² =0.63; 374 women; 3 studies; <a href="./references#CD007701-fig-0135" title="">Analysis 9.29</a>). </p> <p>However, <a href="./references#CD007701-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a> reported that the interval from onset of labour to birth (hours) was not different between IMN and placebo (MD ‐1.24 hours, 95% CI ‐1.82 to ‐0.66; 200 women; 1 study; <a href="./references#CD007701-fig-0138" title="">Analysis 9.32</a>), and <a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a> reported that the rate of cervix unchanged after 48 hours was higher in the IMN group compared to placebo (RR 0.83, 95% CI 0.70 to 0.97; 257 women; 1 study; <a href="./references#CD007701-fig-0139" title="">Analysis 9.33</a>). </p> <p><a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a> also reported the mean interval from hospital admission to birth (hours) for all women (MD ‐0.70 hours, 95% CI ‐6.11 to 4.71; 128 women; 1 study; <a href="./references#CD007701-fig-0140" title="">Analysis 9.34</a>), and for those women having vaginal deliveries, along with the mean change in Bishop scores at 48 hours after baseline; there were no differences between groups for any of these outcomes (data not shown). </p> <p><a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a> collected information on the cost of providing care; the mean overall cost of the care (GBP) package was very similar for women in both groups (MD 11.98 GBP, 95% CI ‐105.34 to 129.30; <a href="./references#CD007701-fig-0141" title="">Analysis 9.35</a>). </p> </section> </section> <section id="CD007701-sec-0177"> <h4 class="title">10. Acupuncture versus routine care: one study 56 women</h4> <p><a href="./references#CD007701-bbs2-0014" title="HarperTC , CoeytauxRR , ChenW , CampbellK , KaufmanJS , MoiseKJ , et al. A randomized controlled trial of acupuncture for initiation of labor in nulliparous women. Journal of Maternal‐Fetal and Neonatal Medicine2006;19(8):465‐70. ">Harper 2006</a> presented limited information relevant to this review. The intervention did not appear to have any impact on the number of women requiring additional agents to induce labour (RR 0.60, 95% CI 0.31 to 1.17; 56 women; 1 study; <a href="./references#CD007701-fig-0142" title="">Analysis 10.1</a>) or having caesarean section (RR 0.43, 95% CI 0.17 to 1.11; 56 women; 1 study; <a href="./references#CD007701-fig-0143" title="">Analysis 10.2</a>). There were no clear differences between groups for women starting labour spontaneously, cervical dilatation at hospital admission, or the mean time from study enrolment to birth (data not shown). No further main or additional outcomes were reported in this study. </p> </section> <section id="CD007701-sec-0178"> <h4 class="title">11. Outpatient amniotomy for induction of labour versus routine care: one study, 521 women </h4> <p><a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a> was an unblinded trial that randomised 521 women to amniotomy in an outpatient setting (at home) for induction between 292 and 294 days gestation, or routine care (as per local guidelines, this was referral to an obstetrician for foetal assessment on the morning of day 294). <a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a> was assessed as being at high risk of attrition bias so should have been removed according to the pre‐specified sensitivity analysis. However as this was the only study in this comparison, sensitivity analysis was not performed. </p> </section> <section id="CD007701-sec-0179"> <h4 class="title">Main outcomes</h4> <section id="CD007701-sec-0180"> <h5 class="title">Maternal satisfaction</h5> <p>While measures of maternal satisfaction were higher in the amniotomy at home group (look back positively on treatment: RR 1.04, 95% CI 0.97 to 1.10; 404 women; 1 study; <a href="./references#CD007701-fig-0144" title="">Analysis 11.1</a>. Would have preferred other treatment: RR 0.51, 95% CI 0.36 to 0.72; 472 women; 1 study; <a href="./references#CD007701-fig-0145" title="">Analysis 11.2</a>), the proportion of women completing the survey was higher in the amniotomy group (82% versus 73%), and it seems likely that a response bias may have occurred for surveys conducted in home settings. </p> <p>There was no information on vaginal birth not achieved within 24 hours, additional induction agents required, length of hospital stay, use of emergency services, caregiver satisfaction, serious neonatal morbidity or perinatal death (composite outcome will include, for example, seizures, birth asphyxia defined by trialists, neonatal encephalopathy, disability in childhood), or serious maternal morbidity or death (composite outcome will include, for example, uterine rupture, admission to intensive care unit, septicaemia). </p> </section> </section> <section id="CD007701-sec-0181"> <h4 class="title">Additional outcomes of interest</h4> <section id="CD007701-sec-0182"> <h5 class="title">Measures of effectiveness</h5> <section id="CD007701-sec-0183"> <h6 class="title">Oxytocin augmentation</h6> <p>Fewer women had augmentation or induction or both in the outpatient amniotomy group than in the routine care group (RR 0.83, 95% CI 0.71 to 0.97; 521 women; 1 study; <a href="./references#CD007701-fig-0146" title="">Analysis 11.3</a>). </p> </section> <section id="CD007701-sec-0184"> <h6 class="title">Pain relief requirements (epidural, opioids)</h6> <p>There was little difference between groups for women receiving epidural or opioids or both (RR 0.99, 95% CI 0.76 to 1.30; 521 women; 1 study; <a href="./references#CD007701-fig-0147" title="">Analysis 11.4</a>). </p> <p>Vaginal birth not achieved within 48 and 72 hours and randomisation to birth interval were not reported. </p> </section> </section> <section id="CD007701-sec-0185"> <h5 class="title">Complications</h5> <p>There were no clear differences between the groups for the following outcomes:</p> <p> <ul id="CD007701-list-0035"> <li> <p>instrumental vaginal birth (RR 0.70, 95% CI 0.46 to 1.08; 521 women; 1 study; <a href="./references#CD007701-fig-0148" title="">Analysis 11.5</a>); </p> </li> <li> <p>caesarean section (RR 1.20, 95% CI 0.78 to 1.86; 521 women; 1 study; <a href="./references#CD007701-fig-0149" title="">Analysis 11.6</a>); </p> </li> <li> <p>Apgar score less than seven at five minutes (RR 1.86, 95% CI 0.34 to 10.06; 521 women; 1 study; <a href="./references#CD007701-fig-0150" title="">Analysis 11.7</a>); and </p> </li> <li> <p>NICU admission (RR 1.09, 95% CI 0.64 to 1.85; 521 women; 1 study; <a href="./references#CD007701-fig-0151" title="">Analysis 11.8</a>). </p> </li> </ul> </p> <p>There was no information for uterine hyperstimulation (with FHR changes), uterine hyperstimulation (without FHR changes), perinatal death, postpartum haemorrhage, serious maternal complications (considered as separate outcomes, e.g. intensive care unit admission, septicaemia, uterine rupture), or serious neonatal complications (considered as separate outcomes). </p> </section> <section id="CD007701-sec-0186"> <h5 class="title">Non‐prespecified outcomes</h5> <p>Mean duration of birth (hours) was very similar in each group (MD 0.40 hours, 95% CI ‐0.72 to 1.52; 521 women; 1 study; <a href="./references#CD007701-fig-0152" title="">Analysis 11.9</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007701-sec-0187" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007701-sec-0187"></div> <section id="CD007701-sec-0188"> <h3 class="title" id="CD007701-sec-0188">Summary of main results</h3> <p>The included studies examined 11 different types of interventions in outpatient settings. Overall, the results demonstrate that outpatient induction of labour is feasible and that important adverse events are rare (<a href="#CD007701-tbl-0004">Table 1</a>; <a href="#CD007701-tbl-0005">Table 2</a>; <a href="#CD007701-tbl-0006">Table 3</a>). However, the safety data should be treated with considerable caution. First, very few of the studies provided information on maternal and neonatal death or serious morbidity. It may not be safe to assume that because adverse outcomes were not reported, they did not occur. Further, even where outcomes such as perinatal mortality, maternal complications or serious neonatal morbidity were reported, the finding that there was no apparent difference between groups was not surprising as none of these studies had the statistical power to detect differences for such rare outcomes in relatively low‐risk populations. </p> <div class="table" id="CD007701-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Uterine hyperstimulation with outpatient inductions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Uterine hyperstimulation</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>PGE₂(vaginal)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0013" title="HageP , ShawJ , ZarouD , FleisherJ , WehbehH . Double blind randomized trial to evaluate the role of outpatient use of PGE2 in cervical ripening. American Journal of Obstetrics and Gynecology1993;168(1 Part 2):430. ">Hage 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/18 PGE group (FHR status unknown),  0/18 in placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0025" title="NewmanM , NewmanR . Multiple‐dose PGE2 cervical ripening on an outpatient basis: safety and efficacy. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S112. ">Newman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/28 PGE group (FHR status unknown), 0/30 in control group (no treatment)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0026" title="O'BrienJM , MercerB , ClearyN , SibaiBM . Efficacy of outpatient induction with low dose intravaginal prostaglandin E2: A randomized, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;172:424. O'BrienJM , MercerBM , ClearyNT , SibaiBM . Efficacy of outpatient induction with low‐dose intravaginal prostaglandin E2: A randomized, double blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;173(6):1855‐9. ">O'Brien 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/50 PGE group (normal FHR), 0/50 in placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>4/96 PGE,  0/98 in control group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>PGE₂(intracervical)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0005" title="ButtinoLTJr , GariteTJ . Intracervical prostaglandin in postdate pregnancy. A randomized trial. Journal of Reproductive Medicine1990;35(2):155‐8. ">Buttino 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/23 PGE group (with FHR decelerations), 0/20 in placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/43 PGE group, 1/47 placebo group with FHR deceleration in both</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/30 PGE group (fetal bradycardia), 0/31 placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/143 PGE group, 0/151 control (no treatment) with hyperstimulation</p> <p>11/143 FHR decelerations in PGE group, 12/151 in control</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5/239 PGE, 1/249 control with hyperstimulation</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Intravaginal misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0034" title="StitelyML , BrowningJ , FowlerM , GendronRT , GhermanRB . Outpatient cervical ripening with intravaginal misoprostol. Obstetrics and Gynecology2000;96(5 Pt 1):684‐8. ">Stitely 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/27 misoprostol group with FHR deceleration, 2/33 placebo group</p> <p>1/27 misoprostol with tachysystole without FHR changes, 0/33 placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0015" title="IncerpiM , FassettM , KjosS , TranS , WingD . Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S120. IncerpiMH , FassettMJ , KjosSL , TranSH , WingDA . Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology2001;185(4):916‐9. ">Incerpi 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/57 misoprostol with hyperstimulation (FHR unknown), 2/63 placebo group</p> <p>2/57 misoprostol with hypertonus, 5/57 misoprostol with tachysystole, none control</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0023" title="McKennaDS , EsterJB , ProffittM , WaddellKR . Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial. Obstetrics and Gynecology2004;104(3):579‐84. ">McKenna 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/33 misoprostol (FHR deceleration), 0/35 placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Oral misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0020" title="LyonsC , RumneyP , HuangW , MorrisonE , ThomasS , NageotteM , et al. Outpatient cervical ripening with oral misoprostol post‐term: induction rates decreased. American Journal of Obstetrics and Gynecology2001;184(1):S116. ">Lyons 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/18 misoprostol, 2/22 placebo group (FHR unknown) with hyperstimulation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0008" title="GaffaneyCA , SaulLL , RumneyPJ , MorrisonEH , ThomasS , NageotteMP , et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. American Journal of Perinatology2009;26(9):673‐7. ">Gaffaney 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8/43 misoprostol, 4/44 placebo group hyperstimulation syndrome (tachysystole or hypertonus, with FHR changes) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>9/61 misoprostol, 6/66 placebo group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Mifepristone</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0010" title="GiacalonePL , TargoszV , LaffargueF , BoogG , FaureJM . Cervical ripening with mifepristone before labor induction: a randomized study. Obstetrics and Gynecology1998;92(4 Pt 1):487‐92. ">Giacalone 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/41 mifepristone group, 0/42 placebo group with hypertonia (FHR unknown)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0018" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101(6):501‐3. ">Lelaidier 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/16 in both groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>4/57 mifepristone, 0/58 placebo with hypertonia</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> IMN</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0012" title="HabibSM , EmamSS , SaberAS . Outpatient cervical ripening with nitric oxide donor isosorbide mononitrate prior to induction of labor. International Journal of Gynaecology and Obstetrics2008;101(1):57‐61. ">Habib 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/51 IMN group, 2/51 placebo group with hyperstimulation (abnormal FHR)</p> <p>1/51 IMN, 8/51 placebo group with tachysystolia (FHR normal)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/100 IMN group, 5/100 placebo group with hyperstimulation (FHR changes unclear)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>1/151 IMN group, 15/151 placebo group (hyperstimulation or tachysystolia,</b> ±<b>FHR changes)</b> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>IMN: isosorbide mononitrate; FHR: fetal heart rate</p> </div> </div> <div class="table" id="CD007701-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Neonatal complications following induction in outpatient setting</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Neonatal complications</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>PGE₂vaginal</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0030" title="SawaiSK , WilliamsMC , O'BrienWF , AngelJL , MastrogiannisDS , JohnsonL . Sequential outpatient application of intravaginal prostaglandin E2 gel in the management of postdates pregnancies. Obstetrics and Gynecology1991;78(1):19‐23. WilliamsMG , O'BrienWF , SawaiSK , KnuppelRA . Outpatient cervical ripening in the postdates pregnancy. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 Jan 23‐27; Houston, Texas, USA. 1990:533. ">Sawai 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/24 in PGE₂ group; 2/26 in placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0031" title="SawaiSK , O'BrienWF , MastrogiannisDS , KrammerJ , MastryMG , PorterGW . Patient‐administered outpatient intravaginal prostaglandin E2 suppositories in post‐date pregnancies: a double‐blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1994;84(5):807‐10. SawaiSK , O'BrienWF , MastrogiannisMS , MastryMG , PorterGW , JohnsonL . Outpatient prostaglandin E2 suppositories in postdates pregnancies. American Journal of Obstetrics and Gynecology1992;166(1 Pt 2):400. ">Sawai 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/38 in PGE₂;  4/42 in placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0026" title="O'BrienJM , MercerB , ClearyN , SibaiBM . Efficacy of outpatient induction with low dose intravaginal prostaglandin E2: A randomized, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;172:424. O'BrienJM , MercerBM , ClearyNT , SibaiBM . Efficacy of outpatient induction with low‐dose intravaginal prostaglandin E2: A randomized, double blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;173(6):1855‐9. ">O'Brien 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/50 in PGE₂;  5/50 in placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>3/112 PGE, 11/118 control to NICU</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>PGE₂intracervical</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6/41 PGE group, 8/43 placebo group with complication such as tachypnoea, meconium aspiration, meconium or admission to NICU </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0021" title="MagannE , ChauhanSP , NevilsBG , McNamaraMF , KinsellaMJ , MorrisonJC . Management of pregnancies beyond forty‐one weeks' gestation with an unfavorable cervix. American Journal of Obstetrics and Gynecology1998;178(6):1279‐87. ">Magann 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/35 PGE₂ versus 0/35 control NICU admission</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/30 PGE, 2/31 placebo group with complication</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>10/106 PGE, 10/109 controls with neonatal complications/admitted to NICU</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> Vaginal misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0034" title="StitelyML , BrowningJ , FowlerM , GendronRT , GhermanRB . Outpatient cervical ripening with intravaginal misoprostol. Obstetrics and Gynecology2000;96(5 Pt 1):684‐8. ">Stitely 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/27 misoprostol, 3/33 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0015" title="IncerpiM , FassettM , KjosS , TranS , WingD . Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S120. IncerpiMH , FassettMJ , KjosSL , TranSH , WingDA . Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology2001;185(4):916‐9. ">Incerpi 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18/57 misoprostol, 20/63 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0023" title="McKennaDS , EsterJB , ProffittM , WaddellKR . Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial. Obstetrics and Gynecology2004;104(3):579‐84. ">McKenna 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/33 misoprostol, 1/35 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0027" title="OboroVO , TaboweiTO . Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post‐term pregnancy. Acta Obstetricia et Gynecologica Scandinavica2005;84(7):628‐31. ">Oboro 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/38 misoprostol, 1/39 control (no treatment) to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0008" title="GaffaneyCA , SaulLL , RumneyPJ , MorrisonEH , ThomasS , NageotteMP , et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. American Journal of Perinatology2009;26(9):673‐7. ">Gaffaney 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/43 misoprostol, 1/44 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>21/198 misoprostol, 26/214 control to NICU</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> Misoprostol 25 µg versus 50 µg</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0016" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynaecology and Obstetrics2005;88(2):108‐11. ">Kipikasa 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1/23 25</b> µ<b>g, 2/26 50</b> µ<b>g misoprostol to NICU</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> Intracervical PGE₂versus intravaginal misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0024" title="MeyerM , PflumJ . Outpatient administration of misoprostol decreases induction time. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S167. MeyerM , PflumJ , HowardD . Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial. Obstetrics and Gynecology2005;105(3):466‐72. ">Meyer 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>5/42 PGE, 4/42 misoprostol to NICU</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> Mifepristone</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0006" title="ElliotCL , BrennandJE , CalderAA . The effect of mifepristone (RU486) on cervical ripening and induction of labour in human pregnancy. 27th British Congress of Obstetrics and Gynaecology; 1995 July 4‐7; Dublin, Ireland. 1995:207. ElliottCL , BrennandJE , CalderAA . The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstetrics and Gynecology1998;92(5):804‐9. ">Elliott 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/50 mifepristone, 1/30 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0010" title="GiacalonePL , TargoszV , LaffargueF , BoogG , FaureJM . Cervical ripening with mifepristone before labor induction: a randomized study. Obstetrics and Gynecology1998;92(4 Pt 1):487‐92. ">Giacalone 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/41 mifepristone, 4/42 control to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>5/91 mifepristone, 5/72 control to NICU</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> IMN</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18/177 IMN, 16/173 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0004" title="BullarboM , OrrskogME , AnderschB , GranströmL , NorströmA , EkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196(1):50.e1‐5. ">Bullarbo 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13/100 IMN, 9/100 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0012" title="HabibSM , EmamSS , SaberAS . Outpatient cervical ripening with nitric oxide donor isosorbide mononitrate prior to induction of labor. International Journal of Gynaecology and Obstetrics2008;101(1):57‐61. ">Habib 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/51 IMN, 1/51 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/100 IMN, 14/100 placebo group to nursery admission</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0009" title="GhanaieMM , MirbloukF , GodarziR , ShakibaM . Effect of outpatient isorbide mononitrate on success of labor induction. Journal of Babol University of Medical Sciences2013;15(2):12‐7. ">Ghanaie 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/36 IMN, 0/36 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0002" title="AttanayakeK , GoonewardeneM . Outpatient cervical ripening with vaginal isosorbide mononitrate in uncomplicated singleton pregnancies at 39 weeks gestation: A double blind randomized controlled trial. Sri Lanka Journal of Obstetrics and Gynaecology2014;36(Suppl 1):28, Abstract no: FC 10.5. ">Attanayake 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/72 IMN, 1/72 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>37/536 IMN, 41/532 placebo group to NICU</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> Outpatient amniotomy for induction versus routine care</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27/270 IMN, 23/251 placebo group to NICU</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>NICU: neonatal intensive‐care unit</p> </div> </div> <div class="table" id="CD007701-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Maternal complications following induction of labour in outpatient setting</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Maternal complications</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Intracervical PGE₂</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/41 PGE, 10/43 placebo group with complication such as endometritis, chorioamnionitis and pre‐eclampsia </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6/43 PGE, 3/47 placebo group with complication such as endometritis and chorioamnionitis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/30 PGE with PPH, 0/31 placebo group</p> <p>2/30 PGE, 2/31 placebo group with infection</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8/143 PGE, 7/151 control (no treatment) with endometritis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>21/257</b> PGE₂<b>, 22/272 control with maternal complications</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Oral misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0008" title="GaffaneyCA , SaulLL , RumneyPJ , MorrisonEH , ThomasS , NageotteMP , et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. American Journal of Perinatology2009;26(9):673‐7. ">Gaffaney 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8/43 misoprostol group, 9/44 placebo group with chorioamnionitis</p> <p>1/43 misoprostol group, 2/44 placebo group with endometritis</p> <p>2/43 misoprostol group, 0/44 placebo group with PPH</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>11/43 misoprostol group, 11/44 placebo group with maternal complications</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> IMN</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood loss &gt; 500 mL: 59/177 IMN, 47/173 placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0004" title="BullarboM , OrrskogME , AnderschB , GranströmL , NorströmA , EkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196(1):50.e1‐5. ">Bullarbo 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood loss &gt; 1000 mL: 14/100 IMN, 12/100 placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0012" title="HabibSM , EmamSS , SaberAS . Outpatient cervical ripening with nitric oxide donor isosorbide mononitrate prior to induction of labor. International Journal of Gynaecology and Obstetrics2008;101(1):57‐61. ">Habib 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PPH: 2/51 IMN, 3/51 placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/100 IMN group, 3/100 placebo group with PPH</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0009" title="GhanaieMM , MirbloukF , GodarziR , ShakibaM . Effect of outpatient isorbide mononitrate on success of labor induction. Journal of Babol University of Medical Sciences2013;15(2):12‐7. ">Ghanaie 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/36 IMN group, 0/36 placebo group with need for blood transfusion</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0032" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/678 IMN group, 0/684 placebo group for maternal death</p> <p>124/678 IMN group, 112/684 placebo group for PPH</p> <p>20/678 IMN group, 13/684 placebo group for severe PPH</p> <p>1/678 IMN group, 0/684 placebo group for deep vein thrombosis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>202/1142 IMN group, 204/1148 placebo group with maternal complications</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Outpatient amniotomy</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26/270 amniotomy group, 29/251 routine care group ‐ mother treated with antibiotics</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>PPH: postpartum haemorrhage</p> </div> </div> <p>There was some evidence that, compared with placebo or no treatment, induction agents reduced the need for further intervention to induce labour, and potentially shorten the interval from intervention to birth. However, we were unable to pool results on outcomes relating to progress in labour, as studies tended to measure a very broad range of outcomes. </p> <p>There was no evidence that induction agents increased interventions in labour such as operative deliveries. Only five studies (<a href="./references#CD007701-bbs2-0002" title="AttanayakeK , GoonewardeneM . Outpatient cervical ripening with vaginal isosorbide mononitrate in uncomplicated singleton pregnancies at 39 weeks gestation: A double blind randomized controlled trial. Sri Lanka Journal of Obstetrics and Gynaecology2014;36(Suppl 1):28, Abstract no: FC 10.5. ">Attanayake 2014</a>; <a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a>; <a href="./references#CD007701-bbs2-0004" title="BullarboM , OrrskogME , AnderschB , GranströmL , NorströmA , EkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196(1):50.e1‐5. ">Bullarbo 2007</a>; <a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a>; <a href="./references#CD007701-bbs2-0032" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a>) collected information on women's views about the induction process, and overall there was very little information on the costs to health services of different methods of induction of labour in outpatient settings. </p> <p>Few studies reported on maternal satisfaction. The <a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a> trial suggested that women receiving isosorbide mononitrate were less satisfied than controls. This finding may have been associated with the relatively high number of women in the intervention group experiencing unpleasant side effects (particularly headaches) during the treatment period. </p> </section> <section id="CD007701-sec-0189"> <h3 class="title" id="CD007701-sec-0189">Overall completeness and applicability of evidence</h3> <p>It is debatable what would constitute definitive evidence on the effectiveness and safety of various induction protocols in the outpatient (home) environment. The issues that are likely to be important to women and healthcare providers were not adequately addressed in the included trials in this review or a related Cochrane Review comparing home and hospital inductions (<a href="./references#CD007701-bbs2-0078" title="KellyAJ , AlfirevicZ , GhoshA . Outpatient versus inpatient induction of labour for improving birth outcomes. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD007372.pub3] ">Kelly 2013</a>). </p> <section id="CD007701-sec-0190"> <h4 class="title">Safety</h4> <p>Adverse events in the pregnant population of women who are likely to be eligible for outpatient induction are rare (<a href="#CD007701-tbl-0004">Table 1</a>; <a href="#CD007701-tbl-0005">Table 2</a>). There is no consensus on what would be an unacceptable risk of an outpatient induction; views may vary among different healthcare systems and among women, doctors and healthcare commissioners in the same system. Assuming that one additional serious adverse event (e.g. perinatal death/serious morbidity) for every 500 outpatient inductions is considered unacceptable (irrespective of the cost savings made), a very large randomised trial or meta‐analysis including thousands of women would be needed to be able to exclude a possibility of such an excess risk. A trial (or meta‐analysis) of this size designed to exclude such an excess risk (equivalence trial) is unlikely to be funded, irrespective of the method used. </p> <p>In the absence of adequate safety data from randomised trials, the only pragmatic solution is to rely on observational data from large cohorts with relatively robust surrogate outcomes such as emergency caesarean section for presumed fetal distress or emergency transfer to hospital. A paper from Canada (<a href="./references#CD007701-bbs2-0087" title="SalvadorSC , SimpsonML , CundiffGW . Dinoprostone vaginal insert for labour induction: a comparison of outpatient and inpatient settings. Journal of Obstetrics and Gynaecology Canada2009;31(11):1028‐34. ">Salvador 2009</a>) reported on 567 outpatient inductions with no serious complications, but it is not entirely clear what was included in this composite outcome. Other surrogate outcomes, such as uterine hyperstimulation or fetal heart rate abnormalities (which have been reported in some studies (e.g. <a href="./references#CD007701-bbs2-0084" title="RamseyPS , MeyerL , WalkesBA , HarrisD , OgburnPLJr , HeiseRH , et al. Cardiotocographic abnormalities associated with dinoprostone and misoprostol cervical ripening. Obstetrics and Gynecology2005;105(1):85‐90. ">Ramsey 2005</a>)), may be difficult to interpret unless there are clear definitions of what these outcomes mean. The use of common outcomes with agreed definitions applicable to all healthcare settings would be welcome; see <a href="#CD007701-sec-0198">Implications for research</a>. </p> </section> <section id="CD007701-sec-0191"> <h4 class="title">Experience of women and staff</h4> <p>Outpatient induction may be more convenient for women, who may feel more comfortable at home, and prefer being there rather than in hospital. On the other hand, women may feel worried about the induction process (especially if they live at some distance from emergency facilities) and the induction agent may cause side effects that are distressing, so some women may prefer the reassurance offered by hospital care. We have very limited information on what women would prefer, and no evidence on whether any women were forced to make arrangements for rapid transfer to hospital. </p> <p>Outcomes such as average time to 'admission in labour' may be difficult to understand if there is no clear definition of what this means. The time may be partly determined by women's decisions about when to attend hospital, which may depend on a broad range of physiological, psychological, social and practical factors. For example, a woman experiencing unpleasant side effects, living at a distance from emergency facilities may seek early admission; under these circumstances the outcome does not serve as a good proxy for progress in labour. Criteria for admission to hospital in the trials were frequently not specified and included active labour (variously defined), ruptured membranes and a range of other indications. Further, a short interval to admission is not necessarily a good thing; a very short interval means that sending women home may not be worthwhile, a long interval may not be harmful provided women are reasonably comfortable and there is no urgent need for birth. A short interval to admission is also meaningless if it is offset by prolonged and painful labour. Reporting these two outcomes separately may not, therefore, be helpful. </p> <p>Measures of cervical change (Bishop score) may also be problematic, for example, mean increases in Bishop scores on hospital admission, or Bishop scores reaching a certain level at given time points, are not straightforward to interpret. Such outcomes may not give any clear idea of when birth will occur, whether more rapid cervical dilatation is predictive of a more rapid labour, or whether the birth will be more or less likely to be normal. </p> </section> <section id="CD007701-sec-0192"> <h4 class="title">Cost</h4> <p>Health service providers may also assume that transferring care to community or outpatient settings may reduce the total costs of care; we have no evidence to support this assumption. In the absence of formal economic evaluation, descriptive information on the total length of hospital stay for mothers and babies receiving active or placebo interventions may have been helpful in understanding the impact of outpatient procedures on health service utilisation. Such information was generally not provided. Instead, studies tended to focus on proxy measures for progress in labour, but we would advise caution in the way such information is collected and interpreted. </p> <p>It is possible that different induction agents perform quite differently at different stages of cervical dilatation or at different gestational ages. Most included studies recruited women requiring induction for 'postdates pregnancy'. In different studies 'postdates' was defined differently, and may have been any gestational age between approximately 39 to 44 weeks; in some studies women were recruited from 37 weeks. The cervical status at recruitment also varied considerably with Bishop scores at recruitment being any value less than nine. One of the included studies recruited women with diabetes; there is insufficient evidence to know whether outpatient induction is safe and acceptable for women in high‐risk groups. </p> <p>With one or two exceptions, information on costs to women was generally not reported in the included trials. In the absence of such data the assumption must be that women were not asked for their views on care, or about costs or inconvenience associated with hospital or outpatient care. The potential importance of such outcomes (patient‐related outcome measures) is increasingly being recognised by commissioners of healthcare services. </p> </section> </section> <section id="CD007701-sec-0193"> <h3 class="title" id="CD007701-sec-0193">Quality of the evidence</h3> <p>Most included studies were assessed as being at relatively low risk of bias; most of the trials were placebo controlled with adequate methods of randomisation and low levels of attrition. There was no blinding in eight trials where interventions were compared with no intervention or routine care. Lack of blinding may be a particular problem in these studies, as many of the outcomes reported may have depended on clinical judgements by staff (e.g. need for hospital admission, prescription of additional drugs to induce or augment labour, and other interventions in labour). In other words, clinical decisions may have been affected by knowledge of treatment allocation. Summaries of 'Risk of bias' assessments are presented in <a href="#CD007701-fig-0003">Figure 3</a> and <a href="#CD007701-fig-0002">Figure 2</a>. </p> <p>For the comparison of vaginal PGE₂ versus placebo or expectant management for the induction of labour in outpatient settings, we graded evidence for uterine hyperstimulation (fetal heart rate (FHR) changes unclear), caesarean section, and neonatal intensive care unit (NICU) admission as low quality (<a href="./full#CD007701-tbl-0001">summary of findings Table for the main comparison</a>). There was no evidence for vaginal birth not achieved within 24 hours, vaginal birth not achieved in 48 to 72 hours, serious neonatal morbidity or death, or serious maternal morbidity or death. </p> <p>For the comparison of intracervical PGE₂ versus placebo, we graded the evidence for vaginal birth not achieved in 48 to 72 hours, uterine hyperstimulation (with FHR changes), and NICU admission as low quality, and evidence for caesarean section as moderate quality (<a href="./full#CD007701-tbl-0002">summary of findings Table 2</a>). Vaginal birth not achieved within 24 hours, serious neonatal morbidity or death, and serious maternal morbidity or death were not reported. </p> <p>For the comparison of vaginal misoprostol versus placebo, we graded the evidence as low for uterine hyperstimulation (with FHR changes), caesarean section, serious neonatal morbidity or death, and NICU admission (<a href="./full#CD007701-tbl-0003">summary of findings Table 3</a>). Vaginal birth not achieved in 24 hours, vaginal birth not achieved within 48 and 72 hours, and serious maternal morbidity or death were not reported. </p> <p>Evidence across the three comparisons was downgraded for imprecision of effect estimates, few events, and small sample sizes. </p> </section> <section id="CD007701-sec-0194"> <h3 class="title" id="CD007701-sec-0194">Potential biases in the review process</h3> <p>We acknowledge that there was a possibility of introducing bias at every stage of the review process. We attempted to minimise bias in a number of ways; two review authors assessed eligibility for inclusion, carried out data extraction and assessed risk of bias. Each worked independently. Nevertheless, the process of assessing risk of bias, for example, is not an exact science and includes many personal judgements. Further, the process of reviewing research studies is known to be affected by prior beliefs and attitudes. It is difficult to control for this type of bias. </p> <p>While we attempted to be as inclusive as possible in the search strategy, the literature identified was predominantly written in English and published in North American and European journals. We did not attempt to formally assess reporting bias, constraints of time meant that assessment of risk of bias largely relied on information available in the published trial reports and thus, reporting bias was not usually apparent. Too few studies were included in each comparison in the review to allow us to explore possible publication bias. </p> </section> <section id="CD007701-sec-0195"> <h3 class="title" id="CD007701-sec-0195">Agreements and disagreements with other studies or reviews</h3> <p>A number of related Cochrane Reviews have examined the same methods of induction of labour considered in this review, namely: vaginal PGE₂ (<a href="./references#CD007701-bbs2-0092" title="ThomasJ , FaircloughA , KavanaghJ , KellyAJ . Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD003101.pub3] ">Thomas 2014</a>), intracervical PGE₂ (<a href="./references#CD007701-bbs2-0065" title="BoulvainM , KellyAJ , IrionO . Intracervical prostaglandins for induction of labour. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD006971] ">Boulvain 2008</a>), vaginal misoprostol (<a href="./references#CD007701-bbs2-0076" title="HofmeyrGJ , GülmezogluAM , PileggiC . Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD000941.pub2] ">Hofmeyr 2010</a>), oral misoprostol (<a href="./references#CD007701-bbs2-0063" title="AlfirevicZ , AflaifelN , WeeksA . Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD001338.pub3] ">Alfirevic 2014</a>), mifepristone (<a href="./references#CD007701-bbs2-0073" title="HapangamaD , NeilsonJP . Mifepristone for induction of labour. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD002865.pub2] ">Hapangama 2009</a>), oestrogens (<a href="./references#CD007701-bbs2-0091" title="ThomasJ , KellyAJ , KavanaghJ . Oestrogens alone or with amniotomy for cervical ripening or induction of labour. Cochrane Database of Systematic Reviews2001, Issue 4. [DOI: 10.1002/14651858.CD003393] ">Thomas 2001</a>), nitric oxide donors (<a href="./references#CD007701-bbs2-0069" title="GhoshA , LatteyKR , KellyAJ . Nitric oxide donors for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2016, Issue 12. [DOI: 10.1002/14651858.CD006901.pub3] ">Ghosh 2016</a>) and acupuncture (<a href="./references#CD007701-bbs2-0090" title="SmithCA , CrowtherCA , GrantSJ . Acupuncture for induction of labour. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD002962.pub3] ">Smith 2013</a>). Compared with these other reviews (which included both hospital (inpatient) and home (outpatient) inductions), the current review contains relatively few studies, and therefore, has insufficient statistical power to demonstrate differences between groups. This is particularly the case for relatively rare outcomes such as uterine rupture, but is also true for more common complications such as uterine hyperstimulation. </p> <p>Evidence from the related Cochrane Reviews is mainly in agreement with the findings of this review. Findings from these reviews indicate that compared with placebo, PGE₂ (vaginal and intracervical) and vaginal and oral misoprostol are effective induction agents in that vaginal birth within 24 hours was more likely for women receiving these agents. There is less evidence regarding the effectiveness of mifepristone, oestrogens, nitric oxide donors (including IMN) and acupuncture. Findings regarding safety suggest that some methods of induction (PGE₂ and vaginal misoprostol) may be associated with an increased risk of uterine hyperstimulation. However, despite the relatively large number of studies included in some of these reviews, even pooled results from studies do not provide strong evidence regarding serious maternal and neonatal morbidity and death; as we have discussed above, with such rare outcomes very large trials are needed to exclude excess risk, or risk must be imputed by examining surrogate outcomes. None of these reviews specifically considered the issue of outpatient induction and we must remain cautious about assuming that methods that appear safe in hospital will achieve the same levels of safety (and indeed effectiveness) in outpatient settings. As we have indicated in this review, related reviews also illustrate that very little attention has been paid to consumer views or the costs of care. </p> <p>Most of the related Cochrane Reviews examined the effectiveness of induction agents compared with placebo. Relatively few studies have examined different methods of induction directly. Where different agents have been compared (e.g. IMN with vaginal PGE₂ (<a href="./references#CD007701-bbs2-0083" title='OsmanI , MacKenzieF , NorrieJ , MurrayHM , GreerIA , NormanJE . The "PRIM" study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. American Journal of Obstetrics and Gynecology2006;194(4):1012‐21. '>Osman 2006</a>)) some agents may have advantages over others, and the safety profile of different agents (and doses) may differ. This may mean that they are more or less suitable for outpatient use. </p> <p>Another Cochrane Review compared the same method of induction in home and hospital settings directly, but this review contained only four trials and was unable to shed much light on issues of either the relative effectiveness, safety or costs associated with outpatient induction (<a href="./references#CD007701-bbs2-0078" title="KellyAJ , AlfirevicZ , GhoshA . Outpatient versus inpatient induction of labour for improving birth outcomes. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD007372.pub3] ">Kelly 2013</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007701-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD007701-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007701-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007701-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 1 Additional induction agents required." data-id="CD007701-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 1 Additional induction agents required. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 2 Epidural." data-id="CD007701-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 2 Epidural. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 3 Uterine hyperstimulation (FHR changes unclear)." data-id="CD007701-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 3 Uterine hyperstimulation (FHR changes unclear). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 4 Caesarean section." data-id="CD007701-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 4 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 5 Apgar score &lt; 7 at 5 minutes." data-id="CD007701-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 5 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 6 NICU admission." data-id="CD007701-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 6 NICU admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 7 Chorioamnionitis." data-id="CD007701-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 7 Chorioamnionitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 8 Indicator of 'progress' in labour ‐ Cervix unchanged at follow up (not pre‐specified)." data-id="CD007701-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 8 Indicator of 'progress' in labour ‐ Cervix unchanged at follow up (not pre‐specified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 9 'Spontaneous labour' within 48 hours." data-id="CD007701-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 9 'Spontaneous labour' within 48 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 10 Indicator of 'progress' in labour ‐ Admitted to hospital for labour." data-id="CD007701-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 10 Indicator of 'progress' in labour ‐ Admitted to hospital for labour. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 11 Time to birth ‐ Gestational age at birth (weeks)." data-id="CD007701-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 11 Time to birth ‐ Gestational age at birth (weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 12 Time to birth ‐ Gestational age on admission (days)." data-id="CD007701-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Intravaginal PGE₂ gel versus placebo or expectant management, Outcome 12 Time to birth ‐ Gestational age on admission (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 1 Additional induction agent required (induction with oxytocin or other means)." data-id="CD007701-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 1 Additional induction agent required (induction with oxytocin or other means). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 2 Additional induction agents required (further prostaglandin required)." data-id="CD007701-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 2 Additional induction agents required (further prostaglandin required). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 3 Uterine rupture." data-id="CD007701-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 3 Uterine rupture.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 4 Birth not achieved in 48 to 72 hours." data-id="CD007701-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 4 Birth not achieved in 48 to 72 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 5 Oxytocin augmentation." data-id="CD007701-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 5 Oxytocin augmentation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 6 Uterine hyperstimulation (with FHR changes)." data-id="CD007701-fig-0021" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 6 Uterine hyperstimulation (with FHR changes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 7 Assisted (instrumental) vaginal birth." data-id="CD007701-fig-0022" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 7 Assisted (instrumental) vaginal birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 8 Caesarean section." data-id="CD007701-fig-0023" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 8 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 9 Apgar score &lt; 7 at 5 minutes." data-id="CD007701-fig-0024" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 9 Apgar score &lt; 7 at 5 minutes.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 10 NICU admission." data-id="CD007701-fig-0025" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 10 NICU admission.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 11 Postpartum haemorrhage (&gt; 500 mL)." data-id="CD007701-fig-0026" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 11 Postpartum haemorrhage (&gt; 500 mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 12 Chorioamnionitis." data-id="CD007701-fig-0027" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 12 Chorioamnionitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 13 Endometritis." data-id="CD007701-fig-0028" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 13 Endometritis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 14 Side effects ‐ Maternal side effects." data-id="CD007701-fig-0029" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 14 Side effects ‐ Maternal side effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 15 Time to birth ‐ Interval from intervention to birth (days)." data-id="CD007701-fig-0030" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.15</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 15 Time to birth ‐ Interval from intervention to birth (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 16 Time to birth ‐ Gestational age at birth (weeks)." data-id="CD007701-fig-0031" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.16</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 16 Time to birth ‐ Gestational age at birth (weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 17 Indicator of 'progress' in labour ‐ Induction for gestational age &gt; 42 weeks." data-id="CD007701-fig-0032" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.17</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 17 Indicator of 'progress' in labour ‐ Induction for gestational age &gt; 42 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-002-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-002-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intracervical PGE₂ versus placebo, Outcome 18 Time to birth ‐ Birth within 48 hours of treatment (all births)." data-id="CD007701-fig-0033" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.18</div> <div class="figure-caption"> <p>Comparison 2 Intracervical PGE₂ versus placebo, Outcome 18 Time to birth ‐ Birth within 48 hours of treatment (all births). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-002-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 1 Serious neonatal morbidity or death." data-id="CD007701-fig-0034" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 1 Serious neonatal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 2 Epidural." data-id="CD007701-fig-0035" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 2 Epidural.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 3 Uterine hyperstimulation (with FHR changes)." data-id="CD007701-fig-0036" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 3 Uterine hyperstimulation (with FHR changes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 4 Uterine hyperstimulation (without FHR changes)." data-id="CD007701-fig-0037" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 4 Uterine hyperstimulation (without FHR changes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 5 Assisted (instrumental) vaginal birth." data-id="CD007701-fig-0038" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 5 Assisted (instrumental) vaginal birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 6 Caesarean section." data-id="CD007701-fig-0039" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 6 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD007701-fig-0040" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 7 Apgar score &lt; 7 at 5 minutes.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 8 NICU admission." data-id="CD007701-fig-0041" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 8 NICU admission.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 9 Perinatal death." data-id="CD007701-fig-0042" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 9 Perinatal death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 10 Neonatal infection." data-id="CD007701-fig-0043" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 10 Neonatal infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 11 Indicator of 'progress' in labour ‐ Oxytocin dose used (mU)." data-id="CD007701-fig-0044" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 11 Indicator of 'progress' in labour ‐ Oxytocin dose used (mU). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 12 Indicator of 'progress' in labour ‐ Number of medication dose." data-id="CD007701-fig-0045" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 12 Indicator of 'progress' in labour ‐ Number of medication dose. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 13 Indicator of 'progress' in labour ‐ Number of women requiring dosing on day 2." data-id="CD007701-fig-0046" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 13 Indicator of 'progress' in labour ‐ Number of women requiring dosing on day 2. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 14 Indicator of 'progress' in labour ‐ Number of women requiring induction on day 3." data-id="CD007701-fig-0047" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 14 Indicator of 'progress' in labour ‐ Number of women requiring induction on day 3. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 15 Indicator of 'progress' in labour ‐ Days to admission (all) (days)." data-id="CD007701-fig-0048" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.15</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 15 Indicator of 'progress' in labour ‐ Days to admission (all) (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 16 Indicator of 'progress' in labour ‐ Days to admission (subgroups by parity) (days)." data-id="CD007701-fig-0049" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.16</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 16 Indicator of 'progress' in labour ‐ Days to admission (subgroups by parity) (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 17 Indicator of 'progress' in labour ‐ Gestational age at labour (weeks)." data-id="CD007701-fig-0050" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.17</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 17 Indicator of 'progress' in labour ‐ Gestational age at labour (weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 18 Indicator of 'progress' in labour ‐ Days to admission (parous) (weeks)." data-id="CD007701-fig-0051" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.18</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 18 Indicator of 'progress' in labour ‐ Days to admission (parous) (weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 19 Indicator of 'progress' in labour ‐ Days to PROM (days)." data-id="CD007701-fig-0052" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.19</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 19 Indicator of 'progress' in labour ‐ Days to PROM (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 20 Time to birth ‐ Interval from intervention to vaginal birth (days)." data-id="CD007701-fig-0053" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.20</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 20 Time to birth ‐ Interval from intervention to vaginal birth (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 21 Time to birth ‐ Days to birth (all) (days)." data-id="CD007701-fig-0054" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.21</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 21 Time to birth ‐ Days to birth (all) (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-003-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-003-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus placebo, Outcome 22 Time to birth ‐ Days to birth (subgroups by parity) (days)." data-id="CD007701-fig-0055" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.22</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus placebo, Outcome 22 Time to birth ‐ Days to birth (subgroups by parity) (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-003-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vaginal misoprostol 25 µg versus 50 µg, Outcome 1 Additional induction agents required (oxytocin)." data-id="CD007701-fig-0056" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Vaginal misoprostol 25 µg versus 50 µg, Outcome 1 Additional induction agents required (oxytocin). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vaginal misoprostol 25 µg versus 50 µg, Outcome 2 Uterine hyperstimulation." data-id="CD007701-fig-0057" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Vaginal misoprostol 25 µg versus 50 µg, Outcome 2 Uterine hyperstimulation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vaginal misoprostol 25 µg versus 50 µg, Outcome 3 Caesarean section." data-id="CD007701-fig-0058" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Vaginal misoprostol 25 µg versus 50 µg, Outcome 3 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vaginal misoprostol 25 µg versus 50 µg, Outcome 4 NICU admission." data-id="CD007701-fig-0059" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Vaginal misoprostol 25 µg versus 50 µg, Outcome 4 NICU admission.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vaginal misoprostol 25 µg versus 50 µg, Outcome 5 Interval from treatment to birth (in days, all births)." data-id="CD007701-fig-0060" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Vaginal misoprostol 25 µg versus 50 µg, Outcome 5 Interval from treatment to birth (in days, all births). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 1 Uterine hyperstimulation (with or without FHR changes)." data-id="CD007701-fig-0061" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 1 Uterine hyperstimulation (with or without FHR changes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 2 Caesarean section." data-id="CD007701-fig-0062" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 2 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 3 Apgar score &lt; 7 after 5 minutes." data-id="CD007701-fig-0063" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 3 Apgar score &lt; 7 after 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 4 Admission to NICU." data-id="CD007701-fig-0064" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 4 Admission to NICU. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 5 Indicator of 'progress' in labour ‐ Interval from administration to admission (hours)." data-id="CD007701-fig-0065" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 5 Indicator of 'progress' in labour ‐ Interval from administration to admission (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 6 Indicator of 'progress' in labour ‐ Labour or SROM during ripening." data-id="CD007701-fig-0066" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 6 Indicator of 'progress' in labour ‐ Labour or SROM during ripening. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 7 Time to birth ‐ Birth within 24 hours." data-id="CD007701-fig-0067" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 7 Time to birth ‐ Birth within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 8 Time to birth ‐ Birth within 48 hours (cumulative)." data-id="CD007701-fig-0068" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Intracervical PGE₂ versus vaginal misoprostol, Outcome 8 Time to birth ‐ Birth within 48 hours (cumulative). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD007701-fig-0069" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 2 Additional induction agents required." data-id="CD007701-fig-0070" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 2 Additional induction agents required. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 3 Oxytocin augmentation." data-id="CD007701-fig-0071" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 3 Oxytocin augmentation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 4 Uterine hyperstimulation (with FHR changes)." data-id="CD007701-fig-0072" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 4 Uterine hyperstimulation (with FHR changes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 5 Uterine hyperstimulation (FHR changes unclear)." data-id="CD007701-fig-0073" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 5 Uterine hyperstimulation (FHR changes unclear). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 6 Instrumental vaginal birth." data-id="CD007701-fig-0074" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 6 Instrumental vaginal birth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 7 Caesarean section." data-id="CD007701-fig-0075" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 7 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 8 Apgar score &lt; 7 at 5 minutes." data-id="CD007701-fig-0076" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 8 Apgar score &lt; 7 at 5 minutes.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 9 Neonatal intensive care unit admission." data-id="CD007701-fig-0077" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 9 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 10 Postpartum haemorrhage." data-id="CD007701-fig-0078" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 10 Postpartum haemorrhage.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 11 Chorioamnionitis." data-id="CD007701-fig-0079" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.11</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 11 Chorioamnionitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 12 Endometritis." data-id="CD007701-fig-0080" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.12</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 12 Endometritis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 13 Indicator of 'progress' in labour ‐ Time from first dose to active labor (hours)." data-id="CD007701-fig-0081" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.13</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 13 Indicator of 'progress' in labour ‐ Time from first dose to active labor (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 14 Time to birth ‐ First dose to birth (hours)." data-id="CD007701-fig-0082" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.14</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 14 Time to birth ‐ First dose to birth (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-006-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-006-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus placebo, Outcome 15 Indicator of 'progress' in labour ‐ Total doses of medication." data-id="CD007701-fig-0083" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.15</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus placebo, Outcome 15 Indicator of 'progress' in labour ‐ Total doses of medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-006-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 1 Additional induction agents required." data-id="CD007701-fig-0084" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 1 Additional induction agents required.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 2 Serious neonatal morbidity or death." data-id="CD007701-fig-0085" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 2 Serious neonatal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 3 Oxytocin augmentation." data-id="CD007701-fig-0086" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 3 Oxytocin augmentation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 4 Epidural." data-id="CD007701-fig-0087" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 4 Epidural.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 5 Assisted (instrumental) vaginal birth." data-id="CD007701-fig-0088" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 5 Assisted (instrumental) vaginal birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 6 Caesarean section." data-id="CD007701-fig-0089" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 6 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD007701-fig-0090" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 7 Apgar score &lt; 7 at 5 minutes.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 8 NICU admission." data-id="CD007701-fig-0091" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.8</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 8 NICU admission.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 9 Perinatal death." data-id="CD007701-fig-0092" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.9</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 9 Perinatal death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 10 Uterine scar separation." data-id="CD007701-fig-0093" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.10</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 10 Uterine scar separation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 11 Chorioamnionitis." data-id="CD007701-fig-0094" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.11</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 11 Chorioamnionitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 12 Indicator of 'progress' in labour ‐ Labour or ripe cervix in 48 hours." data-id="CD007701-fig-0095" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.12</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 12 Indicator of 'progress' in labour ‐ Labour or ripe cervix in 48 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 13 Indicator of 'progress' in labour ‐ Cervix unchanged after 24/48 hours." data-id="CD007701-fig-0096" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.13</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 13 Indicator of 'progress' in labour ‐ Cervix unchanged after 24/48 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 14 Indicator of 'progress' in labour ‐ Spontaneous labour within 72 hours." data-id="CD007701-fig-0097" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.14</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 14 Indicator of 'progress' in labour ‐ Spontaneous labour within 72 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 15 Indicator of 'progress' in labour ‐ Spontaneous labour within 48 hours." data-id="CD007701-fig-0098" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.15</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 15 Indicator of 'progress' in labour ‐ Spontaneous labour within 48 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 16 Indicator of 'progress' in labour ‐ Oxytocin requirements (IU)." data-id="CD007701-fig-0099" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.16</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 16 Indicator of 'progress' in labour ‐ Oxytocin requirements (IU). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-007-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-007-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Mifepristone versus placebo, Outcome 17 Indicator of 'progress' in labour ‐ Interval between day 1 and start of labour (hours)." data-id="CD007701-fig-0100" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.17</div> <div class="figure-caption"> <p>Comparison 7 Mifepristone versus placebo, Outcome 17 Indicator of 'progress' in labour ‐ Interval between day 1 and start of labour (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-007-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Oestrogens versus placebo, Outcome 1 Oxytocin augmentation." data-id="CD007701-fig-0101" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Oestrogens versus placebo, Outcome 1 Oxytocin augmentation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Oestrogens versus placebo, Outcome 2 Assisted (instrumental) vaginal birth." data-id="CD007701-fig-0102" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Oestrogens versus placebo, Outcome 2 Assisted (instrumental) vaginal birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Oestrogens versus placebo, Outcome 3 Caesarean section." data-id="CD007701-fig-0103" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Oestrogens versus placebo, Outcome 3 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Oestrogens versus placebo, Outcome 4 NICU admission." data-id="CD007701-fig-0104" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Oestrogens versus placebo, Outcome 4 NICU admission.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Oestrogens versus placebo, Outcome 5 Chorioamnionitis." data-id="CD007701-fig-0105" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 Oestrogens versus placebo, Outcome 5 Chorioamnionitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-008-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-008-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Oestrogens versus placebo, Outcome 6 Endometritis." data-id="CD007701-fig-0106" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-008-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8 Oestrogens versus placebo, Outcome 6 Endometritis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-008-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 1 Vaginal birth not achieved in 24/48 hours." data-id="CD007701-fig-0107" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 1 Vaginal birth not achieved in 24/48 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 2 Additional induction agents required." data-id="CD007701-fig-0108" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 2 Additional induction agents required. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 3 Maternal satisfaction." data-id="CD007701-fig-0109" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 3 Maternal satisfaction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 4 Maternal satisfaction." data-id="CD007701-fig-0110" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 4 Maternal satisfaction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 5 Perinatal death." data-id="CD007701-fig-0111" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 5 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 6 Neonatal trauma (long bone fracture, collarbone fracture, basal skull fracture, brachial plexus palsy, facial nerve palsy, phrenic nerve palsy, or subdural haemorrhage)." data-id="CD007701-fig-0112" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 6 Neonatal trauma (long bone fracture, collarbone fracture, basal skull fracture, brachial plexus palsy, facial nerve palsy, phrenic nerve palsy, or subdural haemorrhage). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 7 Neonatal convulsions in the first 24 hours." data-id="CD007701-fig-0113" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.7</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 7 Neonatal convulsions in the first 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 8 Tracheal ventilation &gt; 24 hours." data-id="CD007701-fig-0114" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.8</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 8 Tracheal ventilation &gt; 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 9 Neonatal ICU admission for 5 or more days." data-id="CD007701-fig-0115" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.9</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 9 Neonatal ICU admission for 5 or more days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 10 Neonatal transfer." data-id="CD007701-fig-0116" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.10</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 10 Neonatal transfer. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 11 Maternal death." data-id="CD007701-fig-0117" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.11</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 11 Maternal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 12 Severe postpartum haemorrhage." data-id="CD007701-fig-0118" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.12</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 12 Severe postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 13 Deep vein thrombosis." data-id="CD007701-fig-0119" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.13</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 13 Deep vein thrombosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 14 Oxytocin augmentation." data-id="CD007701-fig-0120" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.14</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 14 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 15 Epidural." data-id="CD007701-fig-0121" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.15</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 15 Epidural.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0122"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 16 Uterine hyperstimulation (with FHR changes)." data-id="CD007701-fig-0122" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.16</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 16 Uterine hyperstimulation (with FHR changes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0122">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0123"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 17 Uterine hyperstimulation (FHR changes unclear)." data-id="CD007701-fig-0123" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.17</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 17 Uterine hyperstimulation (FHR changes unclear). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0123">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0124"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 18 Assisted (instrumental) vaginal birth." data-id="CD007701-fig-0124" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.18</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 18 Assisted (instrumental) vaginal birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0124">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0125"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 19 Caesarean section." data-id="CD007701-fig-0125" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.19</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 19 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0125">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0126"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 20 Apgar score &lt; 7 at 5 minutes." data-id="CD007701-fig-0126" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.20</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 20 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0126">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0127"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 21 NICU (or SCBU) admission." data-id="CD007701-fig-0127" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.21</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 21 NICU (or SCBU) admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0127">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0128"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 22 Postpartum haemorrhage (&gt; 500 mL)." data-id="CD007701-fig-0128" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.22</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 22 Postpartum haemorrhage (&gt; 500 mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0128">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0129"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 23 Neonatal infection." data-id="CD007701-fig-0129" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.23</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 23 Neonatal infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0129">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0130"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 24 Side effects ‐ Maternal side effect ‐ nausea." data-id="CD007701-fig-0130" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.24</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 24 Side effects ‐ Maternal side effect ‐ nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0130">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0131"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 25 Side effects ‐ Maternal side effect ‐ headache." data-id="CD007701-fig-0131" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.25</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 25 Side effects ‐ Maternal side effect ‐ headache. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0131">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0132"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 26 Side effects ‐ Maternal side effects ‐ severe headache." data-id="CD007701-fig-0132" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.26</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 26 Side effects ‐ Maternal side effects ‐ severe headache. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0132">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0133"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 27 Indicator of 'progress' in labour ‐ Admitted in established labour within 24 hours." data-id="CD007701-fig-0133" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.27</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 27 Indicator of 'progress' in labour ‐ Admitted in established labour within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0133">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0134"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 28 Indicator of 'progress' in labour ‐ Bishop score &gt; 6 or active labour at 36 hours." data-id="CD007701-fig-0134" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.28</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 28 Indicator of 'progress' in labour ‐ Bishop score &gt; 6 or active labour at 36 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0134">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0135"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 29 Time to birth ‐ Time in hours from admission to birth (all women)." data-id="CD007701-fig-0135" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.29</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 29 Time to birth ‐ Time in hours from admission to birth (all women). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0135">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0136"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 30 Indicator of 'progress' in labour ‐ Bishop score on admission after treatment." data-id="CD007701-fig-0136" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.30</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 30 Indicator of 'progress' in labour ‐ Bishop score on admission after treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0136">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0137"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 31 Indicator of 'progress' in labour ‐ Change in Bishop score." data-id="CD007701-fig-0137" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.31</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 31 Indicator of 'progress' in labour ‐ Change in Bishop score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0137">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0138"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 32 Time to birth ‐ Interval from onset of labour to birth (hours)." data-id="CD007701-fig-0138" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.32</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 32 Time to birth ‐ Interval from onset of labour to birth (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0138">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0139"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 33 Indicator of 'progress' in labour ‐ Cervix unchanged after 48 hours." data-id="CD007701-fig-0139" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.33</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 33 Indicator of 'progress' in labour ‐ Cervix unchanged after 48 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0139">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0140"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 34 Time to birth ‐ Interval from admission to vaginal birth (hours)." data-id="CD007701-fig-0140" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.34</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 34 Time to birth ‐ Interval from admission to vaginal birth (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0140">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0141"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-009-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-009-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 35 Total cost of care package (GBP)." data-id="CD007701-fig-0141" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.35</div> <div class="figure-caption"> <p>Comparison 9 Vaginal isosorbide mononitrate (IMN) versus placebo, Outcome 35 Total cost of care package (GBP). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0141">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-009-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0142"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Acupuncture versus routine care, Outcome 1 Additional induction agents required." data-id="CD007701-fig-0142" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Acupuncture versus routine care, Outcome 1 Additional induction agents required. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0142">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0143"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Acupuncture versus routine care, Outcome 2 Caesarean section." data-id="CD007701-fig-0143" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Acupuncture versus routine care, Outcome 2 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0143">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0144"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 1 Maternal satisfaction ‐ I look back positively on the treatment I received." data-id="CD007701-fig-0144" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 1 Maternal satisfaction ‐ I look back positively on the treatment I received. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0144">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0145"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 2 Maternal satisfaction ‐ In retrospect, I would have preferred another treatment than received." data-id="CD007701-fig-0145" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 2 Maternal satisfaction ‐ In retrospect, I would have preferred another treatment than received. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0145">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0146"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-011-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-011-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 3 Augmentation, induction or both." data-id="CD007701-fig-0146" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 3 Augmentation, induction or both. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0146">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0147"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-011-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-011-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 4 Epidural, opioids or both for pain relief." data-id="CD007701-fig-0147" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 4 Epidural, opioids or both for pain relief. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0147">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0148"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-011-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-011-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 5 Instrumental vaginal birth." data-id="CD007701-fig-0148" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.5</div> <div class="figure-caption"> <p>Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 5 Instrumental vaginal birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0148">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0149"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-011-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-011-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 6 Caesarean section." data-id="CD007701-fig-0149" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.6</div> <div class="figure-caption"> <p>Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 6 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0149">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0150"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-011-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-011-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 7 Apgar &lt; 7 at 5 minutes." data-id="CD007701-fig-0150" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.7</div> <div class="figure-caption"> <p>Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 7 Apgar &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0150">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0151"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-011-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-011-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 8 Neonatal intensive care unit admission." data-id="CD007701-fig-0151" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.8</div> <div class="figure-caption"> <p>Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 8 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0151">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007701-fig-0152"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/urn:x-wiley:14651858:media:CD007701:CD007701-CMP-011-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_t/tCD007701-CMP-011-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 9 Duration of birth (hours)." data-id="CD007701-fig-0152" src="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.9</div> <div class="figure-caption"> <p>Comparison 11 Outpatient amniotomy for induction versus routine care, Outcome 9 Duration of birth (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-fig-0152">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/media/CDSR/CD007701/image_n/nCD007701-CMP-011-09.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007701-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vaginal PGE₂ compared to placebo or expectant management for the induction of labour in outpatient settings</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal PGE₂ compared to placebo or expectant management for the induction of labour in outpatient settings</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women requiring term labour induction<br/> <b>Setting:</b> outpatient clinics and hospitals in the USA<br/> <b>Intervention:</b> vaginal PGE₂<br/> <b>Comparison:</b> placebo or expectant management </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo or expectant management</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intravaginal PGE₂ gel</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal birth not achieved within 24 h</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Vaginal birth not achieved in 48 to 72 h</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>see comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Uterine hyperstimulation (fetal heart rate changes unclear)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.76<br/> (0.64 to 22.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>244<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were no events in the control group and so it was not possible to calculate the anticipated absolute effects. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.80<br/> (0.49 to 1.31) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>288<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>196 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>157 per 1000<br/> (96 to 257) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious neonatal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious maternal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Neonatal intensive care unit admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.32<br/> (0.10 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>230<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>93 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>30 per 1000<br/> (9 to 96) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Wide confidence interval crossing the line of no effect, few events and small sample size (‐2). </p> <p><sup>2</sup> Wide confidence interval crossing the line of no effect and small sample size (‐2). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vaginal PGE₂ compared to placebo or expectant management for the induction of labour in outpatient settings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007701-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intracervical PGE₂ compared to placebo for the induction of labour in outpatient settings</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intracervical PGE₂ compared to placebo for the induction of labour in outpatient settings</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women requiring induction of labour<br/> <b>Setting:</b> outpatient clinics and hospitals in the USA<br/> <b>Intervention:</b> intracervical PGE₂<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intracervical PGE₂</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal birth not achieved within 24 h</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal birth not achieved in 48 to 72 h</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.83<br/> (0.68 to 1.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>43<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>830 per 1000<br/> (680 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Uterine hyperstimulation (with fetal heart rate changes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.66<br/> (0.63 to 11.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>488<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000<br/> (3 to 45) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.90<br/> (0.72 to 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>674<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>310 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>279 per 1000<br/> (223 to 347) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious neonatal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious maternal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Neonatal intensive care unit admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.61<br/> (0.43 to 6.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>215<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>44 per 1000<br/> (12 to 167) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Wide confidence interval crossing the line of no effect, few events and small sample size (‐2). </p> <p><sup>2</sup> Wide confidence interval crossing the line of no effect (‐1). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intracervical PGE₂ compared to placebo for the induction of labour in outpatient settings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007701-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Vaginal misoprostol compared to placebo for the induction of labour in outpatient settings</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal misoprostol compared to placebo for the induction of labour in outpatient settings</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women requiring induction of labour<br/> <b>Setting:</b> outpatient clinics and hospitals in the USA and Nigeria<br/> <b>Intervention:</b> Vaginal misoprostol<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with vaginal misoprostol</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal birth not achieved within 24 h</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal birth not achieved within 48 and 72 h</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Uterine hyperstimulation (with fetal heart rate changes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.97<br/> (0.43 to 9.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>265<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000<br/> (6 to 131) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.94<br/> (0.61 to 1.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>325<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>206 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>194 per 1000<br/> (126 to 301) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious neonatal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.34<br/> (0.01 to 8.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Study reported perinatal deaths.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>26 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/> (0 to 209) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious maternal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No included trial reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Neonatal intensive care unit admission</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.89<br/> (0.54 to 1.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>325<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>147 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>131 per 1000<br/> (79 to 216) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Wide confidence interval crossing the line of no effect, few events and small sample size (‐2). </p> <p><sup>2</sup> Wide confidence interval crossing the line of no effect and small sample size (‐2). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Vaginal misoprostol compared to placebo for the induction of labour in outpatient settings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007701-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Uterine hyperstimulation with outpatient inductions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Uterine hyperstimulation</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>PGE₂(vaginal)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0013" title="HageP , ShawJ , ZarouD , FleisherJ , WehbehH . Double blind randomized trial to evaluate the role of outpatient use of PGE2 in cervical ripening. American Journal of Obstetrics and Gynecology1993;168(1 Part 2):430. ">Hage 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/18 PGE group (FHR status unknown),  0/18 in placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0025" title="NewmanM , NewmanR . Multiple‐dose PGE2 cervical ripening on an outpatient basis: safety and efficacy. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S112. ">Newman 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/28 PGE group (FHR status unknown), 0/30 in control group (no treatment)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0026" title="O'BrienJM , MercerB , ClearyN , SibaiBM . Efficacy of outpatient induction with low dose intravaginal prostaglandin E2: A randomized, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;172:424. O'BrienJM , MercerBM , ClearyNT , SibaiBM . Efficacy of outpatient induction with low‐dose intravaginal prostaglandin E2: A randomized, double blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;173(6):1855‐9. ">O'Brien 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/50 PGE group (normal FHR), 0/50 in placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>4/96 PGE,  0/98 in control group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>PGE₂(intracervical)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0005" title="ButtinoLTJr , GariteTJ . Intracervical prostaglandin in postdate pregnancy. A randomized trial. Journal of Reproductive Medicine1990;35(2):155‐8. ">Buttino 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/23 PGE group (with FHR decelerations), 0/20 in placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/43 PGE group, 1/47 placebo group with FHR deceleration in both</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/30 PGE group (fetal bradycardia), 0/31 placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/143 PGE group, 0/151 control (no treatment) with hyperstimulation</p> <p>11/143 FHR decelerations in PGE group, 12/151 in control</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5/239 PGE, 1/249 control with hyperstimulation</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Intravaginal misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0034" title="StitelyML , BrowningJ , FowlerM , GendronRT , GhermanRB . Outpatient cervical ripening with intravaginal misoprostol. Obstetrics and Gynecology2000;96(5 Pt 1):684‐8. ">Stitely 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/27 misoprostol group with FHR deceleration, 2/33 placebo group</p> <p>1/27 misoprostol with tachysystole without FHR changes, 0/33 placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0015" title="IncerpiM , FassettM , KjosS , TranS , WingD . Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S120. IncerpiMH , FassettMJ , KjosSL , TranSH , WingDA . Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology2001;185(4):916‐9. ">Incerpi 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/57 misoprostol with hyperstimulation (FHR unknown), 2/63 placebo group</p> <p>2/57 misoprostol with hypertonus, 5/57 misoprostol with tachysystole, none control</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0023" title="McKennaDS , EsterJB , ProffittM , WaddellKR . Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial. Obstetrics and Gynecology2004;104(3):579‐84. ">McKenna 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/33 misoprostol (FHR deceleration), 0/35 placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Oral misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0020" title="LyonsC , RumneyP , HuangW , MorrisonE , ThomasS , NageotteM , et al. Outpatient cervical ripening with oral misoprostol post‐term: induction rates decreased. American Journal of Obstetrics and Gynecology2001;184(1):S116. ">Lyons 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/18 misoprostol, 2/22 placebo group (FHR unknown) with hyperstimulation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0008" title="GaffaneyCA , SaulLL , RumneyPJ , MorrisonEH , ThomasS , NageotteMP , et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. American Journal of Perinatology2009;26(9):673‐7. ">Gaffaney 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8/43 misoprostol, 4/44 placebo group hyperstimulation syndrome (tachysystole or hypertonus, with FHR changes) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>9/61 misoprostol, 6/66 placebo group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Mifepristone</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0010" title="GiacalonePL , TargoszV , LaffargueF , BoogG , FaureJM . Cervical ripening with mifepristone before labor induction: a randomized study. Obstetrics and Gynecology1998;92(4 Pt 1):487‐92. ">Giacalone 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/41 mifepristone group, 0/42 placebo group with hypertonia (FHR unknown)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0018" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101(6):501‐3. ">Lelaidier 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/16 in both groups</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>4/57 mifepristone, 0/58 placebo with hypertonia</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> IMN</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0012" title="HabibSM , EmamSS , SaberAS . Outpatient cervical ripening with nitric oxide donor isosorbide mononitrate prior to induction of labor. International Journal of Gynaecology and Obstetrics2008;101(1):57‐61. ">Habib 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/51 IMN group, 2/51 placebo group with hyperstimulation (abnormal FHR)</p> <p>1/51 IMN, 8/51 placebo group with tachysystolia (FHR normal)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/100 IMN group, 5/100 placebo group with hyperstimulation (FHR changes unclear)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>1/151 IMN group, 15/151 placebo group (hyperstimulation or tachysystolia,</b> ±<b>FHR changes)</b> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>IMN: isosorbide mononitrate; FHR: fetal heart rate</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Uterine hyperstimulation with outpatient inductions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007701-tbl-0005"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Neonatal complications following induction in outpatient setting</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Neonatal complications</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>PGE₂vaginal</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0030" title="SawaiSK , WilliamsMC , O'BrienWF , AngelJL , MastrogiannisDS , JohnsonL . Sequential outpatient application of intravaginal prostaglandin E2 gel in the management of postdates pregnancies. Obstetrics and Gynecology1991;78(1):19‐23. WilliamsMG , O'BrienWF , SawaiSK , KnuppelRA . Outpatient cervical ripening in the postdates pregnancy. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 Jan 23‐27; Houston, Texas, USA. 1990:533. ">Sawai 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/24 in PGE₂ group; 2/26 in placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0031" title="SawaiSK , O'BrienWF , MastrogiannisDS , KrammerJ , MastryMG , PorterGW . Patient‐administered outpatient intravaginal prostaglandin E2 suppositories in post‐date pregnancies: a double‐blind, randomized, placebo‐controlled study. Obstetrics and Gynecology1994;84(5):807‐10. SawaiSK , O'BrienWF , MastrogiannisMS , MastryMG , PorterGW , JohnsonL . Outpatient prostaglandin E2 suppositories in postdates pregnancies. American Journal of Obstetrics and Gynecology1992;166(1 Pt 2):400. ">Sawai 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/38 in PGE₂;  4/42 in placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0026" title="O'BrienJM , MercerB , ClearyN , SibaiBM . Efficacy of outpatient induction with low dose intravaginal prostaglandin E2: A randomized, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;172:424. O'BrienJM , MercerBM , ClearyNT , SibaiBM . Efficacy of outpatient induction with low‐dose intravaginal prostaglandin E2: A randomized, double blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology1995;173(6):1855‐9. ">O'Brien 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/50 in PGE₂;  5/50 in placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>3/112 PGE, 11/118 control to NICU</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>PGE₂intracervical</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6/41 PGE group, 8/43 placebo group with complication such as tachypnoea, meconium aspiration, meconium or admission to NICU </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0021" title="MagannE , ChauhanSP , NevilsBG , McNamaraMF , KinsellaMJ , MorrisonJC . Management of pregnancies beyond forty‐one weeks' gestation with an unfavorable cervix. American Journal of Obstetrics and Gynecology1998;178(6):1279‐87. ">Magann 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/35 PGE₂ versus 0/35 control NICU admission</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/30 PGE, 2/31 placebo group with complication</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>10/106 PGE, 10/109 controls with neonatal complications/admitted to NICU</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> Vaginal misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0034" title="StitelyML , BrowningJ , FowlerM , GendronRT , GhermanRB . Outpatient cervical ripening with intravaginal misoprostol. Obstetrics and Gynecology2000;96(5 Pt 1):684‐8. ">Stitely 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/27 misoprostol, 3/33 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0015" title="IncerpiM , FassettM , KjosS , TranS , WingD . Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S120. IncerpiMH , FassettMJ , KjosSL , TranSH , WingDA . Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology2001;185(4):916‐9. ">Incerpi 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18/57 misoprostol, 20/63 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0023" title="McKennaDS , EsterJB , ProffittM , WaddellKR . Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial. Obstetrics and Gynecology2004;104(3):579‐84. ">McKenna 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/33 misoprostol, 1/35 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0027" title="OboroVO , TaboweiTO . Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post‐term pregnancy. Acta Obstetricia et Gynecologica Scandinavica2005;84(7):628‐31. ">Oboro 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/38 misoprostol, 1/39 control (no treatment) to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0008" title="GaffaneyCA , SaulLL , RumneyPJ , MorrisonEH , ThomasS , NageotteMP , et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. American Journal of Perinatology2009;26(9):673‐7. ">Gaffaney 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/43 misoprostol, 1/44 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>21/198 misoprostol, 26/214 control to NICU</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> Misoprostol 25 µg versus 50 µg</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0016" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynaecology and Obstetrics2005;88(2):108‐11. ">Kipikasa 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1/23 25</b> µ<b>g, 2/26 50</b> µ<b>g misoprostol to NICU</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> Intracervical PGE₂versus intravaginal misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0024" title="MeyerM , PflumJ . Outpatient administration of misoprostol decreases induction time. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S167. MeyerM , PflumJ , HowardD . Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial. Obstetrics and Gynecology2005;105(3):466‐72. ">Meyer 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>5/42 PGE, 4/42 misoprostol to NICU</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> Mifepristone</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0006" title="ElliotCL , BrennandJE , CalderAA . The effect of mifepristone (RU486) on cervical ripening and induction of labour in human pregnancy. 27th British Congress of Obstetrics and Gynaecology; 1995 July 4‐7; Dublin, Ireland. 1995:207. ElliottCL , BrennandJE , CalderAA . The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstetrics and Gynecology1998;92(5):804‐9. ">Elliott 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/50 mifepristone, 1/30 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0010" title="GiacalonePL , TargoszV , LaffargueF , BoogG , FaureJM . Cervical ripening with mifepristone before labor induction: a randomized study. Obstetrics and Gynecology1998;92(4 Pt 1):487‐92. ">Giacalone 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/41 mifepristone, 4/42 control to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>5/91 mifepristone, 5/72 control to NICU</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> IMN</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18/177 IMN, 16/173 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0004" title="BullarboM , OrrskogME , AnderschB , GranströmL , NorströmA , EkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196(1):50.e1‐5. ">Bullarbo 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13/100 IMN, 9/100 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0012" title="HabibSM , EmamSS , SaberAS . Outpatient cervical ripening with nitric oxide donor isosorbide mononitrate prior to induction of labor. International Journal of Gynaecology and Obstetrics2008;101(1):57‐61. ">Habib 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/51 IMN, 1/51 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/100 IMN, 14/100 placebo group to nursery admission</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0009" title="GhanaieMM , MirbloukF , GodarziR , ShakibaM . Effect of outpatient isorbide mononitrate on success of labor induction. Journal of Babol University of Medical Sciences2013;15(2):12‐7. ">Ghanaie 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/36 IMN, 0/36 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0002" title="AttanayakeK , GoonewardeneM . Outpatient cervical ripening with vaginal isosorbide mononitrate in uncomplicated singleton pregnancies at 39 weeks gestation: A double blind randomized controlled trial. Sri Lanka Journal of Obstetrics and Gynaecology2014;36(Suppl 1):28, Abstract no: FC 10.5. ">Attanayake 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/72 IMN, 1/72 placebo group to NICU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>37/536 IMN, 41/532 placebo group to NICU</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> Outpatient amniotomy for induction versus routine care</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27/270 IMN, 23/251 placebo group to NICU</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>NICU: neonatal intensive‐care unit</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Neonatal complications following induction in outpatient setting</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007701-tbl-0006"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Maternal complications following induction of labour in outpatient setting</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Maternal complications</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Intracervical PGE₂</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0017" title="LarmonJE , MagannEF , DickersonGA , MorrisonJC . Outpatient cervical ripening with prostaglandin E2 and estradiol. Journal of Maternal‐Fetal and Neonatal Medicine2002;11(2):113‐7. ">Larmon 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/41 PGE, 10/43 placebo group with complication such as endometritis, chorioamnionitis and pre‐eclampsia </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0019" title="LienJM , MorganMA , GariteTJ , KennedyKA , SassoonDA , FreemanRK . Antepartum cervical ripening: applying prostaglandin e2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. American Journal of Obstetrics and Gynecology1998;179(2):453‐8. ">Lien 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6/43 PGE, 3/47 placebo group with complication such as endometritis and chorioamnionitis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0022" title="McKennaDS , CostaSW , SamuelsP . Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstetrics and Gynecology1999;94(1):11‐4. ">McKenna 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/30 PGE with PPH, 0/31 placebo group</p> <p>2/30 PGE, 2/31 placebo group with infection</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0028" title="RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics and Gynecology1999;94(2):250‐4. ">Rayburn 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8/143 PGE, 7/151 control (no treatment) with endometritis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>21/257</b> PGE₂<b>, 22/272 control with maternal complications</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Oral misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0008" title="GaffaneyCA , SaulLL , RumneyPJ , MorrisonEH , ThomasS , NageotteMP , et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. American Journal of Perinatology2009;26(9):673‐7. ">Gaffaney 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8/43 misoprostol group, 9/44 placebo group with chorioamnionitis</p> <p>1/43 misoprostol group, 2/44 placebo group with endometritis</p> <p>2/43 misoprostol group, 0/44 placebo group with PPH</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>11/43 misoprostol group, 11/44 placebo group with maternal complications</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> IMN</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0003" title="BollapragadaS , MackenzieF , NorrieJ , PetrouS , ReidM , GreerI , et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth2006;6:25. [DOI: 10.1186/1471‐2393‐6‐25] BollapragadaSS , MacKenzieF , NorrieJ , PetrouS , ReidM , GreerIA , et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour ‐ clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22. BollapragadaSS , MacKenzieF , NorrieJD , EddamaO , PetrouS , ReidM , et al. Randomised placebo‐controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour‐clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1185‐95. EddamaO , PetrouS , SchroederL , BollapragadaSS , MackenzieF , NorrieJ , et al. The cost‐effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology2009;116(9):1196‐203. ReidM , LorimerK , NormanJE , BollapragadaSS , NorrieJ . The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery2011;27(1):30‐5. ">Bollapragada 2006a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood loss &gt; 500 mL: 59/177 IMN, 47/173 placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0004" title="BullarboM , OrrskogME , AnderschB , GranströmL , NorströmA , EkerhovdE . Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics and Gynecology2007;196(1):50.e1‐5. ">Bullarbo 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood loss &gt; 1000 mL: 14/100 IMN, 12/100 placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0012" title="HabibSM , EmamSS , SaberAS . Outpatient cervical ripening with nitric oxide donor isosorbide mononitrate prior to induction of labor. International Journal of Gynaecology and Obstetrics2008;101(1):57‐61. ">Habib 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PPH: 2/51 IMN, 3/51 placebo group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0001" title="AgarwalK , BatraA , DabralA , AggarwalA . Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting. International Journal of Gynecology and Obstetrics2012;118(3):205‐9. ">Agarwal 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/100 IMN group, 3/100 placebo group with PPH</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0009" title="GhanaieMM , MirbloukF , GodarziR , ShakibaM . Effect of outpatient isorbide mononitrate on success of labor induction. Journal of Babol University of Medical Sciences2013;15(2):12‐7. ">Ghanaie 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/36 IMN group, 0/36 placebo group with need for blood transfusion</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0032" title="SchmitzT , ClossetE , FuchsF , MaillardF , RozenbergP , AnselemO , et al. Outpatient cervical ripening with nitric oxide (NO) donors for prolonged pregnancy in nullipara: the NOCETER randomized, multicentre, double‐blind, placebo‐controlled trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S19. SchmitzT , FuchsF , ClossetE , RozenbergP , WinerN , PerrotinF , et al. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial. Obstetrics and Gynecology2014;124(6):1089‐97. ">Schmitz 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/678 IMN group, 0/684 placebo group for maternal death</p> <p>124/678 IMN group, 112/684 placebo group for PPH</p> <p>20/678 IMN group, 13/684 placebo group for severe PPH</p> <p>1/678 IMN group, 0/684 placebo group for deep vein thrombosis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>202/1142 IMN group, 204/1148 placebo group with maternal complications</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Outpatient amniotomy</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007701-bbs2-0029" title="ISRCTN47736435 . Costs and effects of amniotomy at home for induction of post term pregnancy. isrctn.com/ISRCTN47736435 (first received 9 January 2006). RijndersMEB . A randomised controlled trial of amniotomy at home for induction between 292 and 294 days gestation. Interventions in Midwife Led Care in the Netherlands to Achieve Optimal Birth Outcomes: Effects and Women's Experiences. Amsterdam: University of Amsterdam, 2011. ">Rijnders 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26/270 amniotomy group, 29/251 routine care group ‐ mother treated with antibiotics</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>PPH: postpartum haemorrhage</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Maternal complications following induction of labour in outpatient setting</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/full#CD007701-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007701-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Intravaginal PGE₂ gel versus placebo or expectant management</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Additional induction agents required <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.27, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Epidural <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.62, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Uterine hyperstimulation (FHR changes unclear) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.76 [0.64, 22.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.49, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.07, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 NICU admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.10, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.15, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Indicator of 'progress' in labour ‐ Cervix unchanged at follow up (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.03, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 'Spontaneous labour' within 48 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.43 [2.12, 19.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Indicator of 'progress' in labour ‐ Admitted to hospital for labour <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.7 [1.47, 4.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Time to birth ‐ Gestational age at birth (weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐0.99, ‐0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Time to birth ‐ Gestational age on admission (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.0 [‐4.17, 0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Intravaginal PGE₂ gel versus placebo or expectant management</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007701-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Intracervical PGE₂ versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Additional induction agent required (induction with oxytocin or other means) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.74, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Additional induction agents required (further prostaglandin required) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.22, 1.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Birth not achieved in 48 to 72 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.68, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.40, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Uterine hyperstimulation (with FHR changes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>488</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.66 [0.63, 11.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Assisted (instrumental) vaginal birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.85, 1.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>674</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.72, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>515</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.42, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 NICU admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>215</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [0.43, 6.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Postpartum haemorrhage (&gt; 500 mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.10 [0.13, 73.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>468</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.03 [0.66, 6.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [0.27, 9.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Side effects ‐ Maternal side effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>384</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.13, 2.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Time to birth ‐ Interval from intervention to birth (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.55, 0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Time to birth ‐ Gestational age at birth (weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.35, 0.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Indicator of 'progress' in labour ‐ Induction for gestational age &gt; 42 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Time to birth ‐ Birth within 48 hours of treatment (all births) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.1 [1.29, 7.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Intracervical PGE₂ versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007701-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Vaginal misoprostol versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serious neonatal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Epidural <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.77, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Uterine hyperstimulation (with FHR changes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.97 [0.43, 9.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Uterine hyperstimulation (without FHR changes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.64 [0.15, 85.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Assisted (instrumental) vaginal birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.50, 1.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.61, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.01, 4.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 NICU admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.54, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Neonatal infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.07, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Indicator of 'progress' in labour ‐ Oxytocin dose used (mU) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1508.70 [‐2357.55, 5374.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Indicator of 'progress' in labour ‐ Number of medication dose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.44 [‐0.49, ‐0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Indicator of 'progress' in labour ‐ Number of women requiring dosing on day 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.43, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Indicator of 'progress' in labour ‐ Number of women requiring induction on day 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.04, 0.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Indicator of 'progress' in labour ‐ Days to admission (all) (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.90 [‐4.99, ‐0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Indicator of 'progress' in labour ‐ Days to admission (subgroups by parity) (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.15 [‐5.40, ‐0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Nulliparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.20 [‐6.44, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 Parous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.10 [‐6.24, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Indicator of 'progress' in labour ‐ Gestational age at labour (weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐1.05, ‐0.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Indicator of 'progress' in labour ‐ Days to admission (parous) (weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.10 [‐6.24, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Indicator of 'progress' in labour ‐ Days to PROM (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.5 [‐4.14, ‐0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Time to birth ‐ Interval from intervention to vaginal birth (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.4 [‐3.51, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Time to birth ‐ Days to birth (all) (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐3.74, ‐0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Time to birth ‐ Days to birth (subgroups by parity) (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Nulliparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.0 [‐5.42, ‐0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 Parous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐3.51, 2.31]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Vaginal misoprostol versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007701-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Vaginal misoprostol 25 µg versus 50 µg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Additional induction agents required (oxytocin) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.26 [0.22, 23.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.33, 2.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 NICU admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.05, 5.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Interval from treatment to birth (in days, all births) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [1.19, 1.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Vaginal misoprostol 25 µg versus 50 µg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007701-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Intracervical PGE₂ versus vaginal misoprostol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation (with or without FHR changes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.03, 2.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.38, 2.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Apgar score &lt; 7 after 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Admission to NICU <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.36, 4.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Indicator of 'progress' in labour ‐ Interval from administration to admission (hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.5 [2.22, 2.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Indicator of 'progress' in labour ‐ Labour or SROM during ripening <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.14, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Time to birth ‐ Birth within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.75, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Time to birth ‐ Birth within 48 hours (cumulative) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.81, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Intracervical PGE₂ versus vaginal misoprostol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007701-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Oral misoprostol versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.48, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Additional induction agents required <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.37, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.61, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Uterine hyperstimulation (with FHR changes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [0.47, 5.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Uterine hyperstimulation (FHR changes unclear) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.06, 6.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Instrumental vaginal birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.17, 1.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.28, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.07, 15.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.11 [0.25, 103.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.52, 2.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.05, 5.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Indicator of 'progress' in labour ‐ Time from first dose to active labor (hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐37.08 [‐52.44, ‐21.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Time to birth ‐ First dose to birth (hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐37.94 [‐57.97, ‐17.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Indicator of 'progress' in labour ‐ Total doses of medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.51 [‐0.92, ‐0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Oral misoprostol versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007701-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Mifepristone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Additional induction agents required <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.37, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serious neonatal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.07, 35.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.63, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Epidural <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.73, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Assisted (instrumental) vaginal birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.93, 1.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.62, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.07, 35.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 NICU admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>163</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.31, 2.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Uterine scar separation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.20, 19.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Indicator of 'progress' in labour ‐ Labour or ripe cervix in 48 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [1.00, 4.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Indicator of 'progress' in labour ‐ Cervix unchanged after 24/48 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.20, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Indicator of 'progress' in labour ‐ Spontaneous labour within 72 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.68, 3.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Indicator of 'progress' in labour ‐ Spontaneous labour within 48 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.05 [1.27, 3.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Indicator of 'progress' in labour ‐ Oxytocin requirements (IU) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.56 [‐4.01, ‐1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Indicator of 'progress' in labour ‐ Interval between day 1 and start of labour (hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐22.15 [‐35.96, ‐8.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Mifepristone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007701-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Oestrogens versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.61, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Assisted (instrumental) vaginal birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.44, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.63, 2.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 NICU admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.06, 15.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.95 [0.38, 10.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.93 [0.32, 27.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Oestrogens versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007701-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Vaginal isosorbide mononitrate (IMN) versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal birth not achieved in 24/48 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.83, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Additional induction agents required <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1921</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.75, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Maternal satisfaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 How do you think your labour went? (easy/very difficult)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.34 [‐0.94, 0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 What do you think about home treatment? (extremely good/not at all good)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.03, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 How painful was the treatment at home? (not at all/very)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [‐0.00, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 How anxious were you being at home taking the treatment? (not at all/very)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.39, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 Would you have the same treatment at home again? (definitely/definitely not)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [‐0.02, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6 Would you advise a friend to have the same treatment at home? (definitely/definitely not) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [‐0.17, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Maternal satisfaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Felt satisfied (very or extremely)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1049</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.67, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Would recommend the same treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1049</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.77, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Would recommend procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.94, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1712</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [0.08, 33.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Neonatal trauma (long bone fracture, collarbone fracture, basal skull fracture, brachial plexus palsy, facial nerve palsy, phrenic nerve palsy, or subdural haemorrhage) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.19, 2.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Neonatal convulsions in the first 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Tracheal ventilation &gt; 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.14, 7.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Neonatal ICU admission for 5 or more days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.19, 2.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Neonatal transfer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.67, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Maternal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Severe postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [0.78, 3.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Deep vein thrombosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.03 [0.12, 74.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1816</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.78, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Epidural <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.82, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Uterine hyperstimulation (with FHR changes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Uterine hyperstimulation (FHR changes unclear) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Assisted (instrumental) vaginal birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1712</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.61, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.87, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.44, 1.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 NICU (or SCBU) admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1068</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.59, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Postpartum haemorrhage (&gt; 500 mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.95, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Neonatal infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.26, 3.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Side effects ‐ Maternal side effect ‐ nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1926</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.39 [1.54, 3.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Side effects ‐ Maternal side effect ‐ headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.45 [3.38, 8.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Side effects ‐ Maternal side effects ‐ severe headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>21.21 [2.91, 154.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Indicator of 'progress' in labour ‐ Admitted in established labour within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.75 [1.29, 5.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Indicator of 'progress' in labour ‐ Bishop score &gt; 6 or active labour at 36 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.8 [1.54, 9.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Time to birth ‐ Time in hours from admission to birth (all women) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>374</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.70 [‐6.08, ‐3.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Indicator of 'progress' in labour ‐ Bishop score on admission after treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.73 [2.17, 3.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Indicator of 'progress' in labour ‐ Change in Bishop score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.76 [2.48, 3.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Time to birth ‐ Interval from onset of labour to birth (hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.24 [‐1.82, ‐0.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Indicator of 'progress' in labour ‐ Cervix unchanged after 48 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.70, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Time to birth ‐ Interval from admission to vaginal birth (hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐6.11, 4.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Total cost of care package (GBP) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.98 [‐105.34, 129.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Vaginal isosorbide mononitrate (IMN) versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007701-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Acupuncture versus routine care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Additional induction agents required <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [0.31, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.17, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Acupuncture versus routine care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007701-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Outpatient amniotomy for induction versus routine care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal satisfaction ‐ I look back positively on the treatment I received <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.97, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Maternal satisfaction ‐ In retrospect, I would have preferred another treatment than received <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>472</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.36, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Augmentation, induction or both <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>521</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.71, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Epidural, opioids or both for pain relief <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>521</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.76, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Instrumental vaginal birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>521</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.46, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>521</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.78, 1.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>521</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.86 [0.34, 10.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>521</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.64, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Duration of birth (hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>521</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐0.72, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Outpatient amniotomy for induction versus routine care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007701.pub3/references#CD007701-tbl-0017">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007701.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD007701-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD007701-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007701-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007701-note-0006">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD007701-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD007701-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD007701-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD007701-note-0003">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD007701-note-0007">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD007701-note-0019">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007701\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007701\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007701\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007701\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007701\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6nHUP32m&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007701.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007701.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007701.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007701.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007701.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717702583"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007701.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717702588"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007701.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dbe5b3b7f936b',t:'MTc0MDcxNzcwMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 